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Abstract
Metagenomics can be defined as the study of DNA sequences from environmental
or community samples. This is a rapidly progressing field and application ideas that
seemed outlandish a few years ago are now routine and familiar. Metagenomics’ scope
is broad and includes the analysis of a diverse set of samples such as environmental
or clinical samples. Human tissues are in essence metagenomic samples due to the
presence of microorganisms, such as bacteria, viruses and fungi in both healthy and
diseased individuals.
Deep sequencing of clinical samples is now an established tool for pathogen detec-
tion, with direct medical applications. The large amount of data generated produces an
opportunity to detect species even at very low levels, provided that computational tools
can effectively profile the relevant metagenomic communities. Data interpretation is
complicated by the fact that short sequencing reads can match multiple organisms and
by the lack of completeness of existing databases, particularly for viruses.
The research presented in this thesis focuses on using Bayesian Mixture Model
techniques to produce taxonomic profiles for metagenomic data. A novel Bayesian
mixture model framework for resolving complex metagenomic mixtures is introduced,
called metaMix. The use of parallel Monte Carlo Markov chains (MCMC) for the
exploration of the species space enables the identification of the set of species most
likely to contribute to the mixture. The improved accuracy of metaMix compared to
relevant methods is demonstrated, particularly for profiling complex communities con-
sisting of several related species. metaMix was designed specifically for the analysis
of deep transcriptome sequencing datasets, with a focus on viral pathogen detection.
However, the principles are generally applicable to all types of metagenomic mixtures.
metaMix is implemented as a user friendly R package, freely available on CRAN:
http://cran.r-project.org/web/packages/metaMix.
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Chapter 1
Introduction
During this PhD project, the problem that interested me the most was how to efficiently
perform sensitive community profiling in a metagenomics sample. Differently stated,
this is the fine-grained identification of species present in a metagenomics sample, cou-
pled with the ability to find the “needle in a haystack”.
Community profiling is an active research question and a substantial amount of
work has been produced towards answering it (Huson et al., 2007; Xia et al., 2011;
Segata et al., 2012; Francis et al., 2013; Wood and Salzberg, 2014). While these meth-
ods have been widely used in practice, there are some yet unaddressed limitations. For
example, many methods perform taxonomic assignment for each read individually, ig-
noring the information provided by the rest of the data. Furthermore, more complex
models typically fit the data better and methods that ignore this known problem are des-
tined to infer increasingly complex profiles, exhibiting low specificity by introducing
a significant number of false positives species. Mixture models (McLachlan and Peel,
2000) can help with the first issue, while Bayesian methods (Jeffreys, 1961; Gull, 1988)
address the second. In this PhD project I worked towards developing a new framework
for community profiling by taking a Bayesian mixture model approach. This also pro-
vides a coherent way to estimate the probability of a species being present as well as
the read assignment probability.
To illustrate the context of the thesis I start with setting the terminology for
metagenomic research. I then provide a historical perspective in molecular biology and
the relevant discoveries and advances in technology that make metagnomics research
feasible today. An introductory overview of diagnostics and metagenomic diagnostics
follows and I discuss the ways high throughput sequencing has reshaped it. Subse-
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quently, the community profiling problem is defined and prior relevant methodological
work is discussed, including the most popular approaches. The relevant challenges
and limitations are highlighted. The bioinformatics analysis required as a prior step to
species identification and quantification when dealing with deep sequencing data gen-
erated from human clinical samples is outlined. Finally, the requirement for a Bayesian
mixture model-based solution is emphasized and the ideas underlying the novel pro-
posed method called metaMix are introduced.
1.1 Microbiome definitions and a few words on viruses
For most of earth’s history, life consisted solely of microscopic life forms and micro-
bial life still dominates the planet in many aspects. The collection of microorganisms
that occupy various sites of the human body is called the human microbiota (Marchesi
and Ravel, 2015) and it includes viruses, bacteria and fungi. The definition of the term
microbiome has a convoluted history. My personal preference is to use the word mi-
crobiome to refer to the set of resident microorganisms and associated abiotic factors
of given environments (Marchesi and Ravel, 2015). However the same term has been
used to either describe just the population of microbes that colonise the human body
(Petrosino et al., 2009) or even further limited to define the complete set of genetic in-
formation associated with a set of microorganisms (Matsen, 2015). The latter definition
in my opinion best describes the metagenome. The microbiome can be characterized by
different approaches such as metagenomics (Blomstro¨m et al., 2010; Ng et al., 2011),
metatranscriptomics (Santos et al., 2011) or their combinations. Metagenomics is thus
the genomic study of uncultured microorganisms living in environmental niches, plants
or animal hosts (Chen and Pachter, 2005) while metatranscriptomics is the analysis of
RNA sequence data from such samples.
The launching of international human microbiome projects (such as http://
hmpdacc.org/) highlights the significance of understanding the microbiome. The
metagenomics field has been progressing rapidly and application ideas that seemed
outlandish a few years ago are now routine and familiar. There are many exciting ap-
plications that require the analysis of a diverse set of samples such as gut microbiome
(Qin et al., 2010; Minot et al., 2011), environmental (Mizuno et al., 2013) or clinical
(Willner et al., 2009; Negredo et al., 2011; McMullan et al., 2012) samples.
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Among these applications, the discovery of viral pathogens is relevant for clini-
cal practice (Fancello et al., 2012; Chiu, 2013). Viruses are recognised to be the most
abundant biological entities on the planet (Breitbart and Rohwer, 2005). Descriptions
of viral infections appear throughout human recorded history and long before viruses
were first discovered. Viruses can cause diseases in plants, animals and humans; how-
ever, healthy individuals are also chronically infected by a number of viruses without
any detectable symptoms (Virgin et al., 2009). Viruses and bacteria are known to play a
role in the pathogenesis of various human diseases. Studying the human metagenome is
thus highly relevant to understanding infectious as well as common complex diseases.
The focus of the work undertaken for this thesis and my main interest was to develop a
method for community profiling and read interpretation from metagenomic data, with
a particular focus on viral detection in human clinical samples. The introduction is
therefore built around a viral core and the following sections will cover in greater depth
the virus-related aspects of this work.
1.2 Molecular biology: a historical perspective
Prior to an exploration of the metagenomics field, we provide an overview of the history
of molecular biology to better appreciate the strengths and limitations of the technolog-
ical advances that revolutionised it.
Molecular biology encompasses all research on the structure, function and inter-
actions of biological macromolecules. This includes research on the molecular nature
of the gene and the mechanisms of gene replication, mutation, and expression (Mor-
ange, 2009). Most historians of biology agree that the origins of molecular biology can
be traced before the World War II (Morange, 2009) when different technologies such
as electrophoresis, X-ray crystallography, electron microscopy were introduced. These
resulted in the initial discoveries on the macromolecules structure and paved the way
for seminal research accomplishments.
1.2.1 Classical era of molecular biology
The classical era of molecular biology roughly spans the period between 1940 and
1965, during which the field blossomed. A first discovery of major scientific impor-
tance identified the deoxyribonucleic acid (DNA) as the major constituent of the genes
1.2. Molecular biology: a historical perspective 18
(Hershey and Chase, 1952). The experiment used phage viruses to confirm that the
genetic material transmitted from generation to generation is DNA and not proteins.
One of the most famous advances, still celebrated today, is the discovery of the
double helix structure of DNA composed of four bases (Figure 1.1) by James Watson
and Francis Crick (Watson and Crick, 1953a,b). Watson and Crick presented a model
of the double helical structure of DNA, where the complementary strands are held
together by hydrogen-bonded base pairs. The two collaborators used extensively the
X-ray crystallography work on DNA by Maurice Wilkins and Rosalind Franklin. In
their second article in Nature a month later, Watson and Crick presented DNA as a
genetic information molecule.
Figure 1.1: The DNA double helix structure: complementary bases are held together as a pair
by hydrogen bonds. The figure is taken from (Pray, 2008).
The double helical structure discovery influenced and shifted contemporary re-
search in molecular biology towards understanding the genetic replication and function
mechanisms. The now famous central dogma of molecular biology according to which
information flows from the nucleic acids to the proteins and only in this direction was
proposed a few yeas later by Crick:
“This states that once information has passed into protein it cannot get
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out again. In more detail, the transfer of information from nucleic acid to
nucleic acid, or from nucleic acid to protein may be possible, but trans-
fer from protein to protein, or from protein to nucleic acid is impossible.
Information means here the precise determination of sequence, either of
bases in the nucleic acid or of amino acid residues in the protein.” (Crick,
1958)
Subsequent discoveries challenged the concept of a linear relationship between a
DNA sequence and the produced protein. Findings included the obervation that DNA
consists of coding regions (exons) interspersed with non-coding regions (introns) and
that the exons may be separated by long stretches of non-coding DNA. Additionally,
different exons may be spliced together thus generating a variety of molecular prod-
ucts. Gradually, molecular biologists started to update their understanding of what
constitutes a gene.
1.2.2 Genomic era and landmarks in DNA Sequencing
The first succesful attempt at sequencing took place in the mid 1960s with the character-
isation of the complete sequence and structure of an RNA molecule (Holley et al., 1965)
Potentially the most significant contributions towards sequencing DNA molecules were
by Frederick Sanger who established elegant DNA sequencing techniques in the 1970s.
Sanger sequencing, an enzymatic method using DNA polymerase, was published in
1975 (Sanger and Coulson, 1975). An easier and more efficient chain termination
method that employes fluorescently labeled dideoxynucleotides (ddNTP) for chain ter-
mination was published two years later (Sanger et al., 1977a). The first ever DNA
genome to be fully sequenced was ΦX174 (Sanger et al., 1977b), a bacteriophage
that infects Escherichia coli. Subsequently, the chain terminator method was rapidly
employed and it was the technological platform conventionally used in genomic and
metagenomic studies up until the arrival of high-throughput sequencing.
Two significant developments further advanced the sequencing field in the 1980s.
The first one was the polymerase chain reaction technique or PCR, a DNA amplifi-
cation technique (Mullis and Faloona, 1987; Saiki et al., 1988). PCR is the method
where a nucleic acid sequence is exponentially amplified in vitro through a polymerase-
catalyzed chain reaction. The second was the development of automated DNA sequenc-
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ing instruments by Applied Biosystems (reviewed in (Liu et al., 2012)).
The International Project on Human Genome was initiated in 1990 and it was ex-
pected to last 15 years. In 2000 after ten years of multinational scientific effort and at
$3 billion cost, a rough draft of the genome was finished using the Sanger sequenc-
ing method with key findings of the draft genome announced soon afterwards (Lander
et al., 2001).
1.3 Deep sequencing technology
Deep sequencing has been a groundbreaking technology, affecting the whole breadth of
the biomedical sciences. The key feature is the potential for massive parallelisation and
automation, making large scale sequencing projects possible. It has had a huge impact
first on genomics and soon afterwards on metagenomics as it provides the opportunity
to sequence uncultured microorganisms sampled directly from their natural habitats.
Since its arrival, intense competition between the major players has contributed
to the constant improvement of the technology. This is specifically expressed by the
continuous increase in numbers and lengths of reads, translating into a reduced cost
per sequenced base. The most popular high throughput platforms are Illumina (Bentley
et al., 2008), Roche 454 (Margulies et al., 2005), IonTorrent (Rothberg et al., 2011),
SOLiD (Shendure et al., 2005) and Pacific Biosciences (Eid et al., 2009). Despite the
continuous improvement in performance over the last years for all platforms, there is
an important variation of throughput and read length between them. The output of
Illumina, SOLiD and Ion Torrent consists of reads at most a few hundred bases long,
while Pacific Biosciences generates longer reads, kilo-bases long.
During the first years of metagenomic studies, the Roche 454 was the favored
platform for sequencing metagenomes due to the longer read length. With longer reads
taxonomic assignment of the reads is relatively easy when the reference genomes are
known. However due to the relatively limited throughput, rare species were habitually
missed. On the other hand, Illumina platform generates an order of magnitude more
reads of reduced length at a lower cost, which increases the chance of identifying low
abundance species. Illumina currently dominates the market with various machines and
offer the best balance between read lengths, error rates and cost (Loman et al., 2012).
The trend of rapid turn-around time and falling cost supports a prediction that once
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high throughput sequencing become widely accessible, its use as a clinical diagnostic
tool will allow more personalized medical applications. Especially relevant to medical
applications is the technology developed by Oxford Nanopore Technologies (ONT).
ONT has given early access of their mobile USB-powered single molecule sequencer to
a number of academic collaborators for evaluation. Even though a commercial launch
has not been announced yet, assuming that ONT deliver on the low-cost portable se-
quencer producing very long sequences with low error rates on the spot, there is great
potential for its use in the emerging clinical market.
1.3.1 Illumina Sequencing
Illumina sequencing will be discussed in more detail, as it has been used for the entirety
of the sequencing carried out for this thesis. Illumina sequencing was first available in
2006. It is based on a sequencing by synthesis approach where a polymerase is used
to synthesise a complementary strand to the single stranded target DNA with termina-
tor nucleotides used to halt the synthesis. The terminators are reversible which means
that the synthesis can continue after each base is detected. The sequencing process is
performed for millions of DNA fragments in parallel. In brief, there are three main
components in the process: library preparation (Figure 1.2), bridge amplification (Fig-
ure 1.3) and sequencing by synthesis (Figure 1.4).
During the library preparation step (Figure 1.2), the DNA is fragmented and tag-
mented. The aim is to generate overlapping fragments within a specific size range.
Short nucleotide sequences called adaptors are attached to the template fragments and
they serve multiple purposes: they include complementary oligos that allow the frag-
ment to ligate to the flowcell1, index tags to label the sample and allow multiplexing
and binding sites for the sequencing primers. Typically after adapter ligation, a PCR
step is used to enrich the library for DNA fragments with the adaptors in the correct
orientation. The DNA is then denatured to produce single strands.
The single-stranded sequencing library is loaded into the flow cell, followed by
bridge amplification (Figure 1.3). This is an amplification reaction that occurs on the
surface of the Illumina flow cell. The library fragments bind to complementary oligos
as they “flow” across the oligo lawn while the opposite end of a ligated fragment bends
1flowcell: a glass slide with one, two, or eight physically separated lanes, depending on instrument
platform. Each lane is coated with a lawn of surface bound, adapter-complimentary oligos.
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c. Advances in Sequencing Technology
Paired-End Sequencing
A major advance in NGS technology occurred with the development of paired-end (PE) sequencing (Figure 4). PE 
sequencing involves sequencing both ends of the DNA fragments in a sequencing library and aligning the forward 
and reverse reads as read pairs. In addition to producing twice the number of reads for the same time and effort 
in library preparation, sequences aligned as read pairs enable more accurate read alignment and the ability to 
detect indels, which is simply not possible with single-read data.8 Analysis of differential read-pair spacing also 
allows removal of PCR duplicates, a common artifact resulting from PCR amplification during library preparation. 
Figure 1.2: Library preparation: the li rary is prepared by fragmenting a gDNA sample and
ligating specialized adapters to both fragment ends. The figure is taken from the
Illumina website.
over to the surface, bridging on a complementary oligo. The repeated denaturation
and extension cycles for each single fragment results into millions of dense clusters of
clonal DNA across the flow cell. This in turn, increases the fluorescent signal intensity.
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c. Advances in Sequencing Technology
Paired-End Sequencing
A major advance in NGS technology occurred with the development of paired-end (PE) sequencing (Figure 4). PE 
sequencing involves sequencing both ends of the DNA fragments in a sequencing library and aligning the forward 
and reverse reads as read pairs. In addition to producing twice the number of reads for the same time and effort 
in library preparation, sequences aligned as read pairs enable more accurate read alignment and the ability to 
detect indels, which is simply not possible with single-read data.8 Analysis of differential read-pair spacing also 
allows removal of PCR duplicates, a common artifact resulting from PCR amplification during library preparation. 
Figure 1.3: Bridge amplifi ation: the library is loa ed into a flow cell and the fragments hy-
bridize to the flow cell surface. E ch bound fragment is amplified into a clonal
cluster through bridge amplification. The figure is taken from the Illumina website.
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c. Advances in Sequencing Technology
Paired-End Sequencing
A major advance in NGS technology occurred with the development of paired-end (PE) sequencing (Figure 4). PE 
sequencing involves sequencing both ends of the DNA fragments in a sequencing library and aligning the forward 
and reverse reads as read pairs. In addition to producing twice the number of reads for the same time and effort 
in library preparation, sequences aligned as read pairs enable more accurate read alignment and the ability to 
detect indels, which is simply not possible with single-read data.8 Analysis of differential read-pair spacing also 
allows removal of PCR duplicates, a common artifact resulting from PCR amplification during library preparation. 
Figure 1.4: SBS sequencing: Sequencing reagents, including fluorescently labeled nucleotides,
are added and the first base is incorporated. The flow cell is imaged and the emis-
sion from each cluster is recorded. The emission wavelength and intensity are used
to id ntify the base. This cycl is repeated n times to cr ate a read length of n bases.
The fi ure is taken from the Illumina website.
The sequencing r ac (Figur 1.4) is carried out with fluorescently labeled re-
versible terminator-bound dNTPs (modified versions of the four nucleotides). These
allow the reaction to proceed one base at a time and therefore the number of cycles
matches the read length. Laser excitation produces fluorescent signals that are recorded
for nucleotide identification. Accurate base calling depends on the signal intensity pro-
duced by the cluster of clonal DNA.
1.3.2 RNA analysis by deep sequencing
RNA sequencing (RNA-Seq) methods are used for in depth transcriptome analysis
through cDNA sequencing at massive scale (Oz olak and Milos, 2011). In short, the
main idea is that collection of RNA molecules is converted to a library of cDNA
fragments which are subsequently sequenced in a high-throughput manner to obtain
sequencing reads.
Prior to the sequencing, RNA is isolated from the biological samples of inter-
est. The ribonuclease enzymes (RNases) presence in cells can rapidly degrade RNA
and significantly hinder the procedure. For this reason the RNA extraction equipment
should be cleaned meticulously and treated with RNase-destroying chemicals. Dif-
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ferent methods exist for extracting RNA from samples such as the phenol-chloroform
based and the silica-gel based column procedures (Sultan et al., 2014). If the size of
the RNA molecules is quite large these need to be randomly fragmented by employing
either RNA or cDNA fragmentation methods (Wang et al., 2009).
Frequently the tissue of interest is preserved using a method called formalin fixed
paraffin embedded (FFPE) processing, where tissue samples are placed in formalin and
subsequently embedded in paraffin (Masuda et al., 1999). While the fixation process
preserves the tissue, these steps can lead to severe degradation and chemical modifi-
cations of the RNA. This results in highly variable and typically poor quality of the
RNA extracted from samples of interest (Roberts et al., 2009), characterised by shorter
lengths. Additionally, compared to using the same mass of fresh tissue, the yields ob-
tained are lower (Zhao et al., 2014).
This quality of RNA in terms of degradation is indicated by a measure called RIN
(RNA Integrity Number) (Schroeder et al., 2006), produced by an algorithm that can
detect presence of degradation products. The RIN score ranges from 1 to 10, where
level 10 denotes completely intact RNA. Therefore the lower the score, the lower the
quality of the RNA (Schroeder et al., 2006). In general, RIN values greater than 7 are
considered good quality.
Following RNA extraction and reverse transcription into a cDNA library, there
may be different choices for library preparation which can affect the results. Highly
abundant ribosomal RNA (rRNA) that constitutes the majority of total RNA in cells as
it is required for protein synthesis (Giannoukos et al., 2012), needs to be removed from
total RNA before sequencing when the goal of the analysis is mRNA or gene detection.
The standard Illumina protocol addresses this by first isolating total RNA and then se-
lecting messanger RNA with a poly(A) - polyadenylated - purification step. A caveat
is that poly(A) purification of degraded RNA may pull out only the most 3’ segments
of the RNA population, due to the 5’ sequence becoming detached from the poly(A)
tail (Zhao et al., 2014). Hence, the poly(A) method is not the optimal approach when
working with FFPE samples. An alternative approach is rRNA depletion or ribodeple-
tion where the man idea is that rRNA is depleted while preserving the small fraction of
messanger RNA (mRNA).
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1.4 Clinical diagnostics
Human pathogens can either be viruses, bacteria, parasites or fungi. The traditional
process of characterizing infection-causing pathogens in clinical speciments is done
through potentially difficult or time consuming techniques. Examples include mi-
croscopy and/or cell culture for investigating the microbial composition of a sample,
identifying colonies and producing sufficient mass of microorganisms for subsequent
use (Didelot et al., 2012). Alternatives include PCR or Sanger sequencing, both intro-
duced in previous section 1.2.2 or DNA microarrays with probes that hybridize known
sequences (Yozwiak et al., 2012). Viral detection is frequently laced with additional
difficulties as discussed in the following section.
1.4.1 Virological diagnostics and Koch’s postulates
Viral pathogens were traditionally detected on cultured cell that exhibited cytopathic
effects or plaques or alternatively by antibody neutralization tests (Bibby, 2013). How-
ever many viruses cannot be cultured in laboratory conditions while the antibody neu-
tralization tests depend on the availability of quality antiserum. PCR assays are con-
sidered the gold standard for diagnostic virology as they are very sensitive, quantitative
and inexpensive and can detect unculturable or nonisolated viruses (Lipkin and Hornig,
2015). However PCR relies heavily on prior information on the target viruses and thus,
clinical diagnoses of viral infections may require wide arrays of PCRs targeting differ-
ent viruses. This does not necesarily guarantee a successful outcome, as demonstrated
in cases of rare or novel pathogens.
Importantly, the detection of a microorganism in a clinical specimen is only the
first step in establishing a causal relationship. Kochs postulates, proposed by Robert
Koch towards the end of the 19th century, attempted to establish rigorous criteria and
provide guidelines for defining a causative relationship between microorganism and
disease. In summary these are the presence of the agent in every case of a disease,
specificity for that disease (the agent occurs in no other disease as a nonpathogen) and
finally, the capacity to cause the same disease in hosts after repeated propagation in
culture (reviewed in (Fredricks and Relman, 1996)). The postulates were soon under-
stood to be non suitable for viruses and a few decades later they were revised (Rivers,
1937). Problems include the fact that several viruses do not cause the disease in all
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infected individuals. An known example is poliovirus which causes paralysis in about
1% of those infected with the majority of cases either subclinical or non paralytic. Ad-
ditionally, infection with the same virus may lead to different diseases demonstrated by
differences in immunocompotent and immunodefecient/immunosuppressed individu-
als. Furthermore infection with different viruses may result in similar disease signs and
symptoms. Finally, there are viruses that do not replicate in cell culture, or for which a
suitable animal model has not been identified.
The postulates were modified to reflect the introduction of culture-independent
molecular methods, and were called molecular Koch’s postulates (Fredricks and Rel-
man, 1996). There are as follows: firstly, the pathogen is consistently associated with
the disease, i.e nucleic acid sequences from the pathogen are present in most cases of
the disease. Secondly, the hosts without the disease have either no sequences or smaller
numbers of the nucleid acid sequences of the pathogen. Additionally, disease resolu-
tion results in decresed numbers of pathogenic sequences. If the sequence copy number
correlates with the disease severity the sequence-disease association is more likely to
be a causal relationship. Furthermore, the sequence-inferred nature of the microorgan-
ism is consistent with the group of organisms it belongs to. Finally, there is specific in
situ hybridization of genomic sequence to the areas of tissue pathology and the results
providing the evidence for causation are reproducible.
The Koch postulates of causation may be modified and adapted in different times,
given changes in technology and disease knowledge (Falkow, 2004). However, even the
newer adapted versions cannot be satisfied in all instances despite their relevance to the
molecular era (Lipkin, 2008). Infection patterns vary along with factors such as genetic
susceptibility, age, nutrition or previous exposure to other agents. In some cases, such
as several acute infectious diseases, the responsible microorganism replicates in the
tissue of interest, can be readily identified with traditional methods, there is evidence
of an adaptive immune response as well as evident morphological changes consistent
with infection. However when classical hallmarks of infection are not present, the
pathogenesis mechanism is not direct, the microorganism has latent effects or requires
cofactors such as coinfection, confirming causation is more challenging. In such cases,
the strength of the epidemiological association in the patients needs to be statistically
assessed.
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Establishing the causal relationship between a virus and a disease is therefore an
important but difficult issue that may require multiple separate studies to be ultimately
resolved (Fredricks and Relman, 1996). In the most difficult of scenarios this may be
obtained only after a specific intervention such as a drug or a vaccine has been shown
to prevent the disease (Lipkin, 2009).
1.4.2 Metagenomics
The process of characterizing viruses in clinical samples is being revolutionized by
advances in high throughput sequencing. The traditional methods typically focus on
identifying a single pathogen at a time and may fail to detect the infectious agent in a
significant percentage of cases in some infectious diseases (Tunkel et al., 2008). High
throughput sequencing driven methodologies hold the promise of a largely unbiased
approach in species detection and of unexpected discoveries, as well as relatively rapid
turnaround time (Quail et al., 2012). As a result, researchers have adopted the technol-
ogy for detecting and characterising either viral or bacterial pathogens responsible for
acute and chronic illnesses of unknown origin in isolated cases (McMullan et al., 2012;
Wilson et al., 2014; Brown et al., 2015) as well as for disease outbreaks (Rohde et al.,
2011; Frank et al., 2011; Chin et al., 2011; Greninger et al., 2010).
Virologists quickly adopted high throughput sequencing for identifying viruses
as many viruses cannot be cultured and lack a universal conserved genetic element
shared between viral genomes. Especially pertinent to viral infections is the emergence
of novel emerging strains which prove additionally challenging for conventional tech-
niques (Brown et al., 2015). Identifying correctly the viruses involved in an illness is
crucial for avoiding misdiagnoses that may lead to improper clinical treatment - such as
the administration of antibiotics - and which negatively affects survival or transmission
rates. The detection and response to viral pathogen outbreaks (Assiri et al., 2013; Cot-
ten et al., 2014; Matranga et al., 2014) is another application of metagenomics. This
approach has been successfully used in influenza outbreaks to determine viral subtype
(Kuroda et al., 2010; Greninger et al., 2010; Deng et al., 2011). Viral metagenomics
also offer the ability to identify coinfections (Yang et al., 2011). Another attractive
feature of deep sequencing is the ability to detect variants at low frequencies. This is
useful for identifying drug resistant mutations or transmission patterns of the viruses
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and for evaluating the impact of minority variants on treatment efficacy (Quin˜ones Ma-
teu et al., 2014). Finally, a number of viruses that have not been associated with human
diseases have been detected in healthy human hosts, establishing the existence of a
normal human virome (Lecuit and Eloit, 2013).
It is important to note that despite the promise metagenomic identification of viral
pathogens offers, there are a number of challenges. The most obvious one is that the
probability of inadvertent microbial contamination is not negligible. Microbial con-
tamination can take place during sample handling in the laboratory or from the use
of contaminated laboratory reagents or nucleic acid extraction kits. The contaminants
may be either bacteria (Salter et al., 2014) or viruses (Naccache et al., 2013; Rosseel
et al., 2014). To address this, the same extraction and deep sequencing methods should
be applied to both clinical case samples and suitable negative controls, such as blank
extractions (Salter et al., 2014).
Inferring causation from metagenomic findings needs to be further supported by
methods that depend upon viral particle isolation, such as protein expression, viral
replication and reactivity to anti-serum in affected tissues (Bibby, 2013). In general,
supportive clinical, epidemiologic and serological data are critical in confirming asso-
ciations of candidate novel agents with disease. These strategies have been previously
used to conclusively refute the putative association of the retrovirus XMRV (xenotropic
murine leukemia virus) with chronic fatigue syndrome or prostate cancer and proved
that XMRV originated as a mouse cell line-derived laboratory contaminant (Hue´ et al.,
2010; Knox et al., 2011; Simmons et al., 2011).
Finally, a limiting factor of the full potential of deep sequencing is the analysis
and interpretation of metagenomic data. The choice of analytic method depends on the
aim of the study as well as the computing resources available to the researchers. The
use of specific analytic methods actively affects the answer to the question we ask. The
methods and the associated limitations and challenges are discussed in the following
section.
1.5 Community profiling in metagenomics
Community profiling of a metagenomic mixture is defined as the identification and
quantification of the present species in the specific sample. This has proved to be a
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challenging problem to solve and it raises complex computational issues. Part of the
difficulty stems from the read length limitation of existing deep sequencing technolo-
gies, an issue compounded by the extensive level of homology across viral and bacterial
species. Another complication is the divergence of the microbial sequences from the
publicly available references. As a consequence, the assignment of a sequencing read
to a database organism is often unclear. Lastly, the number of reads originating from
a disease causing pathogen can be low (Barzon et al., 2013), underlying the need for
highly sensitive methods. The pathogen contribution to the mixture depends on the bi-
ological context, the timing of sample extraction and the type of pathogen considered.
Therefore, highly sensitive computational approaches are required.
1.5.1 Related work
A first approach to the problem is read classification, that is the assignment of a given
sequencing read to a species. Several tools have been developed and these belong to
two broadly defined classes: composition-based and similarity-based approaches. That
means that methods generally use the following information sources: sequence com-
position or sequence identity to reference databases, with hybrid methods using both.
A third related approach is to phylogenetically analyze metagenomes by subsetting to
core genes that are expected to follow the same evolutionary path and are present in
a large proportion of microorganisms. The core genes represent only a small propor-
tion of a metagenome (Matsen, 2015) and thus, the task is not entirely equivalent to
read classification. The portion of the remaining metagenome can be taxonomically
classified using either similarity or composition based methods.
The read classification based on sequence composition relies on the intrinsic fea-
tures of the reads, such as CG content or oligonucleotide distributions (Deschavanne
et al., 1999; Bentley and Parkhill, 2004). Methods include TETRA (Teeling et al.,
2004), PhyloPythia (McHardy et al., 2007), Phymm (Brady and Salzberg, 2009) and
LikelyBin (Kislyuk et al., 2009).These tend to focus on major classes in a dataset and
may not perform well on low-abundance populations (Kunin et al., 2008). Addition-
ally, results are usually reliable only for longer reads or assembled contigs, usually at
least 1,000bp and generally are less accurate compared to similarity based approaches
(Dro¨ge and McHardy, 2012). For this reason these methods are not optimal when the
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goal is to detect a candidate disease agent that is only supported by a low number of
short reads in the data.
A tool that leverages phylogenetic analysis of metagenomic sequence data is Phy-
loSift (Darling et al., 2014). PlyloSift places short sequencing reads or assembled
contigs onto a phylogeny of core reference genes which include viral gene families.
PhyloSift relies on a relatively small set of widely conserved marker genes so there is
little informative variation at high taxonomic resolution. PhyloSift is not a taxonomic
classification method but rather its interest is in providing the phylogenetic framework
for the deduced informations and is more intended for quantification of abundances of
relatively large clades.
Similarity based methods, using similarity search algorithms such as BLAST
(Altschul et al., 1990), are considered the most sensitive methods for read classifi-
cation (Brady and Salzberg, 2009). One of the most popular tools using the output of
a similarity search algorithm is MEGAN (Huson et al., 2007). MEGAN addresses am-
biguous matches by assigning reads that have multiple possible assignments to several
species to the taxonomic group containing all these species, or else their lowest com-
mon ancestor (LCA). This approach is accurate on a higher taxonomic level. However,
it is lacking a formal solution to resolving ambiguous matches. Kraken (Wood and
Salzberg, 2014) couples the LCA approach with exact k-mer (words of k nucleotides)
matching. Its use of k-mers may result in low specificity, performing better on genus-
level classification. Additionally, a single value for Kraken’s k-mer might not work
equally well for viral and bacterial genome due to the viral higher mutation rate, ham-
pering its performance in samples where both co-exist. CLARK (Ounit et al., 2015)
is another recent k-mer based assignment tool. MetaPhlAn2 (Segata et al., 2012) uses
a reference database consisting of clade-specific defining genes, as opposed to Phy-
loSift’s universally conserved genes. Similarly it cannot classify non-marker reads,
additionally it was developed primarily for profiling metagenomic samples where the
coverage of many microbes is reasonably high, therefore is suboptimal for detecting
traces of a microbe. MetaPhlAn2 does not try to classify each read but it rather focuses
on estimating relative abundances.
An obvious general limitiation of similarity based methods is their reliance on the
content and completeness of public reference databases. Public databases hardly rep-
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resent the real biological diversity, especially pertinent for the viruses that are mostly
undiscovered (Fancello et al., 2012). Additionally their content is biased towards cul-
tivable organisms and human pathogens (McHardy and Rigoutsos, 2007). Therefore
reads from novel microorganisms that are sufficiently divergent from known species
will either be misclassified or unclassified. The resulting classification will differ de-
pending on the choice of the database. It is possible that using the same database
source but a different updated version with improved annotations and new additions
may produce different results. Informed database selection can limit the presence of
false positives, however more important is to bear in mind the database limitations and
biases and interpret findings with care. In the event of an exciting but unlikely finding,
researchers need to proceed with caution and apply real life Bayesian reasoning. Dif-
ferent sanity checks, bioinformatic ones but also in the form of new experiments are
crucial for accepting a finding.
The type of the database is also important when the goal is to uncover viral se-
quences in the sequencing data. Viruses in general are characterized by high genetic
diversity and divergence (Fancello et al., 2012) therefore we are more frequently inter-
ested in recovering remote similarities. A higher level of conservation is expected at
the protein level compared to nucleotides, therefore protein databases that allow peptide
rather than nucleotide similarity searches, are suggested (Kunin et al., 2008).
Another weakness of the similarity based methods is that a long tail of species,
each supported only by few reads can appear in the results. This is due to two factors:
first, the classification is decided one read at a time, in contrast to considering all reads
simultaneously. Second, while the more complex read interpretation fits the data better,
it can lead us to infer overcomplicated profiles, i.e assuming thousands of species to
be the origin of the sequencing reads. However any proposed explanation should not
be more complicated than necessary; consideration of the plausibility of the models
(profiles) needs to be part of the inference. Bayesian methods automatically incorporate
this “Occam’s razor” in the form of priors for the considered models (Mackay, 1992).
Even when researchers do not explicitly think in terms of prior probabilities for their
hypotheses, when they consider simple hypotheses before complex ones, they are in
fact intuitively doing exactly that.
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1.5.2 Similarity based - mixture model approach
Methods designed to infer the set of present species as well as estimate their relative
proportions, incorporate knowledge from all reads to assign each individual read to a
species. From a statistical standpoint, this identification and quantification question can
be thought of as an application of finite mixture models. Mixture models have been ap-
plied in the metagenomics context in frequentist and Bayesian settings. GRAMMy (Xia
et al., 2011) formulates the problem as a finite mixture model, using the Expectation-
Maximization (EM) algorithm to estimate the relative genome abundances. However it
cannot work with BLASTx output which is better suited for viral discovery for reasons
explained in the previous section. Pathoscope (Francis et al., 2013) refines this pro-
cess by penalizing reads with ambiguous matches in the presence of reads with unique
matches and enforcing parsimony within a Bayesian context.
Fitting a mixture model is useful for the species relative abundance estimation as
well as for the read to species assignment. A related but distinct question concerns the
set of species which should be included in the mixture model. This question is closely
related to the biological question of asking what species are present in the mixture.
Including all species flagged as potential matches by the read annotation can introduce
a large number of species, often in the low thousands. Mixture models will then identify
a large number of species at low levels. This interpretation is appropriate in some
applications. In many other cases, the expectation is that the underlying species set
should be parsimonious and that some divergence with database species or sequencing
errors can explain a large fraction of the non matching reads.
Pathoscope is the only other community profiling approach to use a Bayesian sta-
tistical framework and thus shares a degree of similarity to the method I propose and
developed for this thesis, called metaMix and introduced below in section 1.7. Patho-
scope was not published until the end of 2013, towards the end of metaMix develop-
ment. metaMix is significantly different to both GRAMMy and Pathoscope in employ-
ing a parallel MCMC approach to explore the state-space of the candidate organisms
by comparing different combinations of species based on their posterior probabilities.
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1.6 Bioinformatics processing
Before we can describe the proposed method for community profiling, we go through
the bioinformatics analysis steps that takes us from the raw sequences to the type of data
metaMix can use. We also briefly talk about the questions that may become relevant
when we have the community profile of a clinical sample.
1.6.1 Prior to community profiling
Prior to applying the community profiling approach using Bayesian mixture models,
several steps are required to process the short read sequence data. The pipeline uses
publicly available bioinformatics tools for each preprocessing step.
1. Remove clonal reads −
in house C++
2. QC & trimming − PRINSEQ
3. Remove human seqs−
a. Novoalign b. BLASTn
5. Remove rRNA seqs − BLASTn
6. Assembly − Velvet
7. Contigs & unassembled reads −
BLASTx
Species profiling −
Bayesian Mixture Model Averaging
Figure 1.5: Bioinformatics pipeline steps prior to species identification. The step of removing
the rRNA sequences is applicable only when the aim is viral discovery.
1.6.1.1 Removal of clonal reads
The very first step is the removal of clonal reads using an in house C++ script, im-
plemented by Vincent Plagnol. Duplicate sequences are a common issue in Illumina
sequencing (Kozarewa et al., 2009). Standard Illumina library preparation involves
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PCR amplification before the sample is loaded into the flowcell and PCR can cause
clonal artifacts. Duplicate reads are typically defined post-alignment to a reference
genome as reads that begin and end at exactly the same start and end coordinates. Col-
lapsing clonal reads reduces the number of reads, hence facilitating all downstream
analyses. Furthermore we infer the relative abundances based on the read counts, so
such duplicates could lead to overestimate the species abundance.
We cannot use position information to detect identical reads as we are interested
in all reads and not reads matching a specific organism such as the host. Instead, the
sequence information of paired-reads is used. If identical, the pairs are being collapsed
keeping the one with the best average pair quality. We do not require identity across
the whole length of the read, instead the first n nucleotides are compared, as it is typical
for Illumina reads to have low quality ends. The number n depends on the read length,
but we typically use ∼ 80% of the read length as signature.
1.6.1.2 Quality control
The quality of the 3’ end of a sequencing read can be low due to phasing artifacts
(Metzker, 2010). This term describes failures in nucleotide incorporation or in block
removal, or incorporation of more than one nucleotide in a particular cycle. This re-
sults in uneven strand lengths, introducing shorter and longer strands within the same
cluster. In turn, this reduces the purity of the signal output and as the variation in strand
lengths increases with every cycle, the precision of base calling drops (Erlich and Mi-
tra, 2008). We use PRINSEQ (Schmieder and Edwards, 2011) for read-based quality
control, removing low quality and complexity reads and performing 3’end trimming.
1.6.1.3 Host filtering
For metagenomic analysis of human samples, reads originating from the human host
are usually not relevant for our research question. We therefore remove human host
reads, using a two-step approach to limit computation time: initially a short read aligner
(novoalign, www.novocraft.com), followed by BLASTn.
It is important to first define homology and similarity in the context of sequence
analysis before we can describe the basis of BLAST and novoalign. Sequence analy-
sis aims to find important sequence similarities that would allow one to infer homology.
Homology is defined as common origin which means that sequences are homologous if
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they share a common evolutionary ancestry. Similarity on the other hand is an observed
quantity and we usually talk about percent identity of two sequences. Homology can be
inferred by sequence but also structural and functional similarity. When two sequences
or structures share more similarity than would be expected by chance, we can infer that
the two sequences did not arise independently but rather from a common ancestor.
There are different algorithms for pairwise sequence alignment, that is the com-
parison of two sequences to establish regions of residue similarity. The Needleman-
Wunsch algorithm (Needleman and Wunsch, 1970) provides a method for finding the
optimal alignment over the entire length of two sequences. This method maximizes
the number of amino acid matches, assign scores to mutations, insertions and deletions
and computes an alignment of two sequences that corresponds to the least costly set
of such changes. Needleman-Wunsch is a global alignment technique and therefore it
cannot be used to find local regions of high similarity. Local sequence alignment is fre-
quently more useful because there is greater variation (insertions, deletions, mutations)
towards the protein sequences ends which are less conserved. The Smith-Waterman
algorithm (Smith and Waterman, 1981) performs local alignment and finds the local
region of highest similarity between two proteins without having to align their ends
that may be highly different. Local alignment is useful for finding sequences that have
low similarity and different lengths.
Both the Needleman-Wunsch and the Smith-Waterman algorithms are optimal se-
quence alignment methods which find the highest scoring alignment for any pair of pro-
tein sequences. These algorithms tend to be slow and performing a sequence alignment
in reasonable time is difficult as reference databases increase in size. BLAST (Altschul
et al., 1990) is a heuristic algorithm based on Smith-Waterman and it was designed to
offer a balance between sensitivity and speed. BLAST first finds all words of a specific
length that exist in the query protein (nucleotide) sequence. BLAST then finds all the
closely related words with conservative substitutions introduced using a substitution
matrix, that is a matrix of similarity scores for all possible pairs of residues. Local
alignments are extended in both directions until the gaps and the mismatches result in
the score of the alignment to drop more than a prespecified amount.
Unlike BLAST (Altschul et al., 1990), whose original purpose is finding homolo-
gous sequences to query protein sequences by searching though large databases, short-
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read aligners are generally used for the alignment of DNA sequence from the species
of interest to the reference genome assembly of that species. This translates into ex-
pecting mismatches to be driven by the species polymorphism rate and the technology
error rate rather than by evolutionary substitutions, hence the big speed gain in pro-
cessing million short reads (Flicek, 2009). Different short read aligners are based on
the Burrows-Wheeler transform (BWT) of the reference genome. BWT is an algo-
rithm that can yield a more compressible dataset (Burrows and Wheeler, 1994) and
only works well with references that are larger than several thousand characters. This
data indexing technique therefore maintains a relatively small memory footprint when
searching through a given data block. Examples of popular aligners that use BWT in-
clude BWA (Li and Durbin, 2009), SOAP2 (Li et al., 2009b) and Bowtie2 (Langmead
and Salzberg, 2012).
Novoalign, the short aligner chosen for this step builds the genome index by divid-
ing the reference sequences into overlapping kmers. The alignment process first finds
alignment locations in the indexed reference sequence that are possible sources of the
read. The alignment locations are then scored using the Needleman-Wunsch algorithm
with affine gap penalties and position specific scoring. The latter is derived from the
read base qualities and the ambiguous codes in the reference sequence. Novoalign was
chosen for this step due to greater experience with this tool and different aligners could
be used to perform this step without major differences in the final results.
The next step is only applicable when the focus is on virus discovery using tran-
scriptome reads. We remove ribosomal RNA sequences to avoid false positive align-
ments to viruses that share sequence similarity with human ribosomal RNA. We use
BLASTn against the Silva rRNA database (http://www.arb-silva.de/).
1.6.1.4 de novo assembly
The remaining reads are assembled into contigs using the Velvet short read assembler
(Zerbino and Birney, 2008). Assembly is the process of combining short read fragments
into contiguous stretches of DNA called contigs. In the era of dealing with long Sanger
reads and single genomes, assembly tools used the overlap graph (Myers, 1995). The
main idea of the overlap graph is straightforward and intuitive: each read is regarded
as a node and two reads presenting a clean overlap are connected by a bidirected edge.
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In the deep sequencing context, the huge number of reads make the overlap graph
extremely large, requiring large computational resources.
De Bruijn graphs (Pevzner et al., 2001) are the basis of a very different approach.
The fundamental difference is that graphs are not centered around reads but around
k-mers, words of k nucleotides. A De Bruijn graph, monitors overlaps of k−1 length
between these k-mers instead of overlaps between the actual reads. Reads are mapped
as paths through the graph, going from one word to the next in a determined order.
High redundancy is naturally handled by the graph without affecting the number of
nodes. Searches for overlaps are simplified, as overlapping reads are mapped onto
the same arcs and can easily be followed simultaneously (Zerbino and Birney, 2008).
De Bruijn assemblers include Velvet (Zerbino and Birney, 2008), ALLPATHS (Butler
et al., 2008), SOAPdenovo (Li et al., 2010). We chose to work with Velvet, one of the
first methods to be developed and still very popular..
These assembly approaches assume uniform coverage and linear genome se-
quence. These are normal assumptions for a single genome assembly which no longer
hold in the metagenomics scenario, where the coverage fluctuates both between organ-
isms and in the case of metatranscriptomics, expressed genes of an organism. There-
fore, the coverage can no longer be used to determine the uniqueness of regions or to
isolate erroneous sequence. Other likely problems are that highly conserved sequences
shared between different species can cause chimeric contigs and sequences of highly
abundant species could be misidentified as repeats.
As part of the pipeline a conservative assembly is attempted in order to avoid
chimeric contigs. A Velvet tuning parameter is the user defined k-mer length that spec-
ifies the extent of overlap required to assemble read pairs. Short k-mers work best
with the low abundance organisms, while long k-mers with the highly abundance ones.
The shorter the k-mer the greater the chance of spurious overlaps, hence we choose
relatively high k-mer length, in order to avoid chimeric contigs.
The approach settled for is not necessarily the one that produces the greater num-
ber of contigs or captures both high and low abundance species. The first year of my
project I worked extensively on optimizing the assembly step, based on the hypothe-
sis that all downstream inference would be based only on contigs. This work resulted
in the realisation that unassembled reads provide crucial information for rare species
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detection. Some of the work that lead to this choice is outlined in the Appendix A.
Following the assembly step, we record for each contig the number of reads required
to construct it. We use this information at the stage of species abundance estimation.
1.6.1.5 Annotation of reads and contigs
Finally, for each contig and unassembled read we record the potentially originating
species, using the nucleotide to protein homology matching tool BLASTx. We use
BLASTx due to the higher level of conservation expected at the protein level compared
to nucleotides. This choice is guided by our focus on viral pathogens - viruses having
high genetic diversity and divergence (Fancello et al., 2012).
We use a custom reference database that combines viral, bacterial, human and
mouse RefSeq proteins for annotation of the reads and contigs. All viruses are used
(ftp://ftp.ncbi.nlm.nih.gov/refseq/release/viral/viral.1.protein.
faa.gz) as well as all the bacteria of the human microbiome, according to ftp:
//ftp.ncbi.nih.gov/genomes/HUMAN_MICROBIOM/Bacteria/all.faa.tar.gz.
The reference database are clearly not complete representations of the biological di-
versity. However for the purposes of this work and the type of analysis we perform,
the complete collection of viruses - human and non human - should be able to capture
even novel viruses that are not greatly divergent from all known viruses to date. The
human proteins will help classify correctly human sequences that were not filtered out
during the two-step host removal and mouse sequences to capture potential laboratory
contamination. In the type of data I have analysed for this thesis pathogenic bacte-
rial infections are not very likely, however the bacteria of the human microbiome are
included to help capture bacterial contaminants.
If taxonomic information is not included in the BLAST output, we obtain it by
using the NCBI taxonomy files that map proteins to taxons. For simplicity we subse-
quently drop the protein information and only keep a record of mismatches between
the read and the species. If a read matches multiple proteins from the same species,
we keep only the best match. This step generates a sparse dissimilarity matrix between
the read sequences and the protein sequences, as in Table 1.1, with species as columns,
reads and contigs as rows.
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Table 1.1: Input data for community profiling - sparse dissimilarity matrix
species1 species2 . . . speciesK
read1 m11 m12 . . . m1K
read2 m21 m22 . . . m2K
. . .
readN mN1 mN2 . . . mNK
where m11 is the number of mismatches between the sequence of read1 and the
sequence of the “best match” protein from species1.
The pipeline can be found online http://github.com/smorfopoulou/
clinicalDiagnostics_pipeline as it has been shared with UCL Genomics (UCL
sequencing services facility) to be used for the analysis of any generated metagenomics
datasets from human clinical samples.
1.6.2 Post community profiling
After the community profiling step has taken place, one may be able to answer fur-
ther research questions regarding a specific species of interest, for example a potential
pathogen detected in a clinical sample. This is conditional on having a sufficient num-
ber of reads originating from the pathogen so that a de novo assembly can be performed
to recover its full genome sequence. Such a question could be, how does the detected
organism compare to different strains of the same species? We may answer this by
inferring a phylogenetic tree. Phylogenetic trees generally represent the evolutionary
relationships within a group of organisms (Delsuc et al., 2005).
A phylogenetic tree contains nodes connected by branches. There are external
nodes called leaves or tips, which correspond to the actual sequences we are inter-
ested in estimating a phylogeny for. The internal nodes represent the putative common
ancestors of the descendants (the tips). The branch lengths indicate the amount of
evolutionary time along the branches and are expressed in units of expected number
of substitutions per site. Phylogenetic trees are inferred from the sequence data with
reconstruction methods falling in two general categories: distance-based and character-
based methods (Yang and Rannala, 2012). In the first category a distance matrix is used
for the tree reconstruction, with a distance calculated for all pairs of sequences. The
neighbour joining algorithm (NJ) (Saitou and Nei, 1987) is a popular distance-based
method, its main advantage being the computational efficiency and resulting speed. The
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method performs well when the sequences for which we want to estimate the phylogeny
are not very divergent. However sacrificing information by using distances instead of
the full sequence information hinders the reliable estimation of pairwise distances for
divergent sequences (Holder and Lewis, 2003).
Maximum likelihood (ML) (Felsenstein, 1981; Yang, 1993), maximum parsimony
(MP) (Day, 1987) and Bayesian inference methods (Huelsenbeck et al., 2001; Holder
and Lewis, 2003) are character-based methods. These methods simultaneously com-
pare all sequences considering a single position in the multiple sequence alignment at
a time in order to calculate a tree score. This is the log-likelihood value for ML, the
minimum number of changes for MP and the posterior probability for the Bayesian
methods. A comparison of all potential trees reveals the tree with the best score, how-
ever in practice due to the great number of trees this exhaustive search is not possible.
Therefore a starting point is created with the help of a fast algorithm that produces an
approximate tree, followed by local rearrangements to improve the tree score. These
methods are naturally much slower compared to NJ however the added accuracy justi-
fies their use and popularity.
A second interesting question is whether variable sites exist between our detected
genome and a genome of interest, typically named as the reference genome. The iden-
tification process is called variant calling and it is based on the observed nucleotide
counts at a single sequence position. Read coverage, base qualities, variant frequencies
and strand bias are of great importance during variant identification in order to differ-
entitate real variants from errors (Koboldt et al., 2012; McElroy et al., 2013, 2014).
A positional error model can be incorporated in the detection process (Flaherty et al.,
2012; Wilm et al., 2012). The reference genome may be a publicly available genome
sequence or the sequence of a currently circulating pathogen strain. When the goal is to
identify minority variants (variants of low frequency) within the pathogen population
in the clinical sample, the reference genome becomes the de novo assembled sequence
generated by the short read data.
Only in one case out of all the clinical samples analysed during the PhD project,
discussed in chapter 5 there were enough reads to recover the full pathogen genome
from a de novo assembly. The phylogenetic tree was reconstructed using PhyML
(Guindon et al., 2010), a maximum likelihood approach. Variants were identified using
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SAMtools (Li et al., 2009a; Li, 2011).
1.7 Objectives and proposed method
We previously discussed some of the limitations of the current classification meth-
ods limitations, especially when the setting is potential pathogen discovery where low
abundance organisms are of interest. A few of the methods are designed to work with
viruses, including sets of viral marker genes or offering support for BLASTx results.
However the most pronounced limitation is the high number of false positives in the
results. This drawback may cause users to focus on the higher abundance organisms in
the results, as the lower abundance organisms may well be false positives. Depending
on the research question, this can be a legitimate approach, however it may become
problematic for scenarios where detection of even minute amounts of a potential viral
pathogen in the sample is of interest. There are statistical tools we can use in order to
address this issue in a formal and elegant way. We propose to classify a single read
by borrowing information from the whole of a dataset and to consider the plausibility
of different community profiles. The main objective of this thesis is thus to develop
an open-source, sensitive, specific and accurate similarity based community profiling
method at a high taxonomic resolution, employing these two ideas.
Similarity methods use the output of tools that perform similarity searches and
record this information for pairs of query and subject sequences. Similarly, metaMix
works with the output of BLAST which can be rewritten as a sparse matrix that records
the mismatches between each sequence in the dataset and each sequence in the refer-
ence database, as presented in Table 1.1.
metaMix employes a parallel MCMC approach to explore the state-space of the
candidate organisms by comparing different combinations of species based on their
posterior probabilities. We can decompose the proposed method into two levels of in-
ference, one nested within the other. First we fit each model that represents a different
profile, that is a different combination of species, to the data. This first level corre-
sponds to the estimation of the model’s parameters given the model and the data. Prior
information or prior belief about the relative plausibility of the competing models can
be incorporated in the inference. Therefore second, we perform model comparison
in the light of the data, assigning suitable priors to the alternative models in order to
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penalise overly complex models.
The proposed method for the community profiling problem requires the explo-
ration of the candidate organisms state-space. The main challenge is computational;
even with a relatively small number of species to consider, the number of subsets of
this space that could explain the mixture grows exponentially. Efficient computational
strategies are required to make this problem tractable, so that the inference can be
achieved for modern scale metagenomics datasets. Our strategy is based on Parallel
Tempering, a Monte Carlo Markov Chain technique, using parallel computing to speed
up the inference. Within the Bayesian framework readily interpretable probabilities
such as the posterior probabilities of species sets can be used to quantify the support
for a species in the mixture.
I implemented metaMix in an R package, available on CRAN (http://cran.
r-project.org/web/packages/metaMix) and described in detail in chapters 3 and
4. metaMix produces posterior probabilities for various models as well as the relative
abundances under each model. Its performance and potential is demonstrated using
clinical samples, discussed in chapters 5 and 6 as well as benchmark metagenomic
datasets in chapter 4.
1.8 Thesis outline
The outline of the remaining thesis is as follows. Chapter 2 provides an introduction
to the statistical concepts that are central to this work: basics of Bayesian inference,
Monte Carlo methods, basic MCMC techniques, introduction to Parallel Tempering,
theory of Mixture Models as well as the missing data formulation. Chapter 3 connects
the concepts introduced in chapter 2 to the metagenomic community profiling problem.
with a description of how they are used to build the novel methodological framework.
Chapter 4 illustrates features of the metaMix R package using a toy dataset. metaMix
performance is assessed using benchmark metagenomic datasets. Chapter 5 demon-
strates the successful use of metaMix towards pathogen identification in two clinical
samples from patients with undiagnosed encephalitis. Chapter 6 describes the project
that was the original motivation for developing metaMix. This work aimed to inves-
tigate whether there viruses are triggering the onset of Type I Diabetes. Chapter 7
provides the conclusions and explores possible directions for future research.
Chapter 2
Bayesian methods and Monte Carlo
strategies
In this chapter we introduce the statistical concepts that are central to this thesis. These
will appear multiple times and are fundamental for understanding the proposed method-
ology for performing community profiling based on metagenomic data. We start by
discussing Bayesian methods in general, followed by an introduction to Markov Chain
Monte Carlo methods and Parallel Tempering MCMC, a discussion on Bayesian model
choice and model averaging and finally, a brief overview of Finite Mixture Models
theory.
2.1 Bayesian methods
Bayesian methods (Jeffreys, 1961; Gull, 1988) were initially introduced by Bayes and
Laplace in the 18th century and subsequently developed in the 20th century. Generally
in the Bayesian context the parameters θ are treated as random variables. Therefore
parameters are described by distributions, representing our belief about the parameters
values given the observed data and prior knowledge. According to Bayes theorem,
the posterior distribution that describes the probability of the parameters θ given the
data can be computed in terms of the data likelihood P(X |θ) and the prior distribution
pi(θ). The likelihood of the data is the probability of X conditioned on θ . The prior
distribution is our a priori belief about the value of parameter θ before observing the
data X . The posterior probability distribution of the parameters θ given the data X is:
P(θ |X) = P(θ ,X)
P(X)
=
P(X |θ)pi(θ)
P(X)
. (2.1)
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Certain choices for the likelihood and the prior can result in a convenient form for
the posterior distribution. In particular, there are cases in which for a given form of
the likelihood function, if the prior belongs to a family of distributions, then the poste-
rior also belongs to the same family. This property is known as closure under sampling
(Gelman et al., 2003) and we say that the prior and posterior are conjugate distributions.
For example, when the likelihood is modeled as a multinomial, the conjugate prior can
be a Dirichlet distribution. That means that the posterior will also be a Dirichlet dis-
tribution. The main motivation for using conjugate priors is their tractability, however
they can be constricting for the user.
The normalising constant P(X):
P(X) =
∫
P(θ ,X)dθ =
∫
P(X |θ)pi(θ)dθ (2.2)
is the average of the likelihood over the whole parameter space. This is an impor-
tant quantity as it represents the evidence for a particular model. P(X) is also called
marginal likelihood as we marginalise out θ from the joint distribution P(θ ,X). We
will discuss the issue of marginal likelihood estimation in a few sections.
Once the posterior distribution is available, features of θ such as means and vari-
ances of the individual θi require integrating over the posterior distribution. Therefore
Bayesian inference problems can be expressed as the expectation of a function of inter-
est f (θ), evaluated over the posterior distribution:
E[ f (θ)] =
∫
pi(θ |X) f (θ)dθ . (2.3)
In simple cases such integrals can be computed analytically, however in most re-
alistic problems computational methods are required. Simulations play a central role in
Bayesian analysis due to the relative ease with which samples can often be generated
from a probability distribution. Generating values from a probability distribution is
straightforward with modern computing techniques using pseudorandom number gen-
erators.
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2.2 Monte Carlo sampling
The main premise of Monte Carlo sampling is to use random samples from a specified
probability distribution to approximate difficult to evaluate integrals. In Bayesian anal-
ysis, this generally involves acquiring samples from the posterior distribution. Monte
Carlo methods approximate the expectation of a function of interest f (θ) evaluated
over the posterior distribution pi(θ |X), or else the integral 2.3, by drawing samples θi,
{i = 1, · · · ,n} independently and randomly from pi(θ |X). Additionally, if f is scalar-
valued then µ = E[ f (θ)] and s =
√
Var( f (θ)) are also scalars. We take the average as
our estimate of µ:
µˆ =
1
n
n
∑
i=1
f (θi). (2.4)
With independent samples θi the approximation can be made as accurate as desired
by increasing the sample size n, as ensured by the law of large numbers (Robert and
Casella, 2004). The mean of the estimator µˆ is:
E[µˆ] =
1
n
n
∑
i=1
E[ f (θi)] = µ. (2.5)
Therefore the Monte Carlo estimator is unbiased for µ . Additionally the variance of
the estimator is:
Var(µˆ) = E[(µˆ−µ)2] = 1
n2
E[(
n
∑
i=1
f (θi)−E[
n
∑
i=1
f (θi)])2] =
1
n2
Var(
n
∑
i=1
f (θi)) =
s2
n
.
(2.6)
Therefore the standard deviation of the Monte Carlo estimator is s√n . It is of importance
to note that the dimension of the space for the function f does not appear in the formula.
The Central Limit Theorem (CLT) tells us that the Monte Carlo converges at a rate of
1√
n (Liu, 2001), the error is normally distributed for large n and the complexity of the
computation depends only on the variance of θ . This is the second attractive feature
of Monte Carlo which motivates its use in high dimension problems, in contrast to
numerical integration methods which suffer from the curse of dimensionality. However
it is worth noting that the computation of f (θ) may also become challenging as when
f is complicated to compute then that step will also take time.
The basic Monte Carlo approach is to sample points randomly from the speci-
fied probability distribution. An obvious issue is that a lot of effort can be wasted
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in evaluating random samples located in regions where the function value is almost
zero. Therefore the basic Monte Carlo typically suffers from low efficiency. The un-
certainty of the estimator can be decreased by increasing n, but this converges very
slowly. There are ways to overcome this using variance reduction techniques, such as
Importance Sampling.
A second issue relevant to Bayesian analysis is that it is not always easy to draw
from a complex posterior distribution directly. In simple Bayesian models, especially
if conjugate prior distributions have been assumed this can be straightforward, how-
ever in more realistic problems this will not be the case. We might instead generate
independent samples from some simpler approximating distribution and then compen-
sate for the use of the wrong distribution. Alternatively, with non-independent samples
θi, equation (2.4) still holds when the samples are drawn throughout the support of
pi(θ |X) in the correct proportions. We can achieve this by simulating a Markov chain
that converges to the correct distribution.
2.3 Importance Sampling
Importance Sampling (IS) (Liu, 2001) is a method of determining the properties of a
distribution by drawing samples from another distribution. More specifically IS is a
method for computing expectations using random samples drawn from an approxima-
tion to the target distribution. The main idea of IS is to use importance functions instead
of the original distributions, in order to focus on regions of importance and not waste
simulations. We are interested in evaluating 2.3, given an arbitrary density g that is
positive when pi(θ) f (θ) is not zero.
The algorithm steps are the following: we first choose an efficient IS proposal
distribution g(θ), generating n samples from it. We then compute the IS weights:
wi =
pi(θi)
g(θi)
(2.7)
and we approximate 2.3 by:
Iˆ =
n
∑
i=1
f (θi)w(θi) (2.8)
which is the unbiased IS estimator. In equation 2.8 the ratio pi(θ)g(θ) needs to be known
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exactly. When this is not the case, we use the following weighted IS estimate:
Iˆ =
∑ni=1 f (θi)w(θi)
∑ni=1 w(θi)
(2.9)
where the ratio pi(θi)g(θi) only needs to be known up to a multiplicative constant.
A common problem with IS is that the selection of a good importance sampling
distribution can be difficult, with a poor choice resulting to mediocre estimators with
infinite variance. This is especially pronounced when the importance weights are
small with high probability but very large with a low probability. This can happen
if pi(θ) f (θ) has wide tails compared to g(θ). This difficulty can limit the applicability
of the method and for this reason we need to introduce more sophisticated sampling
algorithms based on Markov chains.
2.4 Markov Chain Monte Carlo
Markov Chain Monte Carlo (MCMC) (Gilks, 1999), (Robert and Casella, 2004) is es-
sentially Monte Carlo integration using Markov Chains. MCMC techniques are often
used to solve integration and optimisation problems in high dimensional spaces. As
discussed before, integration has a central role in Bayesian statistics and MCMC is a
known general approach for providing a solution within a reasonable time, when it is
not numerically tractable. Some typically intractable integration problems are involved
in making inference for model parameters or making predictions. The main idea for
the MCMC methods is that they can construct a Markov chain whose stationary distri-
bution (or else invariant distribution) is the posterior distribution of interest. We briefly
introduce the theory underlying MCMC methods, and we then describe the general
form of MCMC given by the Metropolis-Hastings algorithm.
2.4.1 Markov Chains
Assume a sequence of random variables {θ (0),θ (1),θ (2), · · ·} such that given the cur-
rent state θ (t) at each time t ≥ 0, the distribution of the next state θ (t+1) does not depend
further on the history of the chain {θ (0),θ (1), · · · ,θ (t−1)}. The distribution of the initial
state θ (0) and the transition kernel Pr(θ (t+1)|θ (t) = θ) define the Markov Chain {θ (t)}.
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A Markov Chain is said to have stationary distribution pi(θ) if:
θ (t) ∼ pi(θ)⇒ θ (t+1) ∼ pi(θ). (2.10)
A Markov chain displays detailed balance for the distribution pi(θ) if the following
holds for any two states θ (t) and θ (t+1):
pi(θ (t))P(θ (t+1)|θ (t)) = pi(θ (t+1))P(θ (t)|θ (t+1)). (2.11)
Finally a Markov chain is irreducible, if there is positive probability to move from any
state to any other state in a finite number of steps.
2.4.2 The Metropolis-Hastings algorithm
The Metropolis-Hastings (MH) algorithm (Hastings, 1970), (Chib and Greenberg,
1995) simplifies the task of creating a chain whose stationary distribution corresponds
to the posterior distribution. With the MH algorithm at each time t, the next state θ (t+1)
is chosen by first sampling a candidate point θ ′ from a proposal distribution q(.|θ (t)).
The proposal distribution q can have any form and it may also depend on the current
point θ (t). The candidate point θ ′ is accepted with probability α(θ ,θ ′) where:
α(θ ,θ ′) = min(1,
pi(θ ′)q(θ |θ ′)
pi(θ)q(θ ′|θ) ). (2.12)
If the candidate point is accepted, the next state becomes θ (t+1) = θ ′, otherwise
θ (t+1) = θ (t). The steps of the algorithm are described below in Alg. 2.1.
Algorithm 2.1 Metropolis Hastings algorithm
• Initialization θ (0)
• At iteration t
1. Sample a point θ ′ from q(.|θ (t)) .
2. Sample a Uniform(0,1) random variable U .
3. If U ≤ α(θ ,θ ′) set θ (t+1) = θ ′ else set θ (t+1) = θ (t) .
To control for the effect of where in the distribution the chain was initialized, the
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initial part of the posterior samples is discarded as burn-in. Burn-in samples are the
initial samples that are not representative of the stationary distribution. Depending on
the context, different fractions of burn-in may be appropriate.
2.5 Parallel Tempering MCMC
In some cases simple MCMC methods are not able to correctly traverse the state space.
This is because the models used to analyse the data are often complex leading to poor
mixing of the chains. That means that Markov chain simulations may remain in the
neighborhood of a single mode for a long period of time. This occurs primarily when
different modes are separated by regions of low posterior density. Then it is difficult to
move from one mode to the other because jumps to the region between the two modes
will be rejected. Such a chain will move between modes only rarely, taking a long time
to reach equilibrium.
A potential solution is to perform parallel tempering MCMC (PT MCMC)
(Brooks, 1998; Earl and Deem, 2005) which relies on a family of “tempered” distri-
butions, each of which is obtained by varying a temperature parameter T . Each chain
simulates from the posterior distribution pi(θ) raised to a temperature
{t1 = 1T1 , t2 =
1
T2
, . . . , tmax =
1
Tmax
}. (2.13)
The different temperature levels result in tempered versions of the posterior distribution
pi(θ)t=1/T , where t ∈ (0,1]. When temperature is low and more specifically when T =
1, the draws are from the posterior distribution, i.e pi(θ)t1 = pi(θ). While pi(θ)t j is not
too different from pi(θ)t j+1 , the temperature ladder results in a considerable difference
between pi(θ) and pi(θ)tmax in that the latter has fewer isolated modes. In practice that
means that the posterior distribution at higher temperatures spreads out its mass and
becomes flatter, so that it is considerably easier to sample using MCMC techniques.
The basis for any subsequent inference is the sample path of the chain with the correct
stationary distribution, i.e solely the original posterior distribution with T = 1.
Therefore the main idea of PT MCMC is to allow a collection of n synchronised
Markov Chains run in parallel and exchange information probabilistically, creating
global moves that result in faster mixing. The algorithm is summarized in Alg. 2.2.
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Algorithm 2.2 Parallel Tempering MCMC algorithm
1. Initialization of Markov chain (done for all n chains).
2. Mutation step at iteration t (done for all n chains).
• Acceptance probability:
α(θ ,θ ′) = min(1,
pi(θ ′)q(θ |θ ′)
pi(θ)q(θ ′|θ) ). (2.14)
q(θ |θ ′) the probability of transitioning from θ ′ to θ .
• If the step is accepted, the chain moves to proposed state θ ′.
• If not accepted, the chain’s current state becomes the previous state of
the chain.
3. Exchange step when all chains have advanced a prespecified number of iter-
ations, e.g one iteration.
• Proposes to swap the value of 2 chains adjacent in terms of T , respective
chain values θi and θ j, respective temperatures t1 = 1T1 & t2 =
1
T2
, T1 <
T2.
• Acceptance probability (Jasra et al., 2007):
A = min{1, pii(θ j)
pii(θi)
pi j(θi)
pi j(θ j)
}. (2.15)
In parallel tempering there are essentially two types of moves. The first is the
mutation step, which simply is the within chain move we described in the previous
section. This is accepted with probability given by (2.14). The other is the exchange
step, a between chains move (Figure 2.2).
This Metropolis-Hastings move proposes to swap the value of two chains i and
j, adjacent in terms of t = 1T , with respective temperatures t1 =
1
T1
and t2 = 1T2 where
T1 < T2. Suppose that the values of the two chains are θi and θ j respectively, corre-
sponding to two different sets of species. The move is accepted with probability given
by equation 2.15.
When θ j has a higher probability than θi, the exchange will always be accepted.
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Chain1
Chain2
Chain3
Chain4
Exchange Unsuccesful
Exchange Unsuccesful
Exchange Succesful
Exchange Succesful
Figure 2.1: Schematic of parallel tempering. Exchanges are attempted between chains of
neighboring temperatures, where Chain1 at T1 = 1, T1 < T2 < T3 < T4.
This is simple to show considering pii(θi) and pi j(θ j):
log
pii(θ j)
pii(θi)
pi j(θi)
pi j(θ j)
= log
pi(θ j)t1pi(θi)t2
pi(θi)t1pi(θ j)t2
(2.16)
= (t1− t2)(logpi(θ j)− logpi(θi)). (2.17)
Since t1 > t2 and logpi(θ j) > logpi(θi), the move is always accepted. Allowing the
chains to swap states facilitates jumps between separate modes and improves the mix-
ing rate of the cold chain, ensuring a global exploration of the model state space. Even-
tually hot and cold chains will progress towards a global mode. We demonstrate this by
plotting the log-likelihoods for 4 tempered chains (out of 16) across iterations (Figure
2.3, based on data from clinical case 1 in chapter 5).
2.6 Bayesian model choice and model averaging
Marginal likelihood estimation has a central role in comparing different models
{M1, . . . ,Mm}, helping us to assess which model is most plausible given the data. The
marginal likelihood is a weighted average of the likelihood, with the weights coming
from the prior. To compute the marginal likelihood P(X |Mk) for the model Mk we have
to average over the parameters with respect to the prior distribution pi(θk|Mk), where
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T1
T2
T3
T4
Figure 2.2: The posterior distribution at higher temperature spreads out its mass and becomes
flatter. Overlap between chains at different temperatures allows for acceptance of
the the exchange moves. T1 = 1, T1 < T2 < T3 < T4.
θk are the model parameters:
P(X |Mk) =
∫
θk
P(X |θk,Mk)pi(θk|Mk)dθk. (2.18)
The posterior probability of the model Mk is:
P(Mk|X) ∝ P(X |Mk)P(Mk). (2.19)
The term P(X |Mk) is the evidence for model Mk, which appears as the normalising
constant in Bayes theorem 2.1. P(Mk) on the other hand is the prior belief we hold for
each model. It essentially expresses how plausible we thought the alternative models
were before observing the data. If we were to assume that there is no strong reason to
assign very different priors to the alternative models, the models would be ranked just
by the marginal likelihood, otherwise by the posterior probability of the models.
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Figure 2.3: Log-likelihood traceplot of tempered distributions, where Chain1 at T1 = 1, T1 <
T6 < T12 < T15.
Let us assume that we want to assess the performance of two different models M1
and M2. The Bayes Factor (Kass and Raftery, 1995) provides the relative weight of
evidence for model M1 compared to model M2 and it is formulated as below:
BF =
P(X |M1)
P(X |M2) (2.20)
and therefore the posterior odds is simply the multiplication of the Bayes Factor with
the prior odds:
P(M1|X)
P(M2|X) =
P(X |M1)
P(X |M2)
P(M1)
P(M2)
. (2.21)
Approximating the marginal likelihood is a task both difficult and time-consuming
(Marin and Robert, 2008). Accounting for the uncertainty in parameters θ , a Monte
Carlo approximation can be used for the marginal likelihood, by drawing independent
samples from the prior to estimate P(X) and averaging the likelihood. The simulation
from the prior is computationally inefficient, as the majority of samples are outside the
regions of high likelihood.
Importance sampling techniques can be used to reduce the variance of the estima-
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tor (Liu, 2001). If we let an MCMC sampler to explore the IS proposal distribution g,
the marginal likelihood can be estimated using n sampled values (y1, · · · ,yn) as below:
Iˆ =
n
∑
i=1
aiP(X |yi)
∑i ai
=
1
n
n
∑
i=1
P(X |yi)pi(yi)
g(yi)
1
n
n
∑
i=1
pi(yi)
g(yi)
(2.22)
where yi represents the ith parameter vector sampled from the importance distribution,
P(X |yi) is the likelihood computed at yi and ai is the importance weight for observation
i computed as in equation 2.7.
The choice of the importance distribution is a crucial step that defines the stability
and the accuracy of the IS estimator. In order for the method to work efficiently we want
to make the estimation error as small as possible. The posterior distribution is a conve-
nient choice as we can use the same MCMC runs we already have from the parameter
estimation step. This essentially means that the marginal likelihood is estimated from
MCMC samples that must be collected anyway. However using the posterior distri-
bution or an approximation to the posterior, as the importance distribution means that
the IS estimator becomes the Harmonic Mean Estimator (HME) (Newton and Raftery,
1994), as shown below:
Iˆ =
1
n
n
∑
i=1
P(X |yi)pi(yi)
1
P(X |yi)pi(yi)
P(X)
1
n
n
∑
i=1
pi(yi)
1
P(X |yi)pi(yi)
P(X)
=
1
n
n
∑
i=1
1
1
n
n
∑
i=1
pi(yi)
P(X |yi)pi(yi)
=
n
n
∑
i=1
1
P(X |yi)
. (2.23)
The Harmonic Mean Estimator has unfortunately been one of the most popular choices
for estimating the marginal likelihood, due to its simplicity. However using the HME
is known to be unstable and to overestimate the marginal likelihood P(X) (Xie et al.,
2011).
In order to overcome this issue and to make the distribution tails heavier, we
perform Defensive mixture Importance Sampling (Hesterberg, 1995). This can be
achieved by selecting the importance distribution g to be fairly similar to the target
distribution but with heavier tails, that is “close” in shape to pi(y)P(X |y). This simple
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solution ensures that the weights will always be finite and in practice will not be ex-
tremely large, by using a mixture of the posterior and the prior as the IS distribution.
The main idea is the incorporation of a heavy tail component in the importance function
g, effectively substituting it by the mixture:
λg+(1−λ )pi,0 < λ < 1 (2.24)
where λ is close to 1, g is the approximation to the posterior using the already obtained
MCMC samples and pi the prior that acts as the stabilizing factor. In practice that means
that the samples we use for the defensive IS estimator are generated with probability
λ from g and with probability 1− λ from pi . This approach is only slightly costlier
in computational time compared to the typical IS. On the other hand the price we pay
for the inclusion of the stabilization factor is that it increases the variance compared to
using ordinary IS.
Up to this point the basis of the discussion has been model selection, however fre-
quently there may be ambiguity over which single model to select. Using a model for
further inference could imply that we are completely certain that the reported model
generated the data, which is typically not the case. Bayesian model averaging (BMA)
(Hoeting et al., 1999) offers a solution to incorporate model uncertainty by averaging
over all models. This model average is proportionally weighted by the models’ poste-
rior probabilities. The posterior probability of model Mk is:
P(Mk|X) = P(X |Mk)P(Mk)∑mi=1 P(X |Mi)P(Mi)
. (2.25)
This equation (2.25) provides a way of summarizing model uncertainty after observing
the data. As an example the BMA estimate of a parameter θ is (Hoeting, 2002)
θˆBMA =
m
∑
k=1
θˆkP(Mk|X) (2.26)
where θˆk is the posterior mean for θ for model Mk.
Bayesian model averaging involves different challenges such as the computation
of marginal likelihood for a large number of models or the specification of the priors
for the different models. A popular approach for managing the sum in 2.25 is to explore
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the space of models using an MCMC.
2.7 Finite mixture model
A finite mixture model provides a flexible way to model heterogeneous data. Mixture
distributions are typically used to model data where each observation has arisen from
one of a number of different groups. Let us assume that the data of interest belong to
one of k classes, while the individual class memberships are unavailable.
In a finite mixture model, data X = (x1, . . . ,xn) is modeled by a mixture of k fixed
probability distributions (McLachlan and Peel, 2000):
p(xi|θ ,k) = p(xi|θ) =
k
∑
j=1
w j f (xi|φ j) (2.27)
where w= (w1, ...,wk) are the mixture weights constrained that 0≤w j ≤ 1 and∑ j w j =
1. The component distributions ( f1 = f (X |φ1), . . . , fk = f (X |φk)), describe the proba-
bilistic mechanism of generating data from each category, with f j(xi) = pi j the probabil-
ity of observing xi conditional on the assumption that it originated from category j. Let
us assume that the component distributions are discrete distributions. For the remainder
of the thesis when we refer to mixtures we assume these are mixtures of discrete disti-
butions over a finite number of categories. φ = (φ1, ...,φk) are the component specific
parameters. With θ we represent the entire set of model parameters, that is both the
mixture weights and the component parameters: (θ1, ...,θk) = ((w1,φ1), ...,(wk,φk)).
Deriving analytically the maximum likelihood estimators or Bayes estimators is
practically impossible due to the mixture model representation in 2.27. Even though
conjugate priors may be used for both mixture and component parameter, the explicit
representation of the corresponding posterior expectation involves the expansion of the
likelihood:
n
∏
i=1
k
∑
j=1
w j f (xi|φ j) (2.28)
into kn terms. This is computationally prohibitive for more than a few observations. Al-
gorithms such as the Expectation-Maximization (EM) algorithm (Dempster and Laird,
1977) or the Gibbs sampler (Diebolt and Robert, 1994) address the problem of solv-
ing the likelihood equations for mixtures of distributions. We introduce both below,
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starting with the concept of missing data.
Before we proceed, let us assume for all following mixture model discussions that
only the mixture weights are unknown (which means that the component parameters are
completely specified and need not be estimated) as this will be the case when applied
to the metagenomics problem of community profiling.
2.7.1 Missing data structure
In the mixture model setting each observation xi, 1 ≤ i ≤ n is assumed to arise from
a specific but unknown component of the mixture. The mixture structure is deconvo-
luted by the introduction of latent variables: we associate xi with zi = (zi1, . . . ,zik), a
k-dimensional vector indicating to which component xi belongs.
zi j =
 1 if xi belongs to class j0 otherwise (2.29)
Therefore, each vector zi is generated by a multinomial distribution consisting of one
draw on k categories with probabilities w. We write zi ∼ Multk(1;w1, . . . ,wk). The
likelihood of the complete-data (the observed and missing data) (X ,Z) = (xi,zi, i =
1, . . . ,n) is:
p(X ,Z|w) =
n
∏
i=1
k
∏
j=1
(w j pi j)zi j . (2.30)
Integrating out the missing data z1, . . . ,zn we get the model (2.27):
p(Xi|w) =
k
∑
j=1
Pr(zi = j|w)p(Xi|zi = j,w) =
k
∑
j=1
w j pi j. (2.31)
The classification probability that observation xi arises from j− th component of the
mixture, is (McLachlan and Peel, 2000):
zˆi j =Pr(zi = j|xi,w)= Pr(zi = j,xi|w)Pr(xi|w) =
Pr(zi = j|w)p(xi|zi = j,w)
∑kj=1 Pr(zi = j|w)p(xi|zi = j,w)
=
w j pi j
∑kj=1 w j pi j
.
(2.32)
2.7.2 Model fitting - EM
The Expectation Maximization (EM) approach to parameter estimation is a numerical
optimisation procedure designed to obtain point estimates of the parameters by maxi-
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mizing the likelihood (Dempster and Laird, 1977). This paper addressed the problem
of solving the likelihood equations for mixtures of distributions, making it one of the
first applications of EM. The algorithm is based on the missing data representation in-
troduced in the previous section 2.7.1 and it consists of two steps. In the first step, the
expected value of the missing variables zi is computed based on p(Z|X ,w). In the next
step we calculate the new mixing parameters w that maximize the expected complete-
data log likelihood. The process is iterated until convergence.
The complete-data likelihood is given by:
p(X ,Z|w) =
n
∏
i=1
k
∏
j=1
(w j pi j)zi j (2.33)
and the expected complete-data log likelihood by:
E[ln p(X ,Z|w)] = ∑
Z∈Z
p(Z|X ,w) ln p(X ,Z|w) (2.34)
where Z is the space of all possible values of Z, p(Z|X ,w) = ∏ni=1 p(zi|xi,w) and
∑Z∈Z p(Z|X ,w) = 1.
The EM algorithm is described below in Algorithm 2.3. It has been proved that at
each iteration the likelihood is guaranteed to increase (Dempster and Laird, 1977).
2.7.3 Model Fitting - Gibbs sampling
Bayesian approaches to mixture modelling have become increasingly popular (Marin
et al., 2005), as they allow for probability statements to be made directly about the
unknown parameters. Additionally prior beliefs can be included in the analysis. Similar
to EM they also allow the complicated structure of a mixture model to be simplified
through the use of latent variables. Gibbs sampler (Diebolt and Robert, 1994) is a
Markov Chain Monte Carlo method particularly suited to the mixture model context.
The Gibbs sampler is based on the successive simulation of z and w. After con-
vergence we obtain the full posterior distribution of w. A practical prior for the mixing
parameters w is the Dirichlet distribution (equation 2.38), owing to its conjugate status
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Algorithm 2.3 EM algorithm
• Initialization w(0)
• At iteration t
1. Expectation step. Generate z(t)i from p(z
(t)
i = j|xi,w(t−1)j ).
zˆi j =
p(zi = j,xi|w)
p(xi|w) =
p(zi = j|w)p(xi|zi = j,w)
∑kj=1 p(zi = j|w)p(xi|zi = j,w)
=
w j pi j
∑kj=1 w j pi j
(2.35)
2. Maximization step. Given zi from E-step, calculate new w(t) that
maximize the expectation of the complete-data log-likelihood (eq.2.34).
w(t) = argmax
w
E[ln p(X ,z|w)] (2.36)
It can be shown that this
w(t) =
∑ni=1 z
(t)
i
N
(2.37)
to the multinomial distribution.
pi(w) = Dir(α1, . . . ,αk) =
Γ(
k
∑
j=1
α j)
k
∏
j=1
Γ(α j)
k
∏
j=1
wα j−1j =
1
B(α)
k
∏
j=1
wα j−1j (2.38)
where α is positive. Generally, choosing a conjugate prior makes it possible to per-
form Bayesian inference in a computationally efficient manner. We can deduce that
the posterior pi(w|z) (equation 2.42) is a Dirichlet with parameters (αk + nk) since
pi(w|z) ∝ pi(z|w)pi(w).
The conjugate prior pi(w) for w is the Dirichlet distribution with parameters α =
{α1. . . . ,αk}. Additionally the likelihood is multinomial:
pi(z|w) = n!
∏nk!
k
∏
j=1
wn jj . (2.39)
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Therefore
pi(w|z) ∝ pi(z|w)pi(w) = n!
∏nk!
k
∏
j=1
wn jj
1
B(α)
k
∏
j=1
wα j−1j =
1
B(α+n)
k
∏
j=1
wα j+n j−1j
(2.40)
i.e sampling from Dir ∼ (α1+n1, . . . ,αk +nk) .
The algorithm is described in Alg. 2.4.
Algorithm 2.4 Gibbs Sampler algorithm
• Initialization w(0)
• At iteration t
1. Generate z(t)i from p(z
(t)
i = j|xi,w(t−1)j ). So
zi ∼Mult(1; ˆzi1(t−1), . . . , zˆik(t−1)) (2.41)
where zˆi j is given by equation 2.35.
2. Compute n(t)j = ∑
n
i=1 z
(t)
i j .
3. Generate w(t) from
pi(w|z(t))∼ D(α1+n(t)1 , . . . ,αk +n(t)k ). (2.42)
Chapter 3
Bayesian mixture models for
metagenomic data
The methodological work presented in this chapter is my proposed approach for per-
forming community profiling in metagenomic data. The ideas introduced in the previ-
ous chapter 2 are connected here to the community profiling problem.
metaMix considers the competing models that could accommodate our observed
data, that is the BLASTx similarity between the reads and the reference proteins (Table
1.1), and compares them. The different models represent different sets of species being
present in the sample. The method works on two levels of inference: in the first instance
we assume a set of species to be present in the sample and we estimate this model’s
parameters given the data. The other level of inference is the model comparison so as to
assess the more plausible model. The process is iterated in order to explore the model
state space. In the following sections we describe in detail how each step of metaMix
is implemented and the algorithm is summarised in Algorithm 3.1.
3.1 Model specification assuming a fixed set of species
Assuming a given set of K species from which the reads can originate, the metagenomic
problem can be summarized as a mixture problem, for which the assignment of the
sequencing reads to species is unknown and must be determined. The data consist of
N sequencing reads X = (x1, . . . ,xN). We have recorded the number of mismatches
between pairs of translated reads and proteins as produced by BLAST (Table 3.1).
If a read matches multiple proteins from the same species, we keep only the best
match. For simplicity, we assume a one to one relationship between a species proteins
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Table 3.1: Sparse dissimilarity matrix - input for community profiling taken from BLAST re-
sults
species1 species2 . . . speciesK
read1 m11 m12 . . . m1K
read2 m21 m22 . . . m2K
. . .
readN mN1 mN2 . . . mNK
and the species itself. Therefore, we drop the protein information and only keep a
record of mismatches between each read and the different species.
Therefore for a given read xi we can write the likelihood based on equation 2.27:
p(xi|w,K) = p(xi|w) =
K
∑
j=1
w j f j(xi) (3.1)
where w= (w1, ...,wK) represent the proportion of each of the K species in the mixture.
The mixture weights are constrained such that 0 ≤ w j ≤ 1 and ∑ j w j = 1. In practice
for our purposes, we also add a single category (species K+1) which we refer to as the
“unknown” category, and captures the fact that some reads cannot be assigned to any
species. This may be due to the fact that the reads originate from species not included
in our reference database of choice and that do not have close relatives in the database.
Alternatively they may be originating from truly undiscovered species.
Additionally f j(xi) = P(xi|xi from species j) = pi j is the probability of observing
the read xi conditional on the assumption that it originated from species j. We model
this probability using the number of mismatches mi j between the translated read se-
quence i and the reference sequence j and a Poisson distribution with parameter λ for
that number of mismatches:
pi j =
Pois(mi j;λ )
lg
(3.2)
where lg is the length of the reference genome, when short reads are matched to a
nucleotide database. For nucleotide matching, lg has a large impact on the probability
computation. However, when matching against protein databases, the more limited het-
erogeneity of protein lengths results in a much smaller impact of the length parameter.
In addition, incomplete annotation can potentially make the inclusion of protein length
problematic for the pi j computation. Consequently, for protein matched sequences, we
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simply defined our pi j as:
pi j = Pois(mi j;λ ) (3.3)
Therefore for a given set of K species, the pi j probabilities are completely speci-
fied (Table 3.2) and only the mixture weights need to be estimated.
Table 3.2: Sparse matrix of pi j probabilities
species1 species2 . . . speciesK
read1 p11 p12 . . . p1K
read2 p21 p22 . . . p2K
. . .
readN pN1 pN2 . . . pNK
Combining the above we conclude that when we know the set of species, the mix-
ture distribution gives the probability of observing read xi: ∑Kj=1 w j pi j namely equation
(2.27). We therefore write the likelihood of the dataset X as a sum of Kn terms:
P(X |w) =
n
∏
i=1
[
K
∑
j=1
w j pi j]. (3.4)
3.1.1 Choice of parameter values
We have currently set λ to 0.03, that is we would expect by chance three mismatched
nucleotides (respectively three mismatched amino acids) per 100 nucleotides (amino
acids), including both sequencing errors and mutations. The λ parameter is currently
non tunable but this will be amended in the next metaMix release. However the users
can control how divergent species are treated by metaMix by increasing or decreasing
the value of piunknown. This is the default probability for reads to be generated by the
unknown category, which is the collective of unknown/undiscovered taxa.
In order to choose a value for the piunknown in the protein comparison context,
we tested different values and settled on 10−6. For λ = 0.03 the reads that have fif-
teen or more mismatches per 100 amino acids (∼85% similarity) to the proteins in the
reference database, will have pi j smaller than piunknown = 10−6. Even though the con-
tribution of each species j to the likelihood is defined by both the pi j and its relative
mixture weight w j as seen by equation 3.4, in the most typical scenarios species that
are supported only by low similarity reads will not be retained in the species profile and
therefore these reads will be assigned to the unknown category. We found this value to
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offer a good balance, allowing us to consider divergent matches but at the same time to
retain a level of stringency in the results. However, users can set different values for the
unknown pi j increasing or decreasing the effect non-exact matches have in the results.
Finally, if the users wish to investigate the nature of their unclassified reads, they
can retrieve these from the results for follow up analyses.
3.2 Estimation of mixture weights
Assuming we know the set of species present, we wish to estimate species abundances,
that is the mixture weights. The probabilistic assignment of reads to species involves
the expansion of the likelihood into Kn terms which is computationally infeasible
through direct computation. An efficient estimation can be performed by the intro-
duction of unobserved latent variables that code for the read assignments. As discussed
previously, either the Expectation-Maximization (EM) algorithm or the Gibbs sampler
could be used to estimate the mixture weights w. EM returns a point estimate for w
while the Gibbs sampler the distribution of w. Both methods were implemented and
provided comparable results, but we chose the EM for computation speed.
3.3 Marginal likelihood estimation
Each combination of species, or else each different community profile, corresponds to
a finite mixture model for which the marginal likelihood can be estimated. Let us as-
sume we wish to compare the different models {M1, . . . ,Mm}. The marginal likelihood
P(X |Mk) for the mixture model Mk with parameters θk is given by equation (2.18). The
posterior probability of the model is given by P(Mk|X) ∝ P(X |Mk)P(Mk).
The prior P(Mk) can be specified depending on the context and the basis of our
interpretation is that parsimonious models with a limited number of species are more
likely. Thus, in this Bayesian framework, our default prior uses a penalty limiting the
number of species in the model: P(Mk)∝ penalty(number of species in Mk). We approximate
this penalty factor based on a user-defined parameter r that represents the species read
support required by the user to believe in the presence of this species.
We compute the logarithmic penalty value as the log-likelihood difference be-
tween two models: model Munknown which is our starting point when we have no
knowledge about which species are present and therefore all N reads come from the
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“unknown” category (pi j = 10−6) and model Mr where r reads have a perfect match to
a species (pi j = 1) and the remaining N−r reads belong to the “unknown” category:
log penalty = logP(Munknown|X)− logP(Mr|X). (3.5)
For DNA sequence analysis, the pi j probabilities for the r reads originating from this
unspecified species are approximated by 1/(median genome length in the reference
database). This read support parameter reflects the number of unique reads required to
support the hypothesis that a species is present.
From now on, when we refer to the marginal likelihood, we mean the marginal
likelihood for a specific model and we forego conditioning on the model Mk in the
notation. Additionally, in our mixture model pi j are completely specified, therefore the
model parameters θk are solely the mixture weights w. Hence the marginal likelihood
equation (2.18) described in the previous chapter becomes:
P(X) =
∫
w
P(X |w)pi(w)dw (3.4)=
∫
w
∏
i
[∑
j
w j pi j]pi(w)dw. (3.6)
We implemented the Defensive mixture IS procedure for the estimation of the marginal
likelihood, by using a mixture of posterior and prior as the IS distribution. We chose
the Defensive mixture IS technique for the relatively simple implementation compared
to other approaches. This is crucial as we perform this approximation numerous times,
for every species combination we consider.
We first approximate the posterior distribution P(w|X) with a normal multivariate
distribution g. We use the output of the Gibbs sampler to estimate the mean vector µ
and the covariance matrix Σ for the parameters w and setting these as the parameters
for the multivariate normal N (µ ,Σ). We then incorporate a heavy tail component in
the importance function g by using the prior distribution pi(w) . Finally, we generate n
samples 1≤ i≤ n, for the defensive IS estimator which are generated with probability
λ = 0.95 from g and with probability 1−λ = 0.05 from pi .
However the goal of this work is to deliver results within an actionable time-frame
in a clinical setting. We wish to speed up the computation without compromising the
accuracy and the sensitivity of the results. For that reason, we use a point estimate of the
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marginal likelihood by means of the Expectation-Maximization (EM) algorithm. The
different approaches were used on the benchmark dataset. The results were compared
and are discussed in chapter 4, section 4.3.6. The resulting taxonomic assignment as
well as the species relative abundance estimates were similar between them, with the
EM approach resulting in a 13-fold speed increase.
3.4 Model comparison: exploring the set of present
species
We use a Monte Carlo Markov Chain (MCMC) to explore the set of present species of
size 2S−1, where S is the total number of potential species. In practice we observe that
S can be greater than 1,000. The MCMC must explore the state-space in a clinically
useful timespan. Therefore we reduce the size of the state-space, by decreasing the
number of S species to the low hundreds. We achieve this by fitting a mixture model
with S categories, considering all potential species simultaneously. Post fitting, we
retain only the species categories that are not empty, that is categories that have at least
one read assigned to them.
Let us assume that at step t, we deal with a set of species that corresponds to the
mixture model Mk. At the next step (t + 1), we either add or remove a species and
the new set corresponds to the mixture model Ml . The step proposing the model Ml is
accepted with probability:
A(Mk→Ml) = min{1, P(X |Ml)
(t+1)P(Ml)
P(X |Mk)(t)P(Mk)
q(Ml →Mk)
q(Mk→Ml)} (3.7)
where q(Ml →Mk) is the probability of proposing model Mk when currently at model
Ml . In other words, this is the probability of adding or removing the species to the Mk
set of species that took us to the Ml set of species. If the step is accepted, then the chain
moves to the new proposed state Ml . Otherwise if not accepted, the chain’s current state
becomes the previous state of the chain, which means that the set of species remains
unchanged.
metaMix outputs log-likelihood traceplots so that the user can visually inspect the
mixing and the convergence of the chain. The original version of metaMix was based
on the use of a single chain MCMC. The likelihood traceplots we would obtain from
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metaMix on different datasets were indicative of poor mixing of the chain (Figure 3.1a).
As discussed in the previous chapter this occurs when different modes are separated by
regions of low posterior density. This suggested that simple MCMC does not efficiently
explore the complex model state space we typically work with in the metagenomic field
and that such a chain would take a long time to reach equilibrium.
In the parallel tempering MCMC setting, each chain simulates from the posterior
distribution P(Mk|X)=g(Mk) raised to a temperature {t1 = 1T1 , t2 =
1
T2
, . . . , tmax = 1Tmax}
where model Mk comes from a collection of models {M1, . . . ,Mm} each corresponding
to a different set of species. The mutation move is defined as above by 3.7 and the
exchange move between two neighboring chains k1 and k2 with values Mk1 and Mk2
respectively, corresponding to two different sets of species, becomes:
A = min{1, gk1(Mk2)
gk1(Mk1)
gk2(Mk1)
gk2(Mk2)
}. (3.8)
The chains are adjacent in terms of t = 1T , with respective temperatures t1 =
1
T1
and
t2 = 1T2 where T1 < T2.
Using the metaMix output for one of the clinical datasets, we plotted the log-
likelihoods for the second half of 3000 iterations for a single chain MCMC (Figure
3.1a). We compare this with the parallel tempering MCMC output, plotting for the
cold chain the second half of 1000 iterations (Figure 3.1b). It is easy to observe that
the cold chain from the PT MCMC exhibits better mixing, as it moves around the state
space with ease. Aditionally a snapshot of the traceplots during iterations 500-1000
reveals that the PT MCMC is moving between areas of greater likelihood compared to
the single chain MCMC (Figure 3.2).
We have found that discarding the first 20% of the iterations as burn-in is enough
and we have therefore set this as the default setting. We concentrate on the remaining
80% to study the posterior distribution over the model choices. We want to incorporate
model uncertainty and thus we perform Bayesian model averaging as described before.
A useful summary is the posterior probability that a specific species is present
in the community profile post burn-in. The different species combinations may be
represented by a vector of binary variables, (S1, . . . ,Sk) where S j is an indicator for the
inclusion of species j under a specific model. We write this posterior probability as
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Figure 3.1: a. Log-likelihood trace plot for single chain MCMC and b. for PT chain at temper-
ature T=1.
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Figure 3.2: Traceplot snapshot at 500-1000 iterations for single chain MCMC and cold chain
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P(S j = 1|X) and it can be obtained by summing the posterior model probabilities over
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all models where species j is present.
P(S j = 1|X) =
m
∑
q=1
p(Mq|X)p(S j = 1|Mq,X). (3.9)
The species presence information is recorded by metaMix as in the example in Table
3.3.
S1 S2 · · · S j · · · Sk
model M1 0 1 · · · 0 · · · 0 p(M1|X)
· · · · · · · · · · · · · · · · · · · · · · · ·
model Mq 1 1 · · · 0 · · · 0 p(Mq|X)
model M(q+1) 1 0 · · · 0 · · · 0 p(Mq+1|X)
· · · · · · · · · · · · · · · · · · · · · · · ·
model Mn 1 1 · · · 1 · · · 0 p(Mn|X)
Table 3.3: metaMix recorded information on species presence at each MCMC iteration.
We can thus summarize appropriately the posterior distribution and answer the
important questions of interest. Examples of such questions include: what species have
probability p or greater being included in the set of present species? what is the prob-
ability of having the n specific closely related strains in the set of present species? De-
pending on the biological context, one may ask numerous similar or other case-specific
questions. Finally, metaMix also outputs Bayes Factors to quantify the evidence in
favour of each species:
log10 BF = log10
P(X |Mspecies present)
P(X |Mspecies absent) . (3.10)
metaMix consists of four steps which are summarised below in Algorithm 3.1 and will
be demonstrated in the following chapter 4 using a toy example.
3.5 Practical considerations
3.5.1 Number of chains and tempering scheme
The optimal number of chains used in the parallel tempering is not obvious. The main
idea is that the number of chains used must be large enough to ensure successful swaps
between all neighboring chains. The first limitation is the number of chains we can run
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Algorithm 3.1 metaMix algorithm
Step 1. Compute pi j generative probabilities using BLAST similarity, using equa-
tion 3.2 or 3.3.
Step 2. Fit mixture model with all potential species as categories, typically k >
1000.
Keep for subsequent MCMC exploration the non-empty categories, i.e species
that have at least one read assigned to them.
Step 3. MCMC exploration of species space using multiple parallel tempered
chains.
• Initialisation of chain:
At iteration t=0, assume all reads come from the unknown category. At
iteration t=1, add a species.
• At iteration t:
– Let us assume we deal with a set of species that corresponds to the
mixture model Mk. At the next step (t + 1), we either add or re-
move a species and the new set corresponds to the mixture model
Ml . The step proposing the model Ml is accepted with probability
3.7:
A(Mk→Ml) = min{1, P(X |Ml)
(t+1)P(Ml)
P(X |Mk)(t)P(Mk)
q(Ml →Mk)
q(Mk→Ml)}
– After each mutation step, attempt exchange move between neigh-
boring chains k1 and k2. Accept with probability 3.8:
A = min{1,exp{(t1− t2)(logpi(Mk1)− logpi(Mk2))}}
where t1 is the temperature for chain k1 and t2 the temperature for
chain k2.
Step 4. Compute the posterior probabilities of species being present by model aver-
aging.
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on a computer. The computing facility we use for all analyses is the UCL Computer
Science cluster. The availability of suitable machines as well as considerations towards
minimizing the queuing time of the submitted jobs, results in choosing N = 12 chains.
The choice of temperature values is motivated by the fact that these must not be
too far apart, so that exchange of values between the chains can occur. Additionally
the maximum value must be high enough so that no chains become trapped in local
minima, hence allowing for global moves. We implemented a power decay heating
scheme:
tn = (tn−1−K)α , where n = 2, . . . ,N, K ∈ (0,1), α > 1 and t1 = 1 (3.11)
and using K = 0.001 and α = 3/2 we achieve a slowly heating sequence of chains with
a lot of chains similar to the target.
We find that for N < 10 the maximum temperature is not very high, hindering a
quick global exploration. Ideally we would prefer to run 14 to 20 chains but given our
computing constraint N = 12 performs satisfactorily.
3.5.2 Number of iterations
Given the described setup of our Parallel Tempering, we find that for metaMix to pro-
duce reasonable results there is a minimum requirement for (5×number of potential species)
MCMC iterations for each chain. A greater number of iterations would naturally help
achieve smaller errors. The user can visually inspect the log-likelihood traceplots to
assess mixing and convergence of the cold chain and may also increase the iterations
number if necessary.
Chapter 4
The metaMix R package
This chapter provides an overview of the features implemented in the metaMix R pack-
age. First, the significant functions are demonstrated with a toy example. The per-
formance of metaMix is then assessed using metagenomic benchmark datasets where
the ground truth is known. Finally metaMix is compared to other community profiling
methods discussed in chapter 1.
4.1 An overview of the metaMix R package
metaMix is the R package implementing the ideas introduced in the previous chapter.
It uses finite mixture models coupled with PT MCMC in order to identify the set of
species most likely to be present in a metagenomic community. metaMix also esti-
mates their relative abundances. Different competing models that could accommodate
the observed data, that is the BLASTx similarity between the read sequences and the
reference protein sequence, are considered and compared. The final output is the proba-
bilistic community profile as well as supporting plots, such as log-likelihood traceplots
as well as cumulative histogram plots of the classification probabilities for each species
in the summary profile. Even though the implementation of the ideas is computation-
ally intensive and requires a supercomputer, the following guide to metaMix uses a toy
example where all the steps can be performed on a single machine.
4.1.1 Installation
metaMix has the following package dependancies: Rmpi, data.table, Matrix,
gtools and ggplot2. Rmpi provides the interface to openMPI (Message Passage In-
terface). The user can check whether openMPI is installed on their computer using
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the command mpirun. More information can be found here http://www.open-mpi.
org/software/ompi.
4.2 Demonstration of functions with toy example
The starting point is to obtain the sequence similarity between a query and a target
sequence. This can be done with the homology tool BLAST. Both nucleotide and
amino acid comparisons are supported. The metaMix demonstration below uses amino
acid similarities, i.e the input file is generated by BLASTx.
4.2.1 Step1
During the first step, metaMix estimates the generative probabilities pi j based on the
amino acid similarity between the translated read sequence and the proteins in the ref-
erence database.
Default BLAST output
The default output tabular file is supported, obtained using -outfmt 6 in the
BLAST command: blastx -db referenceDB -query input.fa -outfmt 6 -
max target seqs 10. The default output file has the following fields: Query ID,
Subject ID, Identity, Alignment Length, Mismatches, Gap Openings, Query
Start, Query End, Subject Start, Subject End, E-value, Bit Score. metaMix
needs information on the read lengths as well as a file mapping the gi identifiers to the
taxon identifiers. These are not included in the default output of BLAST and need to
be provided as additional arguments.
>library(metaMix)
###Location of input files.
>datapath <- system.file("extdata", package="metaMix")
>blastOut.default<-file.path(datapath, "blastOut_default.tab")
>read.lengths<-file.path(datapath, "read_lengths.tab")
>read.weights<-file.path(datapath, "read_weights.tab")
taxon.file<-file.path(datapath, "gi_taxid_prot_example.dmp")
>read.table(read.lengths, nrows=2, sep="\t")
## read read.length
NODE_427 209
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NODE_428 162
>read.table(read.weights, nrows=2, sep="\t")
##read read.weight
NODE_476 10
NODE_524 26
>read.table(taxon.file, nrows=2, sep="\t")
## GI_id taxon_id
9625360 10849
9625363 10849
Custom BLAST output
Alternatively, metaMix accepts a custom BLAST output file that has already incor-
porated the read lengths and the taxon identifiers. This custom file has the following
fields: Query ID, Query Length, Subject ID, Subject Length, Mismatches,
Bit Score, Alignment Length, %Identity, E-value, Taxon ID. It is produced by
the following BLAST command: blastx -db referenceDB -query input.fa -
max target seqs 10 -outfmt "6 qacc qlen sacc slen mismatch bitscore
length pident evalue staxids".
The pi j probabilities are estimated by the generative.prob() function:
blastOut.custom<-file.path(datapath, "blastOut_custom.tab")
step1 <-generative.prob(blast.output.file = blastOut.custom,
contig.weight.file=read.weights,
blast.default=FALSE,
outDir=NULL)
where blast.default denotes usage of the BLAST default output (TRUE) or the cus-
tom output specified above (FALSE). The value for the blast.output.file argument
is the tabular BLASTx output file. The argument contig.weight.file can be omit-
ted when working with unassembled reads, as the weight is set by default to be 1 - same
for all reads. However if an assembly step has been performed as in this example, in-
formation on the number of reads that make up each contig needs to be provided. This
will be a two column tab-separated file, where the first column is the contig identifier
and the second the number of reads. Finally outDir is the directory where the results
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are written and where an object from each step is saved. When it is set to NULL no
objects will be saved.
On the other hand, when working with the default BLAST output the command
would be the following:
step1 <-generative.prob(blast.output.file = blastOut.default,
read.length.file=read.lengths,
contig.weight.file=read.weights,
gi.taxon.file = taxon.file,
blast.default=TRUE,
outDir=NULL)
The information missing from the BLAST file is now provided with two extra argu-
ments: read.length.file can either be the file mapping each read to its sequence
length or a numerical value, representing the average read length (default value=100).
gi_taxid_prot.dmp is a taxonomy file, mapping each protein gi identifier to the cor-
responding taxon identifier. It can be downloaded from ftp://ftp.ncbi.nih.gov/
pub/taxonomy/gi_taxid_prot.dmp.gz.
The function generative.prob creates a list of five elements. The first element
is a sparse matrix pij.sparse.mat where each row corresponds to one read and each
column to a species. The value of the cell is the generative probability pi j. The second
element is ordered.species containing all the species that correspond to the proteins
in the BLASTx output file. Finally the read.weights, gen.prob.unknown and out-
Dir are the other three elements of the list step1, carried forward to be used in the
second step.
###The resulting list consists of five elements
names(step1)
[1] "ordered.species" "pij.sparse.mat" "read.weights" "outDir"
[5] "gen.prob.unknown"
### There are that many potential species in the sample:
nrow(step1$ordered.species)
[1] 224
### The sparse matrix of generative probs.
step1$pij.sparse.mat[1:2,c("374840", "258", "unknown")]
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5 x 3 sparse Matrix of class "dgCMatrix"
374840 258 unknown
@M01520:37:13805:1480_1:N:0:1 7.366e-01 . 1e-06
@M01520:37:16186:1480_2:N:0:1 9.389e-01 . 1e-06
4.2.2 Step2
Theoretically the next step would be the state space exploration with the PT MCMC. In
practice, the number of all potential species S is large and this step works on reducing
the size of the species pool from the thousands to the low hundreds.
In this simple example there are only 224 organisms and thus step2 fits a mixture
model with 224 categories, considering all the potential species simultaneously. Post
fitting only the non-empty categories are retained for the MCMC exploration, that is
the species that have at least one read assigned to them. The required argument for the
reduce.space function is simply the list created in the first step using the genera-
tive.prob function.
>step2 <- reduce.space(step1=step1)
##These are the elements of the step2 list.
>names(step2)
[1] "outputEM" "pij.sparse.mat" "ordered.species" "read.weights"
[5] "outDir" "gen.prob.unknown"
## After this approximating step, there are 7 potential species in the sample:
>nrow(step2$ordered.species)
[1] 7
## And these are:
>step2$ordered.species
taxonID countReads samplingWeight
374840 1888 0.165017
28090 93 0.034611
13690 62 0.023074
645687 46 0.017119
The reduced species pool consists solely of 7 potential taxa down from 224. In the
typical scenario the species reduction is from the thousands to the hundreds.
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4.2.3 Step3
In this step, the different models are considered and compared. The space exploration
by the parallel tempering MCMC is implemented by the function parallel.temper.
The required argument is the list created in the second step using the reduce.space
function. An important optional argument of this function is readSupport. As men-
tioned in the previous chapter, the default model prior uses a penalty limiting the num-
ber of species in the model. The penalty factor is approximated based on readSupport,
which represents the species read support required from the user in order to believe in
the presence of a species in the sample. The default value is 10.
>step3<-parallel.temper(step2=step2)
##These are the elements of the step3 list.
>names(step3)
## [1] "result" "duration"
## Steps MCMC took during some iterations.
>step3$result$slave1$record[10:15,]
Iter Move Candidate Species 374840 2 28090 13690 645687 258 1035 unknown
logL
10 Remove 645687 1 0 1 1 1 0 0 1 -2988
11 Remove 374840 1 0 1 1 1 0 0 1 -2988
12 Add 2 1 1 1 1 1 0 0 1 -3070
13 Add 258 1 1 1 1 1 0 0 1 -3070
14 Remove 13690 1 0 1 0 1 0 0 1 -3505
15 Add 2 1 0 1 0 1 0 0 1 -3505
For each parallel chain, the MCMC trajectory has been recorded. The record in-
cludes information on what species were proposed and which were accepted or rejected
throughout the iterations. For example at iteration 10, removing species 645687 was
proposed but not accepted, as denoted by the 1 in the column 645687. Between it-
erations 13 and 14 an exchange of the sets of species between Chain 1 and Chain 2
occurred. At iteration 13 species 2 was present, while at the next one, it is no longer
there. That means that the attempt at swapping the values of the two neighboring chains
was successful. This information is also recorded, i.e how many swaps were attempted
and how many accepted.
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4.2.4 Step4
Having explored the different possible models, the final step is to compute the poste-
rior probabilities for each species by performing model averaging. The MCMC model
choices for Chain 1 are used to produce a probabilistic summary for the presence of the
species.
The required arguments are the lists created in the second and third steps, using the
reduce.space and the parallel.temper functions. Finally, the taxonomy names file
’names.dmp’ which can be downloaded and extracted from ftp://ftp.ncbi.nih.
gov/pub/taxonomy/taxdump.tar.gz has to be provided.
## Location of the taxonomy names file.
taxon.file<-file.path(datapath, "names_example.dmp")
step4<-bayes.model.aver(step2=step2,
step3=step3,
taxon.name.map=taxon.file)
##These are the elements of the step4 list.
>names(step4)
[1] "result" "pij.sparse.mat" "presentSpecies.allInfo"
[4] "output100" "assignedReads" "classProb"
##This is the species summary
>print(step4$presentSpecies.allInfo)
taxonID scientName finalAssignments poster.prob
374840 Enterobacteria phage phiX174 2419 1.0
28090 Acinetobacter lwoffii 93 0.9
unknown unknown 66 1.0
13690 Sphingobium yanoikuyae 62 0.9
645687 Astrovirus VA1 46 1.0
In the resulting profile there are four species and the unknown category. In this step
supporting plots that help the user further assess the results are generated. These in-
clude log-likelihood traceplots as well as cumulative histogram plots of the classifica-
tion probabilities for each species in the summary profile.
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4.3 Benchmark datasets
The performance of metaMix on datasets where the ground truth is known was exam-
ined to compare the metaMix estimates with the real values. metaMix was applied on
a popular benchmark dataset where the exact community composition and read assign-
ment are specified. metaMix results are compared with the ones produced by two other
similarity-based community profiling methods, MEGAN version 5.3 and Pathoscope
2.0. The similarity-based aspect and more specifically their flexibility to work with
BLASTx output makes them better candidates for viral discovery that is the focus in
this thesis, compared to composition-based methods. From the mixture model meth-
ods, we have chosen Pathoscope. Default parameters were used for all methods, unless
stated otherwise.
The FAMeS artificial datasets (http://fames.jgi-psf.org/description.
html) are mock metagenomic community datasets (Mavromatis et al., 2007),
composed of randomly selected real Sanger shotgun sequecing reads (average
length≈800bp) from the original sequencing projects of 113 microbial genomes (In-
tegrated Microbial Genomes database (Markowitz et al., 2012)). They are a popular
choice to use as benchmark datasets for various metagenomics methods. Their suit-
ability stems from the fact that the number of species that form the metagenomic
community is known as well as their relative abundances. The FAMeS datasets have
been designed to model real metagenomic communities in terms of complexity and
phylogenetic composition.
For the metaMix output, we reported organisms with a posterior probability
greater than 0.8 (default). The metaMix read support parameter r, which essentially
sets the sensitivity/specificity of the method, has an impact on the number of reported
species. A large r value can result in the method merging together strains that are dif-
ferentiated by fewer reads than r. On the other hand a low r can have the opposite
effect, whereby the methods splits a strain into two or more strains, by moving a few
reads from one strain to a very similar one with which they have equally good matches.
The user’s choice for this key parameter r should be informed by the biological
context. As an example, for the typical human clinical sample where the sample col-
lection might have occurred some time after the infection has taken place, a low value
in order to adopt a sensitive approach is reasonable. Hence, for viral identification in
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human clinical samples, a low and sensitive value (r = 10) is a reasonable choice. In
a highly complex environmental metagenomic community where there is a plethora of
species of similar abundances, the choice becomes less straightforward especially in the
case of closely related strains. We set the default value for general community profiling
in environmental samples to be r = 30. We also compare the output of metaMix for
different values of this parameter as well as for different posterior probability cutoffs.
4.3.1 metaMix comparison to MEGAN, Pathoscope
There are three FAMeS datasets: simHC, simMC, simLC corresponding to high,
medium and low complexity of the metagenomic community respectively. Complexity
in this instance means that the communities differ in their relative abundances setup
(Figure 4.1). The low complexity community (simLC) consists of reads from mostly
one dominant population (28%) while the remaining 112 taxa have significantly fewer
reads. In the medium complexity community (simMC) there is more than one dom-
inant population (18%, 13%, 9%) and also similarly to simLC, the remaining taxa
are of lower abundance. Finally, the high complexity dataset (simHC) lacks domi-
nant populations and all taxa are of low abundance (below 3%). Most of the taxa are
different species while there are instances of different strains within the same species
group (∼10 instances of strains within Burkholderia cenocepacia, Rhodopseudomonas
palustris, Xylella fastidiosa).
We first discuss in detail the results of the three methods for simHC, the high-
est complexity dataset. simHC consists of 113 bacterial taxa, most of them distinct
species (and some instances of strains from the same species) with similar abundances
and no dominant population. The lowest abundance is 255 reads out of 118,000
reads. We then summarise the results for the other two mock communities, simLC and
simMC. The bioinformatics processing in this instance consisted of a BLASTn com-
parison to all NCBI bacterial genomes (ftp://ftp.ncbi.nlm.nih.gov/genomes/
Bacteria/all.fna.tar.gz). The number of genomes mapped, retrieved from the
the BLASTn output was ∼2,500. As discussed below, metaMix outperforms Patho-
scope and MEGAN in the community profiling task and consequently in the relative
abundance estimation (Table 4.2).
metaMix
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Figure 4.1: Complexity of FAMeS simLC, simMC and simHC mock communities.
To limit the complexity of the fit, the two step procedure described previously was
used. First, we fitted the mixture model with the complete set of 2,500 species using
EM with a limited run length of 500 iterations. Based on this analysis, we identified
1,312 species supported by at least one read and explored this state space. To limit
the computational time, we also considered a stronger approximation, including only
the 374 potential species supported by at least 10 sequencing reads. Both approaches
generated similar results, albeit the more complex one with 1,312 potential species
required the quadruple of the computation time (12 hours for 6,560 iterations instead
of 3 hours for 1,870 iterations). metaMix identified 116 species, detecting successfully
all the members of the metagenomic community. These were detected on the strain
level except in four instances where a different strain of the same species, or different
species within the same genus was detected. Four species were identified and not in the
simulated dataset, hence can be considered as false positives (Table B.2).
In order to assess the variability of metaMix results, we ran the analysis 25 times
changing the random seed. We report the number of species detected, the sensitivity and
specificity as well as relative abundance estimate measure errors, at various posterior
probability cutoffs (Table 4.1). We summarise the resulting community profile based
on one of these runs in Table B.1.
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Table 4.1: simHC community: number of species detected by metaMix as well as sensitivity,
specificity, AVGRE, RRMSE for metaMix at various posterior probability cutoffs
(default in bold font) . The results are average values based on 25 runs.
Cutoff 0.9 0.8 0.7 0.6 0.5
Sensitivity (mean) 99.82 99.96 99.96 100 100
Sensitivity (sd) 0.0036 0.0017 0.0017 0 0
Specificity (mean) 99.86 99.82 99.77 99.73 99.70
Specificity (sd) 0.0004 0.0004 0.0005 0.0003 0.0001
RRMSE 16.69 16.85 16.73 17.50 17.48
AVGRE 8.20 8.31 8.16 8.60 8.56
# Species -median 115 116 117 118 119
# Species - s.d 1.2 0.9 1.2 0.7 0.3
Pathoscope
Pathoscope identified 47 species. Of these 45 are members of the metagenomic com-
munity. 42 are the exact same strain, while 3 are either the same species but different
strain or same genus but different species. However it fails to detect 68 species that
are actually present in the mixture. Tuning the parameter that enforces the parsimo-
nious results (any thetaPrior greater than 10), thereby removing the unique read penalty,
Pathoscope behaves as a standard mixture model and identifies 165 species (Table 4.2).
With these settings, it identifies all but one members of the community (Table B.1). The
organisms are identified at the strain level, except in three instances where it identified
different species within the same genus. The major interpretation issue is the presence
of a long tail of species (54 species) that are actually not present in the mixture (Table
B.2). Pathoscope produced the results in one minute.
MEGAN
MEGAN identified 232 taxa. It discovered all original species of the community on
the strain level, except for 9 instances where it identified the lowest common ancestor
(LCA). Aside from the lack of strain or species specificity for 8% of the community
members, the main issue is the long tail of false positives appearing in the results, that
is MEGAN exhibits low specificity (Table 4.2). In the species summary provided by
MEGAN, there are 119 taxa (species or higher order) which are not actually present,
but supported by a sufficient number of reads (default value: 50 reads) for MEGAN to
include these in the output. It finished the computations in less than one minute. To
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lower the false positive rate, we also filtered the BLAST results prior to MEGAN anal-
ysis, imposing stringent E-value and similarity cutoffs, to assess how these affect the
MEGAN performance. An E-value < 1E-10 removed only 9 entries from the results,
requiring similarity greater than 90% removed only 5, while both filters resulted in 208
taxa in the summary results.
4.3.2 Relative abundances
The primary aim for metaMix is to be a diagnostic tool and to answer whether a species
is present or absent from the mixture we study. As a secondary aim, we are also inter-
ested in estimating accurately the relative abundance of the present organisms. We can
assess the abundance estimates produced by the methods by using error measures such
as the relative root mean square error, RRMSE and the average relative error, AVGRE.
For metaMix, we use the relative abundance estimates from the 25 runs. For all meth-
ods, when the exact strain was not identified but the correct species or genus was, we
used this abundance.
RRMSE =
√√√√ 1
K
K
∑
j=1
(
|w j− t j|
t j
)
2
(4.1)
AVGRE =
1
K
K
∑
j=1
(
|w j− t j|
t j
) (4.2)
where t j is the true abundance of species j and w j the estimated abundance.
metaMix produces the most accurate abundance estimates and the results are sum-
marized in Table 4.2.
4.3.3 Importance of read support parameter
We then assessed the importance of the read support parameter r on the output of
metaMix. We ran metaMix on the benchmark simHC FAMeS dataset with r = {10, 20,
30, 50} reads, 25 runs for each (Table 4.3). We observe that as r decreases, a few more
related strains from the reference database that are not in the community are retained
in the output. As r increases two similar strains are merged into one.
We compared these results with the output of Pathoscope and MEGAN. None of
these methods have a read support parameter serving the same purpose as in metaMix,
so we tuned the most relevant parameters in these tools. Pathoscope has a thetaPrior
parameter that enforces a unique read penalty. This parameter represents the read pseu-
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Table 4.2: Number of species identified for the FAMeS simLC and simMC datasets, as well
as sensitivity, specificity and abundance estimates error measures RRMSE and AV-
GRE. The metaMix results are based on 25 runs.
metaMix Pathoscope MEGAN
simHC
Number of Species 116 165 232
Sensitivity 99.96 99.1 100
Specificity 99.8 97.7 95.0
RRMSE 16.9 36.6 35.9
AVGRE 8.3 29.7 18
simLC
Number of Species 114 147 208
Sensitivity 98.8 97.3 100
Specificity 99.8 98.4 95.9
RRMSE 21.1 185.6 32
AVGRE 8.9 53.3 16.1
simMC
Number of Species 115 144 208
Sensitivity 98.5 98.2 100
Specificity 99.8 98.6 95.9
RRMSE 29.6 152.7 31.9
AVGRE 12.9 49.2 19.3
docounts for the non-unique matches and the default setting is zero which allows for
non informative priors. Using the default setting Pathoscope identifies 47 taxa. When
thetaP is in (1,7) it identifies 22 taxa, while with thetaP>7 it identifies 165. With this
latter setting which is the one we chose for the comparison, Pathoscope behaves as a
standard mixture model.
MEGAN has a “Min Support” parameter which sets a threshold for the number of
reads that must be assigned to a taxon so that it appears in the result. Any read assigned
to a taxon not having the required support is pushed up the taxonomy until a taxon is
found that has sufficient support. We used Min support = {10, 20, 30, 50} reads. The
respective number of taxa in the summary files were 250, 243, 236, 232.
We then also applied a post-run read count threshold to both methods’ output
summary. We set the threshold for 10,20,30,50 reads respectively, disregarding taxa
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that have less than that number of reads assigned to them. In all instances metaMix
produces a community profile closer to the real one, along with a better balance of
sensitivity and specificity compared to the other two methods (Table 4.3). Pathoscope
finds∼ 15 more false positives while MEGAN∼ 40 more compared to metaMix at the
same read support level, except for the lowest r=10 where metaMix and Pathoscope
achieve the same specificity. We also report further results using different posterior
probability cutoffs for the different r settings.
Table 4.3: simHC FAMeS dataset: number of species (sd in parenthesis), sensitivity and speci-
ficity by metaMix (25 runs), Pathoscope and MEGAN, as a function of the min.
number of reads required for each species to appear in the output. metaMix: r={10,
20, 30, 50} reads, Pathoscope: thetaPrior> 7+ post-run threshold ={10, 20, 30, 50}
reads, MEGAN: “Min Support” + post-run threshold ={10, 20, 30, 50} reads.
Read Support metaMix Pathoscope MEGAN
50 114 (0.9) 131 147
Sensitivity - Specificity 99.1 - 99.9 98.2 - 99.1 100 - 98.5
30 116 (0.95) 131 156
Sensitivity - Specificity 99.96 - 99.8 98.2 - 99.1 100 - 98.2
20 124 (1.65) 141 166
Sensitivity - Specificity 100 - 99.5 98.2 - 98.7 100 - 98
10 155 (1.9) 155 188
Sensitivity - Specificity 100 - 98.2 99.1 - 98.2 100 - 97.4
4.3.4 simMC and simLC communities
The FAMeS project includes two additional mock communities that consist of the same
113 species as simHC, but they differ in their relative abundances setup: in simLC
(low complexity) there is one dominant species or a few more in simMC (medium
complexity). We ran metaMix 25 times for both, changing the random seed. These 2
datasets turned out to be more challenging for all three methods, missing or merging
together some similar related strains. metaMix outperforms Pathoscope and MEGAN
in terms of producing a parsimonious community profile and having the best sensitivity
and specificity trade-off (Table 4.2).
For the simMC and simLC communities we also ran metaMix for different poste-
rior probability cutoffs (0.5-0.9) and different read support values (r={10,20,30}). We
present the results in Tables 4.4 and 4.5. Naturally, as we allow species with lower pos-
terior probabilities in the results, the sensitivity increases and the specificity decreases.
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Changing the read support value and comparing with MEGAN and Pathoscope, we ob-
serve the same pattern as for simHC: metaMix has the best balance of specificity and
sensitivity between the three methods.
Table 4.4: simLC, simMC: Number of species detected by metaMix as well as sensitivity,
specificity, AVGRE, RRMSE for metaMix at various posterior probability cutoffs.
The results are average values based on 25 runs.
Cutoff 0.9 0.8 0.7 0.6 0.5
simLC
Sensitivity (mean) 98.32 98.82 99.00 99.07 99.11
Sensitivity (sd) 0.0083 0.0050 0.0030 0.0018 0
Specificity (mean) 99.89 99.85 99.82 99.78 99.75
Specificity (sd) 0.0004 0.0003 0.0004 0.0004 0.0002
# Species - median 113 114 115 116 117
# Species - sd 1.4 1.1 1.0 0.9 0.4
rRMSE 21.1 21.0 21.1 21.3 21.6
AVGRE 8.9 8.8 8.9 8.9 9.2
simMC
Sensitivity (mean) 97.96 98.46 98.79 98.93 99.11
Sensitivity (sd) 0.0061 0.0048 0.0044 0.0036 0
Specificity (mean) 99.83 99.77 99.71 99.66 99.63
Specificity (sd) 0.0005 0.0004 0.0004 0.0004 0.0002
# Species - median 114 115 118 119 120
# Species - s.d 1.17 1.07 1.08 1.08 0.48
RRMSE 29.98 29.93 30.05 30.11 29.96
AVGRE 13.05 13.18 13.31 13.37 13.26
4.3.5 simHC - assembled data
The results we have reported in the main text far are based on unassembled simHC
FAMeS data. We subsequently wanted to compare the performance of metaMix on the
same dataset, doing first an assembly step. We used Velvet with a high kmer value
(k = 89) in order to obtain high quality contigs. This resulted in 733 contigs made up
by 2,403 reads, i.e approximately 2% of the total reads were contributing to contigs.
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Table 4.5: simLC, simMC FAMeS datasets: number of species detected as well as sensitivity
and specificity of metaMix, Pathoscope and MEGAN, as a function of the minimum
number of reads required for each species to appear in the output. For metaMix that
is r={10, 20, 30} reads, for Pathoscope thetaPrior> 7+ post-run threshold ={10, 20,
30} reads, for MEGAN “Min Support” + post-run threshold ={10, 20, 30} reads.
metaMix Pathoscope MEGAN
simLC
r30 114 (1.09) 126 142
Sensitivity- Specificity 98.82 99.84 97.32 - 99.27 100 - 98.71
r20 116 (1.17) 127 147
Sensitivity- Specificity 98.89 99.76 97.32 - 99.22 100 - 98.5
r10 133 (1.22) 131 157
Sensitivity- Specificity 100 99.11 97.3 - 99.05 100 - 98
simMC
r30 115 (0.69) 126 141
Sensitivity- Specificity 98.46 99.77 98.21 - 99.35 99.1 - 98.8
r20 117 (1.1) 126 145
Sensitivity- Specificity 98.21 99.67 98.21 - 99.35 99.1 - 98.6
r10 144 (2.3) 130 158
Sensitivity- Specificity 99.46 98.56 98.2 - 99.18 99.1 - 98
We then annotated contigs and unassembled reads with BLASTn and applied metaMix
with default parameters. We find all members of the metagenomic community and one
false positive (based on one run: sensitivity=100, specificity=99.96). The estimates for
relative abundance were also close to the true values (RRMSE = 16.9 and AV GRE =
8.2). We therefore observe that the metaMix results are very similar whether we choose
to include or forego an assembly step, with the resulting community profile very close
to the true one.
4.3.6 Comparison of IS - Defensive Sampling - MLE
We compared the performance of metaMix on the same simHC FAMeS dataset, using
Importance Sampling and Defensive Importance Sampling (95% samples produced by
posterior approximating g and 5% by pi) for the marginal likelihood estimation as well
as using the MLE approximation. In the above section, we discussed the results using
the latter option. For the IS and the defensive IS of the marginal likelihood, 1,000
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samples were drawn from the importance distribution for each model considered, i.e at
each MCMC iteration .
The resulting species profiles can be seen in Table 4.6. We ran all three versions of
metaMix for 1,000 MCMC iterations in order to obtain results within 24 hours. All the
approaches produced almost identical results, in terms of species identified and abun-
dance estimates, with the defensive IS performing slightly better in terms of abundance
estimation accuracy. However the MLE approximation method was ∼13x times faster
than the other two, reducing the time required from ∼19 hours to 90 minutes.
Table 4.6: FAMeS simHC - comparing the effect of different marginal likelihood estimation
methods on metaMix performance: species profiling, accuracy of abundance esti-
mation and computational time.
Importance Defensive MLE
Sampling Sampling approximation
Number of species 116 116 116
w estimate - rRMSE 17 16.8 17.1
w estimate - AVGRE 8.5 8.3 8.6
Computational time (hours) 18.6 18.6 1.5
4.3.7 Benchmarking conclusions
With the benchmark datasets used, metaMix provides a good balance of sensitivity and
specificity, outperforming MEGAN and Pathoscope. A consequence of the increased
accuracy is that metaMix produces better estimates for the relative abundances of the
species in the mixture. The method can deal with either unassembled reads or assem-
bled contigs or both, allowing for flexibility of choice for the bioinformatics prepro-
cessing.
The FAMeS datasets are complex and distinct from the typical human clinical
samples we have worked with, where we wish to detect the presence of viral infectious
agents. In these we typically have mixtures of eukaryote (human), bacterial and viral
sequences and we require the method to be sensitive enough to be able to detect viral
traces. Additionally the samples we work with are normally from sterile sites, therefore
we do not expect a large number of organisms. At the time of testing metaMix there
were no mock datasets with viral infections so that we could benchmark the methods in
a scenario more similar to the one we have developed metaMix for. This is the reason
we extended the methods comparison to the following chapter 5 on the sequencing
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data from human clinical samples with viral infections. These viral infections were
unknown prior to the metaMix analysis of the data, however they were subsequently
confirmed using other molecular methods. Despite the differences, the FAMeS dataset
are essential to use as benchmark for examining the performance of the methods in
varyingly complex communities, where there are also some closely related strains in
the sample.
Chapter 5
Pathogen identification in clinical
samples
We discussed in the introduction the potential that deep-sequencing technology has for
detecting pathogens in clinical samples. Diagnostic tools based on high-throughput
sequencing can offer valuable insight, especially for patients suffering from infectious
diseases. An important feature of this methodology is that it does not make prior as-
sumptions about the type of pathogen, but has the potential to detect DNA or RNA
from all species.
In this chapter we discuss the use of metaMix as a diagnostic tool in clinical cases
where the pathogen could not be identified with conventional testing. UCL is the pri-
mary research partner of the Great Ormond Street Hospital for Children (GOSH) where
academics and clinicians collaborate towards diagnosing and treating childhood dis-
ease. Our collaboration is with Professor Judith Breuer at the Division of Infection
& Immunity in UCL and who is also a consultant Virologist at GOSH. Following the
successful diagnosis of the first case (discussed below), Prof. Breuer has now adopted
the use of RNA-seq as part of routine testing for all undiagnosed cases. In all cases a
plausible infectious pathogen was identified, using metaMix for read interpretation and
confirmed with laboratory methods. These are PCR assays, discussed in chapter 1 and
immunohistochemistry methods. All bioinformatics and statistical analysis of the gen-
erated data were undertaken by me, while the laboratory work to confirm the metaMix
finding was done by Julianne Brown, PhD candidate in the Breuer group.
The PCR assays provide information on viral load and results are obtained using
separate RNA extractions from the clinical sample. Cycle threshold (CT) is a relative
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measure of the concentration of target in the PCR reaction, with values representing
the cycle number at which amplification was detected. CT has an inverse relationship
with viral titer, with a small value indicating high titer. In clinical practice, CT>38
may be considered ambiguous but in the context of other positive results, is considered
a true positive. Immunohistochemistry (IHC) is another technique used for confirma-
tion purposes, designed to detect the presence of abnormal cells. IHC is based on the
interaction of target antigens with specific antibodies tagged with a visible label. This
allows the visualization of specific cellular components within cells that act as markers.
Here we discuss the first two cases of two immunosuppressed patients who de-
veloped an infectious disease, more specifically encephalitis. We first give some back-
ground on encephalitis and then we present and discuss the results for each case.
5.1 Encephalitis background
Encephalitis is a complex and potentially devastating neurological syndrome, charac-
terized by inflammation in the brain and associated with brain dysfunction (Thomp-
son et al., 2012). In the majority of encephalitis cases direct viral infection, that is
the virus crossing the blood-brain barrier, is thought to be the cause (Granerod et al.,
2010). However in over half of the cases a causative agent is not found (Glaser et al.,
2006). The gold standard diagnostic testing for encephalitis is polymerase chain reac-
tion (PCR), a method suitable for determining the amount of a target sequence that is
present in a sample. PCR requires prior knowledge of potential infectious agents and
can therefore be narrow in scope. Different treatment options for infectious and non-
infectious cases render understanding the pathology of encephalitis of crucial clinical
importance. The most commonly identified causes of encephalitis are the herpes sim-
plex virus (HSV) and the varicella zoster virus (VZV), however immunocompromised
patients are more likely to get encephalitis from a greater variety of viruses (Thomp-
son et al., 2012). Deep sequencing of clinical samples has increasingly been used as a
diagnostic tool (Barzon et al., 2013) (Handley et al., 2012), specifically in cases where
traditional techniques fail to unveil the disease-associate pathogens (Chiu, 2013) (Wil-
son et al., 2014).
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5.2 Clinical Case 1
The first case was an immunosuppressed 18-month old boy with a case of encephalitis
for which traditional tests could not find the causative agent. Using RNA-seq from
a brain biopsy, we identified an astrovirus, highly divergent from human astrovirus
genotypes typically associated with diarroea, but closely related to an astrovirus that has
been once before implicated in a fatal encephalitis in an immunocompromised patient
(Quan et al., 2010). The work undertaken is published (Brown et al., 2015), our clinical
collaborators having obtained written consent for publication from the family.
5.2.1 Case Report
The patient had Cartilage Hair Hypoplasia (CHH) and associated immunodeficiency.
CHH is a rare autosomal recessive disorder characterised by limited bone growth. The
patient underwent an uncomplicated peripheral blood stem cell transplant in GOSH
in 2013, however two weeks later he became acutely unwell with irritability, dystonia
and reduced consciousness. The differential diagnosis concluded this was a case of
encephalitis of infectious aetiology. An extensive PCR panel for 18 different viruses,
including the Human Astrovirus, on cerebrospinal fluid (CSF) after the onset of symp-
toms at three different time intervals (two days, two weeks and one month after the
onset) was negative for all the tested pathogens. Brain biopsy performed eight weeks
after the neurological deterioration was also negative for these pathogens, as well as
fungal and bacterial ribosomal RNA gene PCRs. It was then decided to perform deep
sequencing on the brain biopsy sample. The pathogen detection from the RNA-seq
analysis informed subsequent patient management. Unfortunately the child died nine
months after the transplantation, in the context of ongoing neurological impairment
with recurrent respiratory and gastrointestinal complications.
5.2.2 Data and preprocessing
Total RNA was purified from the biopsy and polyA RNA was separated for sequenc-
ing library preparation. Rapid RNA-Seq was performed on an Illumina Miseq. The
Illumina MiSeq instrument generated 20 million paired-end reads.
I analysed the raw data using the bioinformatics pipeline and reference database
described in Chapter 1. Non-clonal and good quality reads made up to 90% of the
dataset, however only 4% of the reads, i.e ∼ 75,000 were non-human. Based on the
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Figure 5.1: Clinical Case 1 - novel virus.
The reads (blue lines) assigned by metaMix to Astrovirus VA1, aligned to its
genome. The purple lines represent the genes of the virus.
BLASTx output there were 1,298 potential species.
5.2.3 metaMix results
Following the initial bioinformatics processing, we used metaMix for species identifi-
cation and abundance estimation. The resulting species profile is shown in Table 5.1;
the 13 metaMix entries correspond to 10 species. The most abundant organism was
theΦX174 bacteriophage, which is routinely used for deep-sequencing quality control.
The bacteriophage could have been filtered out prior to community profiling. However
this was the first clinical case metaMix was used on and its role as positive control was
useful.
More interestingly, we identified an astrovirus. Five short assembled contigs (44
reads) with length ranging from 167bp to 471bp and two non-assembled reads were
assigned to the Astrovirus VA1. The posterior probability of the virus being present in
the sample was one (Figure 5.1). The individual read classification probabilities were
high (plotted in Figure 5.2), indicating that the reads were unambiguously assigned.
metaMix also identified a number of bacteria supported by a few reads. These are
either known human skin associated contaminants or laboratory reagent or extraction
kit contaminants (Salter et al., 2014). The analysis completed in 29 minutes.
The contig sequences generated in the bioinformatics step were used to design a
PCR assay specific to the astrovirus identified in this study. This confirmed the astro-
virus at a high viral titer in the brain biopsy, as indicated by the CT value at 25. The
PCR assay that was designed based on the assembled contigs (AstV-contig) was used
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Table 5.1: Clinical Case 1 - metaMix summary profile consisting of twelve taxa.
Taxon Scientific Assigned Posterior
Identifier Name Reads Probability
374840 Enterobacteria phage phiX174 sensu lato 60449 1
NA unknown 10254 1
9606 Homo sapiens 216 1
28090 Acinetobacter lwoffii 89 1
469 Acinetobacter 78 0.99
13690 Sphingobium yanoikuyae 60 0.99
645687 Astrovirus VA1 46 1
133448 Citrobacter youngae 37 0.91
199310 Escherichia coli CFT073 33 1
56946 Afipia broomeae 28 1
618 Serratia odorifera 23 0.92
409438 Escherichia coli SE11 21 0.98
1747 Propionibacterium acnes 13 0.97
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Figure 5.2: Clinical Case 1 - Classification probabilities for the detected Astrovirus.
to retrospectively test all stored samples from the patient during his hospital admission.
Even though the highest titers of astroviral RNA were found in the brain tissue, viral
RNA was also detected in the CSF as well as in stool and serum samples, the latter
confirming viremic spread.
Sections of the brain biopsy were stained using AstV-specific antibody for the
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capsid protein and the results revealed extensive staining of cell bodies. The positive
immunohistochemistry for the capsid protein provided further confirmation of replica-
tion competent virus in the brain.
Additionally, the full viral genome sequence was generated using overlapping
PCR and subsequent Sanger sequencing. Phylogenetic analysis of the RNA-dependent
RNA polymerase nucleotide sequences (shown in Figure 5.3, taken from our paper
(Brown et al., 2015) and generated by Julianne Brown) showed that the virus iden-
tified in the brain clustered with a group of viruses more closely related to animal
astroviruses than the human HAstV 1-8 (less than 47% pairwise similarity) primarily
associated with gastroenteritis. The novel virus was termed HAstV-VA1/HMO-C-UK1
and it exhibited 98%, 97% and 95% pairwise similarity with the VA1, HMO-C, SG
strains respectively. The latter has once before been reported to cause fatal encephalitis
to a 15 year old boy with X-linked agammaglobulinemia (Quan et al., 2010). This fur-
ther points towards a pathogenic role for this virus group, likely to have been previously
under-recognised in immunocompromised patients.
Finally, to investigate the possible source of infection, all stored specimens from
patients on the same ward as our patient were tested by the AstV-contig PCR assay. This
included eighteen samples (stool and urine) from nine patients that were collected from
two weeks before to two weeks after our patient’s first positive AstV-contig PCR result,
There was a single patient who had a positive stool sample. There was insufficient
residual sample for repeat testing by quantitative PCR or for sequencing, therefore the
positive result could not be confirmed. No other stored samples from this second patient
were positive.
5.2.4 Comparing metaMix results to other methods
We also analysed the dataset using both Pathoscope and MEGAN to compare the per-
formance of the three tools in a clinical sample where the viral load is low.
Pathoscope
Pathoscope identified 22 taxa, corresponding to 15 species and some genera or families
(Appendix Table B.3). It also assigned all 46 reads to the Astrovirus VA1. Almost all
the species identified from metaMix were identified by Pathoscope, with an additional 9
taxa supported by few reads. As the method can only properly work with unassembled
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Figure 5.3: Clinical Case 1 - Phylogenetic analysis based on the RdRp gene. The astrovirus
(AstV) identified in the brain of the patient is denoted by a green rhombus (HAstV-
VA1/HMO-C-UK1(a)) while the AstV identified in the second patient’s stool by
a red rhombus. The black inverted triangles indicate AstV species previously re-
ported in patients with neurological disease. The black circles indicate sequences
of animal origin. Abbreviations: BAstV, bat astrovirus; MAstV, mink astrovirus;
OAstV, ovine astrovirus; TAstV, turkey astrovirus. Scale bar represents the number
of base substitutions per site.
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sequence data, an extra BLASTx similarity step had to be performed for the 91,516
reads that had contributed to the 679 assembled contigs. Pathoscope produced the
results in less than one minute.
MEGAN
MEGAN identified 19 taxa and did not detect the astrovirus signal. We modified the
minimum read support parameter from 50 reads to 10 to increase sensitivity. MEGAN
then identified 25 taxa, including the Astrovirus VA1. The remaining 24 were mostly
genera, relevant to the species detected by metaMix and Pathoscope. MEGAN pro-
duced the results in less than one minute.
Kraken
We also used the Kraken App for the Illumina BaseSpace. BaseSpace (http:
//basespace.illumina.com) is the Illumina genomics computing environment for
high-throughput sequencing data analysis and management, available as a cloud so-
lution. There are several Applications (Apps) that the BaseSpace user can launch
to analyse data online. Kraken (Wood and Salzberg, 2014) mentioned previously in
chapter 1, assigns taxonomic labels to reads using exact alignments of k-mers and the
LCA approach. The BaseSpace uses version 0.10.4-beta and the MiniKraken reference
database which contains bacteria, archaea and viruses. The raw data were used along
with the option for host read filtering.
Kraken classified 78% of the reads as human. Of the non-host reads 72% subse-
quently remained unclassified, while it classified the other 28% in 907 taxa. Among
these there were 108 viruses including three astroviruses. There was no parameter
tuning option available on the BaseSpace version of Kraken. It is plausible that cus-
tomisation, i.e setting different k-mer values, of the command line version of the tool
may correct the poor specificity to some degree. However assessed on default settings
and compared to the other three methods discussed in the previous sections, it manifests
worst specificity.
PhyloSift
Finally we used PhyloSift, which employes a phylogenetic approach. PhyloSift uses a
core set of genes and identifies the phylogenetic relationship of the read sequences to
the database sequences. We used the host filtered data as an input to PhyloSift. The
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summary with the taxa present in the sample consists of 1217 taxa, including 219 vi-
ral taxa and 5 astroviruses. A filtered version of the summary which contains only
candidate sequences where the placement probability is greater than 0.9, has removed
a substantial number of erroneous taxon assignments, however it still consists of 191
taxa, 94 viruses and 4 astroviruses. Along with Kraken, they exhibited the worst speci-
ficity among the tested methods. As mentioned in Chapter 1, PhyloSift is designed
to infer the large phylogenetic framework rather than act as a taxonomic classification
method and therefore the comparison is a little unfair and the results perhaps not sur-
prising. However we included it for the sake of completeness and to highlight that
when accurate and specific detection is of interest, a similarity Bayesian mixture model
is the best choice.
5.3 Clinical Case 2 - Coronavirus
The potential for deep sequencing to detect nucleic acids from a broad range of species
and the success in the astrovirus case prompted us to use RNA-sequencing of a brain
biopsy from an immunosuppressed 10-month-old boy with symptoms of viral en-
cephalitis in whom conventional diagnostic PCRs were negative. We identified a newly
emerged strain of human coronavirus OC43 as the most likely causative agent. In re-
cent years Coronaviruses have emerged as increasingly important pathogens in serious
human infections. However this is the first instance to confirm the associations between
coronavirus and central nervous system (CNS) disease in humans, long hypothesized
based on observations from mouse models. The work undertaken is under review (Mor-
fopoulou et al., Identification by deep-sequencing of a novel human coronavirus OC43
strain in an infant with severe combined immunodeficiency and fatal encephalitis), our
clinical collaborators having obtained written consent for publication from the patient’s
family.
5.3.1 Case Report
A male infant suffered recurrent respiratory infections and failure to thrive from 4
months of age. He was diagnosed at 7 months with severe combined immunodefi-
ciency (SCID) and at 9 months while waiting for a bone marrow donor, deteriorated
with the onset of neurological symptoms. Magnetic resonance imaging (MRI) revealed
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Figure 5.4: Clinical timeline for case 2. Arrows mark important events over the course of the
illness.
viral encephalitis. Apart from rotavirus in stool, an extensive panel of PCR for viruses
and bacteria on cerebrospinal fluid (CSF), blood, stool, urine and nasopharyngeal aspi-
rate did not identify a pathogen. At 10 months he underwent a cord blood transplant,
however he continued to deteriorate. A brain biopsy was taken at 11 months and the
patient died 1.5 months post-transplant. A schematic of the clinical timeline can be
seen in Figure 5.4.
5.3.2 Data and preprocessing
Total RNA was purified from a frozen brain biopsy and polyA RNA separated for
sequencing library preparation. 64 million RNA-Seq 80bp paired-end reads were ob-
tained using the HiSeq Illumina 2500 instrument. We processed the raw data using
the bioinformatic pipeline described in Chapter 1. 1.4 Million reads were identified
as non human, accounting for 2% of the raw data. These were then annotated with
BLASTx against the custom protein database mentioned. The BLASTx output con-
tained matches to 3,150 potential species.
5.3.3 metaMix results
The resulting species profile consisted of 7 species 5.2. The method ran in 4.7 hours.
The vast majority of the reads (∼one million) were assigned to Human coronavirus
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OC43, with 67K reads also matching a different human coronavirus. We see that de-
spite the initial host filtering, a few thousand reads were annotated as human on the
protein level. A few hundred reads matched environmental bacteria and known labora-
tory contaminants.
Table 5.2: Clinical Case 2 - metaMix summary profile consisting of eight taxa.
Taxon Scientific Assigned Posterior
identifier Name Reads Probability
31631 Human coronavirus OC43 997453 1
unknown unknown 170535 1
627439 Human enteric coronavirus strain 4408 67118 1
9606 Homo sapiens 23676 1
10090 Mus musculus 2301 1
47229 Massilia timonae 240 0.99
85698 Achromobacter xylosoxidans 127 0.9
72556 Achromobacter piechaudii 64 0.9
56946 Afipia broomeae 61 0.97
The summary contains two different human coronaviruses, however upon further
study both entries indicate the sole presence of an HCoV-OC43 strain. GenBank cur-
rently lists 58 HCoV-OC43 strains, but our database contains only the RefSeq sequence,
which is the laboratory prototype strain first isolated in 1967 (Vijgen et al., 2005b).
These other strains feature genomic insertions and deletions in reference to the proto-
type strain (Vijgen et al., 2005a). Some of the dissimilarities are present in the second
coronavirus species we identified, as well as in the virus in our sample. Therefore
metaMix results suggest that consideration of the different HCoV-OC43 strains could
reveal the closest one to the virus in the sample.
This is further supported by the cumulative histogram plot of the classification
probabilities for each species in the summary profile (Figure 5.5). There is a very
clean signal for HCoV-OC43 and we see that the vast majority of the reads assigned
to it have classification probabilities greater than 0.9. On the other hand only 25% of
the reads assigned to the 4408 species have high classification probabilities while the
remaining have very poor ones. Therefore, while a few thousand reads match better
to the 4408 proteins rather than HCoV-OC43 ones, the most plausible explanation is
that the virus in the brain looks more like the HCoV-OC43 but in some regions shares
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greater similarity with the second coronavirus species. There are a number of reasons
why a mixed infection is unlikely: first, even though the occurrence of multiple virus
infections in immunodeficient patients is not uncommon, mixed viral infections that
occur at the same site and involve viruses with similar expressions of disease are less
frequent (Waner, 1994). When coinfection of the same specimen does occur, it usually
involves viruses from different families (such as rhinoviruses, coronaviruses, influenza
A viruses). Finally, the Human enteric coronavirus strain 4408 was originally isolated
from the stool of a child from a rural area with acute diarrhoea (Zhang et al., 1994)
and shows greater relatedness to bovine coronaviruses than human coronaviruses. As
opposed to HCoV-OC43, this is not a common, circulating human pathogen.
We mentioned previously issues with the choice of reference database and how
depending on the database the answer may differ. Our choice included the viral RefSeq
database, a curated and well annotated collection of sequences. Its limited size renders
it a suitable choice for annotating sequences prior to community profiling due to rea-
sonable computation times. However depending on the question of interest, additional
analyses using a more inclusive database may be undertaken for greater taxonomic
resolution, as was done in this case and described in the next section.
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Figure 5.5: Clinical Case 2 - Classification probabilities for the 2 coronaviruses in the results.
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The presence of HCOV-OC43 was confirmed by real-time PCR performed in brain
tissue with a CT value of 24, as well as positive IHC staining in neurons.
5.3.4 Phylogenetic Analysis
We then wanted to see how the viral sequence detected in the brain biopsy compared
to other HCoV-OC43 sequences in GenBank. A consensus sequence was extracted
from the mapped reads, using Samtools (Li et al., 2009a) (version 0.1.19) and the de
novo assembled sequence by Velvet as a template. Multiple sequence analysis was per-
formed using ClustalO (Sievers et al., 2011) between the consensus sequence of the
virus from the sample and selected sequences from GenBank. A full-genome phyloge-
netic maximum likelihood tree was estimated by PhyML (Guindon et al., 2010) using
the multiplatform interface SeaView (Gouy et al., 2010) (version 4.3.1). Details for the
parameter settings of PhyML can be found in Appendix C.
Different studies support that HCoV-OC43 sequences can be classified in distinct
classes (Vijgen et al., 2005a) or genotypes (Lau et al., 2011). In the most recent study
(Zhang et al., 2014) five potential genotypes are discussed, the oldest one being the
original laboratory prototype (genotype A) and the most recently identified one being
E. Genotype E has been discussed solely in the context of respiratory tract infections
as it was identified in late 2014, despite being thought to have emerged in 2010.
We chose five sequences from GenBank (NC 005147, AY903459, JN129834,
AY903460, KL198610), one to represent each genotype. The bovine coronavirus se-
quence (NC 003045) was used as an outgroup. The estimated full-genome phyloge-
netic tree reveals a clear similarity of the consensus viral sequence to the novel geno-
type E as seen in Figure 5.6. This is the most recent one, thought to be a recombinant
from B, C and D (Zhang et al., 2014) . We had additionally confirmed this was the case
for our detected consensus viral sequence using bootscanning, a method for anaysis of
viral recombination (Lole et al., 1999). The main idea is that a potentially recombinant
sequence is compared to a set of plausible parental sequences. We produce a multiple
sequence alignment which is subsequently broken into sliding windows. Phylogenetic
trees with bootstrap support are built for each window and the bootstrap value is plot-
ted along the genome of interest. Figure 5.7 demonstrates the genetic distances of the
detected HCoV-OC43 to genotypes B, C and D accross its genome.
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Figure 5.6: Clinical Case 2 - Full genome phylogenetic tree for the viral sequence identified in
this study (13M2664 consensus in blue font) and the other 5 genotypes of coron-
avirus OC43. A, B, C, D and E represent OC43 genotypes.
The bootscanning analysis may appear redundant, however it was carried out when
attempts at reconstructing the phylogenetic tree resulted in the brain virus not clustering
with any genomes in the tree. This was due to the fact that the genotype E genome
was not published in GenBank until January of 2015 (Zhang et al., 2014) and thus,
this sequence was not included in our initial analyses. Without any closely related
sequences in the public databases, we wanted to understand how this virus related to
the other genotypes and therefore performed this analysis.
5.3.5 Variant Detection
The large number of short reads mapping to the HCoV-OC43 genome enabled us to
confidently identify single nucleotide polymorphisms (SNPs) as compared with the
published genotype E of the HCoV-OC43 strain. We aligned all QC short reads to
the genotype E genome (genbank identifier: KP198610) using novoalign, resulting in
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Figure 5.7: Clinical Case 2 - Recombination bootscan plot analysis of the viral sequence iden-
tified in this study (13M2664 consensus used as a query) compared to reference
strains in genotypes B, C and D. The analysis used a sliding window of 200 bp and
100 bootstraps.
1,175,294 mapped reads. We identified 102 variants (quality>= 30 and depth>= 20)
using Samtools (Li et al., 2009a) (version 0.1.19) (Figure 5.8). From these 47 were
missense variants, i.e resulting in a codon that codes for a different amino acid, based on
annotation with SnpEff (Cingolani et al., 2012). The full list of variants is in (Appendix
Table B.5).
It is of interest to note that one third of the missense mutations occurred in the
coding region of the S protein, a region with greater sequence variation compared to
the rest (Arbour et al., 1999). The S protein is the main viral protein involved in recep-
tor recognition on the cell surface and its role in determining neurovirulence has been
established in various studies (St-Jean et al., 2004; Pierre J. Talbot and Jacomy, 2011;
Desforges et al., 2014). However none of the mutations we identified has been pre-
viously associated with increased neurovirulence (Favreau et al., 2009; Jacomy et al.,
2006).
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Figure 5.8: Clinical Case 2 - Circos plot displaying the genomic structure of human coron-
avirus OC43 strain 258A/10 (genotype E) and the variants called. Missense vari-
ants are in red, while synonymous in blue. The grey histogram in the middle is the
read coverage (log10 values).
5.3.6 Discussion
Encephalitis is a severe neurological pathology, characterized by parenchymal inflam-
mation of the brain, rare in the general population but more frequent in immunocom-
promised patients. The combination of a large number of pathogens known to cause
viral encephalitis and the use of PCR for diagnostic testing contribute to the high fre-
quency of unknown aetiology encephalitis cases. Here we diagnosed post-mortem an
immunocompromised infant with acute encephalitis using deep sequencing on frozen
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brain biopsy. We identified high RNA levels of a novel HCoV-OC43 strain, confirmed
by PCR and immunohistochemistry. This is one of the few times where direct evidence
of HCoV RNA has been detected in the brain of a patient with encephalitis.
Coronaviruses (CoVs) are potentially lethal pathogens of the Coronaviridae fam-
ily, a group of linear single-stranded enveloped RNA viruses, with the largest genome
(∼ 31 kb) among known RNA viruses. They are of great interest to human and an-
imal health and are associated with a broad infection spectrum. CoVs are primarily
recognised as respiratoric pathogens, involved in mild to serious lower respiratory tract
infections (Perlman and Netland, 2009). They have been associated with a wide range
of disorders such as pneumonia, encephalitis, hepatitis and enteritis (Pierre J. Talbot
and Jacomy, 2011). Depending on the coronavirus type, they first interact with respi-
ratory tract and mucous cells and can potentially spread to other tissues, including the
central nervous system (Pierre J. Talbot and Jacomy, 2011; Desforges et al., 2014).
Coronaviruses are divided into four groups, Alphacoronavirus, Betacoronavirus,
Gammacoronavirus and Deltacoronavirus. Betacoronaviruses include the human coro-
naviruses which are major causes of the common cold such as HCoV-OC43 and HCoV-
HKU1, and can occasionally cause pneumonia. They also include SARS-CoV (Peiris
et al., 2003; Marra et al., 2003) and MERS-CoV (Zaki et al., 2012) that emerged in
the last fifteen years and cause severe acute respiratory syndrome, with a high rate of
mortality and morbidity, resulting in the revived interest of the scientific community in
the species (Graham et al., 2013) .
Three human CoVs OC43, 229E as well as SARS have been shown to have neu-
roinvasive and neurotropic properties (Arbour et al., 1999, 2000; Xu et al., 2005). In
vivo studies in mice show that HCoV-OC43 is able to infect neuros and cause en-
cephalitis (St-Jean et al., 2004; Jacomy et al., 2006) . The virus has also been shown
to cause persistent infections in human neural cell lines (Favreau et al., 2009). Inter-
estingly, HCoV-OC43 RNA has been detected by PCR in human brains from multi-
ple sclerosis (MS) patients and healthy subjects (Arbour et al., 2000). A single case
report identified HCoV-OC43 RNA in the CSF of a child with acute disseminated en-
cephalomyelitis (Ann Yeh, Arlene Collins, Michael Cohen and Faden, 2004). However
this is the first case in which HCoV-OC43 has been demonstrated by three independent
methods to be present in brain tissue of a case of acute encephalitis.
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The HCoV-OC43 strain we identified in the study is similar to a novel OC43 geno-
type E recently described for the first time (Zhang et al., 2014). In this study of res-
piratory tract infections, 65 clinical samples were analyzed. The novel genotype is
hypothesized to have emerged in 2010 and was identified in five children, all aged less
than three years old.
5.3.7 Comparing metaMix results to other methods
We also analysed the dataset using both Pathoscope and MEGAN to compare the per-
formance of the three tools in a clinical sample where there are species absent from the
database.
Pathoscope
Pathoscope identified 177 species in this sample. We optimized the value of the unique
read penalty parameter and we achieved the best results with the thetaPrior parameter
set within the range 10-100. With these settings, the method identified 52 species, in-
cluding five different coronavirus species (Appendix Table B.4). Our assessment is that
Pathoscope is confused by the lack of completeness of databases combined with the ab-
sence of an “unknown” category, which prevents it from dealing with these unassigned
reads sensibly. Pathoscope completed its analysis in 10 minutes.
MEGAN
MEGAN assigned the reads to 30 taxa. These included some species and genera but
most were families. Approximately 250K reads could not be assigned to any taxonomic
level. MEGAN ran in 8 minutes.
5.3.8 Concluding remarks
We discussed in chapter 1 the intrinsic limitiation of similarity based methods due to
their reliance on the content and completeness of public reference databases. With this
case it is emphasized how the database choice impacts the results: the RefSeq database
we used has only one HCoV-OC43 strain, while in GenBank there are several, capturing
the high mutation rates of this species. Since it is not computationally efficient to use all
publicly availble sequences, it is necessary to follow up any similarity based community
profiling with further analyses, such as phylogenetic ones for greater resolution and
accuracy.
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An interesting related point is that we followed up on the sequences assigned to
the “unknown category”, looking for nucleotide similarity with NR-NT using BLASTn.
Half of the reads originated from an untranslated region of the Coronavirus genome,
which is not captured by the protein reference database. The remaining reads matched
confidently to either zebrafish or chicken sequences, two organisms whose proteins are
not in the custom human microbiome reference we are using. These matches were
explained as barcode leakage that resulted from multiplexing on the same flowcell ze-
brafish and chicken RNA-Seq libraries. metaMix appropriately assigned all these reads
to the “unknown” category, producing a clean probabilistic summary. Pathoscope on
the other hand, does not have a formal way to handle the absence of closely related se-
quences in the database and misassigns these reads to species that share very low levels
of similarity, resulting in the great number of false positives.
Chapter 6
Viral trigger for Type I Diabetes
In this chapter we discuss the project that was the original motivation for deciding to
work on the community profiling research question and for developing metaMix. The
exact aetiology for Type I Diabetes (T1D) onset has not been determined, for all the
dedicated research effort over the last 100 years. That said, researchers agree that T1D
onset results from the interaction between an individual’s genetic predisposition, their
immune system and various environmental factors (Atkinson, 2014). T1D incidence
is increasing in many countries (Harjutsalo, 2008) and it is now believed that one or
more environmental factors are driving this increase. Part of this mosaic picture are
viruses, especially enteroviruses, whose role in T1D onset has long been implicated
(Yeung et al., 2011; Oikarinen et al., 2011, 2014; Richardson et al., 2014a), however
the evidence is still inconclusive.
A large collaboration between several institutions across different countries is the
JDRF nPOD-Virus group which aims to investigate the role of viruses in T1D. The
nPOD-V group brings together researchers with a common interest in viruses and T1D,
of diverse expertise from multiple disciplines. The goal is to facilitate the application of
multiple methods for enteroviral detection using the same sample set. The nPOD col-
lection (Campbell-Thompson et al., 2012) (http://www.jdrfnpod.org/) consists of
post-mortem pancreatic samples from organ donors with T1D or at varying levels of
risk for the disease. nPOD-V is organised in 6 subgroups (tasks) each with a specific fo-
cus. The overall goal of the task we participate in is to apply an integrated approach for
RNA analysis towards the identification of viruses associated with T1D. More specifi-
cally for our group the aim is to attempt to identify and characterize viruses associated
with T1D using high throughput sequencing. nPOD-V investigators from other institu-
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tions use alternative methods, such as laser-capture microscopy, real-time PCR and in
situ hybridization.
We begin with a section introducing the highlights of the relevant research on the
role of viruses in T1D onset. We then discuss the results of the RNA-seq work at each
stage of our participation in the nPOD-V project. The sample selection as well as the
technology employed throughout the years was informed from the findings in previous
stages or other tasks.
6.1 Background
6.1.1 T1D
T1D is characterised by a significant shortage or complete lack of insulin secretion.
Insulin is normally produced by endocrine cells which are found in the pancreas. These
cells are islands of endocrine tissue distributed throughout the pancreas. One of the
cell types that form these islets are the β -cells, which are the ones producing insulin.
T1D results from autoimmune destruction of these cells (Bluestone et al., 2010). The
resulting insulin deficiency requires daily insulin injections for survival. By the time
the diagnosis is made, the β -cells have almost completely been destroyed, making
prediction and prevention a high priority (Polychronakos and Li, 2011). Both require
knowledge on the causal factors and pathways to disease.
Much of the T1D risk is accounted for by genetic predisposition, with the sibling
relative risk (λS) estimated to be close to ten (Clayton, 2009). The predominant genetic
contribution in humans comes from the HLA complex on the short arm of chromo-
some 6 (Thorsby, 1997). However, the contribution of other non-genetic factors to the
aetiology of T1D is supported by the existence of T1D cases who have developed the
disease despite protective genetic loci (Christen and von Herrath, 2011). Furthermore
a predominance of susceptibility genes in individuals does not necessarily result in de-
velopment of T1D (Ziegler and Nepom, 2010). Finally, there is no strict concordance
between homozygous twins (Redondo et al., 1999). Also epidemiological evidence
shows an annual increase of 3% (Tuomilehto et al., 1999) in T1D incidence in many
countries over the past decades (Gale, 2002). This indicates that environmental factors
are necessary to initiate and propagate the disease (Bach, 2002).
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6.1.2 Viral trigger hypothesis
There is a long standing hypothesis that viral infection can act as a trigger for T1D
in genetically susceptible individuals. The most robustly documented relationship be-
tween a virus and T1D has been with enteroviruses. Enterovirus is a single-stranded
RNA virus and it belongs to the picornaviruses (Coppieters et al., 2012). However there
has not been a definite proof for the viral connection. On the contrary the path towards
understanding the possible role of viruses in the disease development has been paved
with challenges, not least due to the limited availability of pancreatic tissue. Therefore
study of even small numbers of pancreatic samples from T1D patients could provide
the most convincing argument for the viral link. The proximity of the pancreas to other
vital organs has deterred sample collection from living patients newly diagnosed with
T1D (Krogvold et al., 2014). Most of the studies described below have been conducted
using post-mortem pancreases with one notable exception where pancreatic biopsy was
performed on living patients.
6.1.3 Supporting evidence
Extensive literature spanning the past forty years has resulted from the effort to study
the role of persistent enteroviral infection of pancreatic β -cells in the initiation and
progression of T1D. One of the first noteworthy findings occurred in the 1970s (Yoon
et al., 1979) when a coxsackievirus which is a human enterovirus, was detected in
the pancreas of a child who died of diabetic ketoacidosis within one week of onset.
The virus was injected into mice resulting in islet inflammation, β -cell necrosis and
diabetes, with viral antigens detected in the β -cells. Thirty years later the same virus
was identified in autopsied pancreatic tissue in half of six T1D patients but in none of
the twenty six control organ donors (Dotta et al., 2007). In a larger study in 2009 the
enteroviral capsid protein VP1 was detected in multiple islets in the pancreas of patients
with T1D who had died within a year of developing the disease (44 out of the 72
patient samples, compared with 3 out of 50 control samples) (Richardson et al., 2009).
More recently and using samples from the nPOD collection which consists of more
recently harvested pancreatic samples, the same team of authors (Richardson et al.,
2013) detected VP1 in 8 of 10 T1D cases that had insulin-containing islets. VP1 was
not detected in any of the cases that were deficient of insulin. A conclusion of this study
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was that enteroviral infection in T1D persists over long periods rather developing as an
acute infection. Enterovirus infections usually proceed very rapidly (Richardson et al.,
2011) and this unusual pattern of only a few islet cells in T1D becoming infected with
this low-level mode may be important in triggering islet autoimmunity. The conclusion
was reached on the basis that the nPOD cases were from T1D patients where the disease
duration was longer, ranging from one to twenty years and mean duration of twelve
years.
It must be noted that the antibody widely employed to detect the enteroviral VP1
in islet cells in immunostaining studies might also cross-react with additional proteins
under some conditions (Richardson et al., 2013). It is therefore crucial that further
evidence is acquired before deducing that the immunodetection of VP1 in T1D case
islets is associated with an underlying viral infection.
A different type of supporting evidence comes from a genome-wide association
study (GWAS). Specifically it has been found that there are four rare variants of IFIH1
(interferon-induced helicase 1) that independently decrease the risk of T1D through
a lost or reduced expression of the protein (Nejentsev et al., 2009). Additionally dis-
abling IFIH1 expression lowers the risk of T1D (Nejentsev et al., 2009). IFIH1 is an in-
terferon response gene which allows the infected cell to sense RNA viruses and increase
interferon production by the host immune system. Interferons are signalling proteins
that trigger the immune system’s defence in order to limit viral replication and prevent
damage to the infected cell. However they also increase the visibility of the infected
cell to the immune system making it highly susceptible to recognition and destruction
by cytotoxic CD8 T cells (CD8+ T cells). CD8+ T cells recognise an antigen when it is
presented to them bound to cellular class I Major Histocompatibility Complex (MHC)
molecules. This presentation is enhanced when there is heightened expression of class I
MHC, commonly seen in the islets of patients with type 1 diabetes (Foulis et al., 1987).
This has been hypothesized to be one mechanism by which β -cells become visible to
the immune system during the development of autoimmunity and can be summarised
as the “fertile field hypothesis” (von Herrath et al., 2003), whereby the virus infects the
β -cells and predisposes them to autoimmune attack (Green et al., 2004).
It is worth noting that recently researchers participating in the Diabetes Virus De-
tection (DiViD) project used pancreatic biopsies of six living individuals with recent
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T1D onset (3-9 weeks) (Krogvold et al., 2015). Enterovirus was detected in all cases
by either RT-PCR (four positive for viral RNA out of six cases) in two different labo-
ratories or IHC (islets cells in all cases positive for viral protein VP1). The amount of
enterovirus RNA was low but its presence was additionally confirmed by sequencing
the PCR products. RNA-seq data for each patient were generated using an Illumina
HiSeq 2000 instrument. No viral reads were identified using RINS (Bhaduri et al.,
2012), an approach where reads are mapped to a pathogen database, matching reads
are assembled into contigs and finally all original reads are mapped on these contigs.
The study was ceased by the DiViD investigators as there were complications for three
of the patients, who ultimately recovered fully. While the biopsy procedure was uncom-
plicated for three participants, the complications that arose for the remaining volunteers
included extensive post-operative bleeding, pancreatic drainage, splenic tear, pain and
fever (Krogvold et al., 2014), resulting in extended hospitalisation.
It is clear that the safest and easiest means for obtaining access to pancreatic tissue
is by using post-mortem samples. These are also rare but our participation to the nPOD-
V group has allowed us to get access to 30 nPOD cases, approximately half of them
T1D cases over the course of 4 years. In the following section we discuss the results
obtained by the analysis of the RNA-seq data we generated from the nPOD samples.
The sample selection at each stage was guided by the results emerging from other tasks
as well as previous stages.
6.2 Results
Samples from cases with short and longer disease duration were selected for sequenc-
ing. Additionally preclinical T1D cases, that is cases without the disease but in high
risk for developing the disease were also included in the selection. The high risk is indi-
cated by the presence of multiple antibodies produced by the immune system that attack
the body’s own cells, tissues and organs causing inflammation and damage, called au-
toantibodies. Presence of persistently positive and multiple autoantibodies is highly
predictive for the development of T1D (Pihoker et al., 2005).
The criteria for sample selection from the nPOD collection evolved through the
years and as the collection increased in size. During Stage I and Stage II these were
simply availability of cases while during the later stages (III and IV) T1D cases were
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selected on the basis of VP-1 immunohistochemistry (IHC) positivity, i.e they were
positively stained for viral antibodies. Additionally hyper-expression of class I MHC,
which as discussed above is common in the islets of T1D cases, was taken into account
for Stage III and Stage IV.
In all generated data so far the results are negative for the presence of en-
teroviruses. However this negative result should be interpreted with caution as ap-
propriate sample collection is challenging. Common problems include the very low
number of infected islets in a T1D pancreas, the timing of collection, the fixation with
formalin the post-mortem tissue undergoes which impacts greatly the RNA stability
and integrity (Richardson et al., 2014b).
The bioinformatics pipeline and metaMix evolved over the years along with this
project, however all results presented here have been reanalysed with the latest pipeline
verion (January 2015) and metaMix 0.1.
6.2.1 Stage I - Prior to nPOD-V
Prior to the formation of the nPOD-V group, we worked on two preclinical T1D cases
which means they were autoantibody positive, from the nPOD collection. Three deep
sequencing datasets were generated from the two samples using two different library
preparation techniques, poly(A)-purification and ribodepletion, discussed in Chapter 1.
Acquiring samples of high quality can be challenging, especially for post mortem
clinical samples, despite standard RNA sample handling procedures (Sigurgeirsson
et al., 2014). Due to the nature of these samples, the quality of RNA in terms of degra-
dation was generally low. This is indicated by a measure called RIN (RNA Integrity
Number) (Schroeder et al., 2006), produced by an algorithm that can detect presence of
degradation products. The RIN score ranges from 1 to 10, where level 10 denotes com-
pletely intact RNA. Therefore the lower the score, the lower the quality of the RNA
(Schroeder et al., 2006). In general, RIN values greater than 7 are considered good
quality.
Unfortunately for these samples we were not able to recover the RIN scores. How-
ever judging from the extensive degradation of all follow up samples, we can assume
these would be low as well. RNA-sequencing was carried out using Illumina GAIIx.
The reads count summary are in Table 6.1.
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Table 6.1: Stage I prenPOD-Virus - 2 nPOD samples, 3 datasets: deep sequencing reads sum-
mary statistics. The asterisk denotes the dataset produced by the ribodepletion ap-
proach.
CaseID Donor Raw Data Unique QC Non-Host Non-rRNA Protein
(in K) % % % % simil. %
6044 preclinical T1D 34538.3 17.5 17.1 1.1 1.1 0.4
6044* preclinical T1D 24014.2 18.8 18.3 1.0 1.0 0.3
6027 preclinical T1D 67391.4 12.1 11.9 0.8 0.8 0.3
The community profile for the three datasets consisted of 132, 95 and 157 taxa
respectively. The majority of the reads remained unassigned (a proportion greater than
70% in all samples) with the remaining reads assigned to several bacteria, each sup-
ported by a low number of reads. These are either real bacteria that exist in the pan-
creatic tissue or they are contaminants originating from PCR reagents and/or extraction
kits (Salter et al., 2014) or human-skin associated bacteria acquired during sample han-
dling. Pancreas is however thought to be a sterile tissue (Funchain and Charis, 2012)
and therefore contamination appears to be the more plausible explanation, even though
negative controls would be necessary to confirm or refute this.
The number of taxa is not necessarily surprising, as the pancreatic samples contain
a low microbial biomass, allowing the contaminating sequences from the extraction kit
or the reagents or the general lab environment to overtake a larger fraction of the se-
quences. Additionally due to the low read numbers originating from each contaminant,
there is not enough information for metaMix to definitively differentiate between differ-
ent strains of the same species. In such a situation metaMix retains all of the competing
strains, increasing the number of reported taxa in the profile. Increasing the read sup-
port parameter to a larger value would result in more parsimonious summaries. As an
example, we ran metaMix again using r=50 and this reduced the number of identified
taxa to 57, 37 and 61 respectively. However our analysis requires a low detection limit
as the goal is to detect traces of viruses that may be potentially present, therefore we
performed all metaMix analyses using the default value of r=10.
The two datasets from case 6044 showed an important difference. In the ribode-
pleted dataset a murine leukemia virus (MLV) was identified. This was due to contam-
ination of laboratory reagents with mouse retroviruses, a known issue (Robinson et al.,
2010; Oakes et al., 2010) which was discussed in chapter 1 . This result is also briefly
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discussed in Appendix A (Section A.2, Figure A.4) as the discovery that helped me
realise the importance of utilising the available information from all reads in contrast
to considering only the assembled contigs.
6.2.2 Stage II
During the first official stage of the nPOD-V group in spring 2012 we sequenced seven
post-mortem pancreatic samples from four T1D patients, one T2D and two healthy
subjects as negative controls. The duration of the disease ranged from 4 to 28 years.
Three of the pancreatic samples had a RIN score of 2-3, so these were pooled to
be sequenced together. The remaining four samples were moderately degraded with a
RIN score above 4 and only one sample having a value greater than 7. Despite this we
proceeded with RNA-sequencing using Illumina GAIIx. The same sample set was also
sequenced at Baylor College of Medicine (BCM), where the library preparation step
included human ribosomal RNA (rRNA) depletion.
I used the bioinformatics pipeline described in chapter 1. Read statistics are sum-
marised in Table 6.2 and plotted in figure 6.1. Even though the number of raw reads is
high, there is a great degree of clonality due to PCR amplification, suggesting that the
complexity of the library had been exhausted. The informative reads for species iden-
tification which are the ones sharing some similarity to the proteins in the reference
database, are a few hundred thousands for all 5 datasets, ranging between 207,000 and
377,000 reads.
Table 6.2: Stage II - 7 nPOD samples: deep sequencing reads summary statistics
CaseID Donor Raw Data Unique QC Non-Host Non-rRNA Protein
(in K) % % % % simil. %
6070 T1D 65134 18.4 17.9 0.8 0.7 0.6
6098 Control 68481 17.7 17.3 0.6 0.6 0.5
6127 T2D 64459 17.8 17.4 0.6 0.6 0.5
6141 T1D 67146 16.9 16.5 0.6 0.6 0.4
6046,6084,6099 T1D, T1D, Cntr 72379 31.9 30.7 0.5 0.5 0.3
We subsequently applied metaMix to the annotated reads and contigs. In general
for all samples excluding the pooled dataset, a very similar profile was produced. No
viruses of interest were found - the majority of reads originated from Enterobacteria
phage phiX174, the positive control for Illumina sequencing, while the rest of the reads
were divided between various contaminants and the “unknown” bin (Table 6.3). The
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Figure 6.1: Stage II nPOD samples: number of reads passing each filter stage. The reads that
show some protein similarity are in the low hundred thousands range.
profile was different for the pooled dataset where half of the sequences could not be
assigned confidently to any of the species in the reference database, while the other
half originated from bacterial contaminants. A representative metaMix summary for
these samples can be found in Appendix Table B.6.
Table 6.3: Stage II - 7 nPOD samples: General profile and relative abundances in 6070, 6098,
6127, 6141.
organisms mean abundance % (sd)
Enterobacteria phage phiX174 62 (0.03)
Environmental bacteria 25 (0.02)
unknown 13 (0.01)
The community profile in all cases consisted of 80-90 taxa. Similar as before the
reagent contaminating sequences dominate numerically the results and metaMix re-
turned several strains of the same bacterial species. As an example it was common to
find different substrains of the Escherichia coli species, most at very low levels (less
than 100 reads). E. coli is a known contaminant of PCR reagents (Silkie et al., 2008).
However the same E. coli signal was detected in the resulting datasets from BCM, in-
dicating that the contamination had occurred before the samples were dispatched to the
two different sequencing centers. The more plausible explanation is that rather than dif-
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ferent E. coli strains being simultaneously present in the samples, metaMix cannot dis-
tinguish between them using the specified read support value of 10 reads. Subsequently
all the strains that have at least ten unique reads assigned to them - or equivalently a
greater number of ambiguous reads that in sum provide as much information as ten
unique ones - are retained in the present species summary. The poor read classification
probabilities for most of the E. coli strains further supports this interpretation, under-
lining the lack of clear signal for all of them. The classification probabilities for two
of the E. coli strains in sample 6127 are plotted below in Figure 6.2. For Escherichia
coli SE11, 6.5K reads have a classification probability greater than 0.8 In contrast, for
Escherichia coli O157:H7 str. EDL933 only 25% out of the 2K reads do so, while the
remaining 1500 reads have lower probabilities, indicating they match better or equally
well other bacterial species, presumably the other E. coli strains.
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Figure 6.2: Stage II - Classification probabilities for two out of ten Escherichia coli strains in
the results of sample 6098.
A second round of annotation for the “unknown” reads followed, using BLASTn
and the NR-NT database. This is a nucleotide sequence database with a significantly
greater number of sequences, as it contains entries from both RefSeq, EMBL and Gen-
Bank. Approximately 15%-25% of the unknown reads in all datasets showed good
similarity to an E. coli strain, while the rest did not have any matches in the ex-
tended database. An alternative approach to consider for future use would be to try to
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characterize the unknown reads with PSI-BLAST (Position Specific Iterative BLAST)
(Altschul et al., 1997) which is run in multiple iterations. The first iteration uses the
results of a BLAST search to create a position specific score matrix. This matrix is
used in the subsequent iterations, instead of the standard scoring matrices for protein
similarities, to generate more specific results. A different path could be explored by
trying to extend by targeted PCR and further sequencing the unclassified contigs in the
unknown category. This may then allow the detection of distant homology to a known
virus.
6.2.3 Stage III
The next stage of the project involved deep sequencing of 12 pancreatic slices. The
goal was to employ again the direct approach used in Stage II, while increasing the
sample size with cases of a shorter disease duration. The shorter duration implies that
samples were collected closer to the onset of the disease and in turn closer to a potential
triggering viral infection. There were four T1D cases, with disease duration ranging
from 1 year to 4 years. The remaining 8 samples were from cases with high VP1
immunohistochemistry positivity.
The samples were degraded with RIN values ranging from 2.5 to 6.7. Same as be-
fore due to the uniqueness of the samples, we proceeded with RNA-sequencing switch-
ing to Illumina HiSeq2500. Read statistics are summarised in Table 6.4 and plotted in
figure 6.3. Similar to Stage II, the proportion of independent (non clonal) reads is low,
while the reads showing homology to proteins range between 30K and 700K.
Table 6.4: Stage III - 12 nPOD samples: deep sequencing reads summary statistics
CaseID Donor Raw Data Unique QC Non-Host Non-rRNA Protein
(in K) % % % % simil. %
6052 T1D 184527 38.8 21.3 0.8 0.5 0.3
6080 Autoab Pos 167442 38.2 23.8 0.8 0.6 0.4
6090 Autoab Pos 107271 13.5 13.2 0.1 0.08 0.05
6113 T1D 83012.8 18.1 16.4 1.7 1.5 0.8
6147 Autoab Pos 99935.6 12.6 12.3 0.06 0.05 0.03
6158 Autoab Pos 89958.2 15.5 14.6 0.2 0.2 0.1
6167 Autoab Pos 154587 39.1 25.4 1.14 0.7 0.4
6171 Autoab Pos 96542.8 17.9 16.3 1.7 1.5 0.8
6195 T1D 101691 12.0 11.9 0.06 0.05 0.03
6197 Autoab Pos 85471.3 18.3 16.9 1.3 1.2 0.6
6198 T1D 89723.8 16.7 15.2 1.1 1.0 0.5
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Figure 6.3: Stage III -12 nPOD samples: number of reads passing each filter stage. The reads
that show some protein similarity are in the low hundred thousands range.
In all 12 cases the majority of the reads (80-90%) could not be assigned by
metaMix to any species. Further analyses on the unknown reads were performed same
as in Stage II, including BLASTn search of the NR-NT. The vast majority of the reads
in the “unknown” bin remained unclassified while a small minority had matches to
bacteria, either human skin associated or associated with contamination of laboratory
reagents and extraction kits. The remaining reads were assigned to either Enterobacte-
ria phage phiX174 (5-10%) or environmental bacteria (less than 1%). In three samples
(6052, 6080, 6171) the Geobacillus virus E2 was detected at low levels. Given its ho-
mology to the Bacillus species which is a known contaminant (Salter et al., 2014), we
consider it as not relevant to the viral trigger pursuit.
In general for all samples the metaMix profiles consisted of 40-60 taxa, with the
similar pattern of several strains of the same species appearing in the results. The
metaMix summary for case 6198 can be found in the Appendix Table B.7 and is repre-
sentative of the profiles in all cases.
6.2.4 Stage IV
The failure to detect viral nucleic acid using direct sequencing of the low volume pan-
creatic samples in Stage II and Stage III prompted us to consider a different method. A
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more suitable approach is a target capture method for purifying low quantities of viral
nucleic acid from samples where the host genome forms the majority. This technique
is used extensively in the Breuer lab. Therefore for the final stage of our involvement
with the nPOD-V project, we collaborated with Judy Breuer and Daniel Depledge who
developed the method for isolating and enriching for specific viral genomes prior to
deep sequencing (Depledge et al., 2011). The sequence capture method enriched the
RNA samples for enteroviral genomes which are the target sequences of interest.
6.2.4.1 Stage IVa
We first assessed the sensitivity of the method on five samples that were spiked-in with
Coxsackie B virus (CBV1) at different dilutions and one negative control. The samples
were multiplexed and run on a Illumina MiSeq. The results from this experiment in-
dicated a linear relationship between the dilution level of the spiked-in virus and the
number of CBV1 reads detected. The read summary is in Table 6.5.
The presence of one pair of CBV1 reads in the negative control suggests low level
cross-contamination occurred between samples with high viral load. This was a bit
worrisome as we generally are interested in detecting low numbers of reads; that said
one pair of reads would not in general be considered as enough evidence to believe in
the virus presence. Furthermore, one pair of reads would not provide sufficient support
for metaMix to keep CBV1 in the present species. Finally, we expect low amounts of
the virus in the actual pancreatic samples and therefore carry-over between samples
would be unlikely.
Table 6.5: Stage IVa - Control experiment: five spiked-in samples with CBV1 and one negative
control
CBV1 Raw QC QC CBV1 aligned CBV1
spike-in # pairs # pairs % # reads %
negative control 4728119 4349094 0.92 2reads→1 pair 2.3E-007
10e-8 4223286 3971535 0.94 32 4.0E-006
10e-7 3710861 3351818 0.90 283 4.2E-005
10e-6 3546996 3229128 0.91 2595 4.0E-004
10e-5 4392146 4015026 0.91 12237 1.5E-003
10e-4 2448108 2149775 0.88 132770 3.1E-002
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6.2.4.2 Stage IVb
Following the promising results from the positive control experiment, the next step was
to apply the enrichment method on further 12 nPOD samples. Of these six were T1D
cases and six were post-mortem pancreatic samples from healthy subjects (controls).
The T1D cases were selected on the basis of positive VP1 staining via IHC and MHC
class I overexpression. The RIN scores revealed extensive degradation with values
ranging from 2.1 to 3.5 and only one sample (6213) having a score of 6.5. The samples
were sequenced on an Illumina NextSeq machine. Read statistics are summarised in
Table 6.6 and plotted in figure 6.4. Same as in Stage II & III, we observe high clonality
in the resulting datasets.
Table 6.6: Stage IVb - 12 nPOD samples: sequence capture technology - deep sequencing reads
summary statistics
CaseID Donor Raw Data Unique QC Non-Host Non-rRNA Protein
(in K) % % % % simil. %
6024 Control 63911.1 21.2 21.1 1.6 1.4 0.4
6052 T1D 73753.2 18.5 18.4 1.2 1.1 0.3
6055 Control 48735.2 21.3 21.2 1.4 1.3 0.4
6073 Control 73871.1 19.6 19.5 1.4 1.2 0.4
6095 Control 67890.3 19.3 19.2 1.3 1.1 0.3
6126 Control 65789.9 20.6 20.5 1.5 1.4 0.4
6165 Control 68196.9 19.6 19.5 1.4 1.2 0.4
6213 T1D 70283.4 19.0 18.9 1.4 1.2 0.4
6228 T1D 72890.7 19.5 19.3 1.3 1.2 0.4
6243 T1D 72498.4 19.7 19.6 1.3 1.1 0.4
6070 02 T1D 76688.9 18.6 18.5 1.4 1.2 0.8
6070 04 T1D 70321.8 19.1 19.0 1.4 1.2 0.4
Community profiling with metaMix identified only two species in the results, with
the vast majority of reads - greater than 95% in all samples - being unassigned. One or
two thousand reads were host sequences while less than a thousand reads assigned to
Enterobacteria phage phiX. A typical summary can be seen in Table 6.7.
Table 6.7: metaMix summary profile for case 6055, deep-sequenced using the sequence capture
approach
taxon id scientific name assigned reads posterior prob
unknown unknown 188927 1
9606 Homo sapiens 2745 1
374840 Enterobacteria phage phiX174 sensu lato 698 0.92
We considered the possibility that unassigned reads could actually originate from
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Figure 6.4: Stage IVb - 12 nPOD samples: number of reads passing each filter stage.
a species that was not present in our reference database. We subsequently performed
a BLASTn search against the nucleotide-NR database but the reads remained unclassi-
fied, with only a few thousand reads matching human, bacterial or uncultured eukaryote
sequences.
In two of the samples we detected the presence of Human Herpesvirus 3 (HHV3),
supported by 18 and 69 reads respectively. The classification probabilities indicated this
was a true signal and that the sequences were indeed originating from HHV3 (Figure
6.5). This is a pathogen of interest in the Breuer lab, frequently sequenced on the
NextSeq and MiSeq machines we used for data generation during Stage IV. Thus the
most likely explanation would be cross-contamination between runs or during library
preparation steps.
6.2.4.3 Stage IVc
Over the years and thanks to relevant research the importance of sequencing the right
cells became obvious. This guided the decision to generate RNA-seq data from laser
microdissected nPOD donor islets. An initial run on the MiSeq has been performed for
these samples. It is also planned to sequence these in greater depth using the NextSeq
instrument. The data summary is in Table 6.8 and plotted in Figure 6.6 and we see that
the reads showing similarity to proteins are only a few thousands.
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Figure 6.5: Stage IVb - Classification probabilities for detected HHV3 in samples 6052 and
6165
Table 6.8: Stage IVc - 4 laser capture microdissected islets samples: sequence capture technol-
ogy - deep sequencing reads summary statistics
CaseID Donor Raw Data Unique QC Non-Host Non-rRNA Protein
(in K) % % % % simil. %
6052 T1D 1523.89 31.01 30.27 0.48 0.39 0.21
6070 T1D 1942.9 20.51 19.97 0.41 0.35 0.21
6213 T1D 1152.03 24.93 24.23 0.59 0.48 0.27
6243 T1D 1078.69 34.47 33.24 0.56 0.45 0.24
The metaMix profile consisted only of two, three species per sample. The famil-
iar outcome was that the vast majority of the reads remained unassigned, however a
few hundred reads were assigned to Human Herpesvirus 1 and 3, in three out of four
samples. The metaMix summary for case 6213 (Table 6.9) has been provided as an
example.
Table 6.9: metaMix summary profile for laser dissected islet from case 6213, deep-sequenced
using the sequence capture approach
taxon id scientific name assigned reads posterior prob
unknown unknown 3726 1
10298 Human herpesvirus 1 227 1
10090 Mus musculus 87 1
10335 Human herpesvirus 3 4 1
Both these pathogens are extensively sequenced in the Breuer lab where our se-
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Figure 6.6: Stage IVc - 4 laser capture microdissected islets samples: number of reads passing
each filter
quencing happened so it was indicative of contamination. This was due to a cross-run
contamination problem of the MiSeq where a small residue of the last library is se-
quenced in the subsequent run. The problem is now well-known and has been resolved
by adopting a new wash procedure between runs using bleach, as suggested by Illu-
mina.
6.3 Concluding remarks
Our involvement in this project is coming to an end but additional experiments are
planned. In the first instance the plan includes deeper sequencing of the the laser-
dissected islets. An additional experiment is to sequence a different set of positive
controls from mice where the pancreases have been infected with the virus. This would
allow a more realistic simulation that more accurately reflects the biology of islet in-
fection by enteroviruses.
We previously discussed that due to the small true microbial biomass in these post
mortem pancreatic samples, the probability that contaminants occupy a big proportion
of the dataset sequences is high. This was demonstrated by the typical community pro-
file for these samples, with high numbers of bacterial taxa in the results, each supported
by few reads. Other sources of laboratory-specific contamination also plagued some of
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the data. Ideally we want to conclusively confirm that the present species are contam-
inants and we could have achieved that with the use of blank negative controls. The
lack of incorporated negative controls renders a smooth interpretation of the deduced
profile more difficult, but the crux of the matter is not affected. In the end and for all
the progress that has been made since the start of the nPOD collaboration, the main
question of interest, that is whether there is a viral trigger for the onset of T1D, is still
unanswered. The rate of scientific discovery is delayed by the limited or complete lack
of access to appropriate specimens for study.
Chapter 7
General Conclusions
In this final chapter, I restate the research objectives of this thesis and outline the
novel methodological ideas and their development. I also discuss the thesis research
achievements, limitations and possible future work directions. I also briefly outline my
thoughts on metagenomic deep sequencing in the service of medical diagnostics as well
as its strengths and limitations.
7.1 Thesis objectives: achievements, limitations and fu-
ture work
Community profiling of a metagenomic mixture can be defined as the identification
and quantification of the present species in a sample. A profile is usually obtained by
assigning the sequencing reads to different taxa. This is a challenging problem which
raises complex computational issues. Similarity based methods use algorithms such as
BLAST and are considered the most accurate methods for read assignment and classi-
fication. The relatively short read lengths of existing deep sequencing technologies and
the homology across viral and bacterial species is part of the reason the current state-of-
the-art methods struggle with ambiguous matches and false positives supported by few
sequencing reads each. This common problem may cause users to ignore the low abun-
dance organisms in the resulting summaries as these may be false positives. Depending
on the research context, this can be a logical approach to bypass false positives. It can
also be troublesome in situations where the detection of a potentially disease causing
pathogen depends on identifying traces (very low number of reads) in the dataset. The
pathogen contribution to the mixture depends on the biological context, the timing of
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sample extraction and the type of pathogen considered.
Accurate viral identification and quantification in an otherwise complex mixture
where other eukaryotic and prokaryotic sequences exist, has been relatively unattended
despite the wealth of profiling and binning methods. Most of the similarity based ap-
proaches use nucleotide similarities for inference which is suboptimal for virus de-
tection as discussed previously, or have only recently added support for viral marker
genes. A limited number of the methods provide support for BLASTx-type searches.
Even these however may exhibit low specificity due to the fact that the comparative
plausibility of different profiles is not considered. This becomes especially pronounced
when discovery of low abundance viral pathogens is of interest, when species are ab-
sent from the database, or when some closely related strains exist in the sample, as
shown in Chapters 4 and 5. Therefore, a sensitive and specific computational approach
was required in such settings for addressing the aforementioned concerns in a formal
and elegant way.
This thesis has presented metaMix, a novel method that unified two ideas: the use
of mixture models for classification of a single read by borrowing information from the
whole of a dataset and the use of parallel MCMC for exploring the state-space of dif-
ferent profiles, by comparing different combinations of species based on their posterior
probabilities. This is a computationally intense task as even with a relatively small num-
ber of species to consider, the number of subsets that could explain the mixture grows
exponentially. Our strategy is based on Parallel Tempering, a Monte Carlo Markov
Chain technique, using parallel computing to speed up the inference. An important
feature of the method is that it provides probabilities that answer pertinent biological
questions, in particular the posterior probability for the presence of a species in the
mixture as well as the relative evidence in the data for the presence or the absence of
species, as captured by Bayes Factors. A consequence of the increased accuracy is that
metaMix produces better estimates for the relative abundances of the organisms in the
mixture.
The working assumption underlying the development, testing and fine tuning of
metaMix was that we are interested in detecting minute amounts of viruses in the sam-
ples, usually from sterile human tissue. This also the reason why the input data for
metaMix are derived from an amino acid similarity search step. Such samples are bet-
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ter described by parsimonious community profiles. The profile may be augmented by
microbial contamination which is possible at various stages of sample handling and
processing and it is important that reads originating from contaminants are not mis-
classified. The method can deal with either unassembled reads or assembled contigs or
both, allowing for flexibility of choice for the bioinformatics preprocessing. In practice,
the choice of bioinformatics processing prior to the application of the Bayesian mixture
analysis must be optimized for each application. The processing pipeline used in this
thesis has been designed with viral sequence identification from RNA-sequencing as a
main goal.
metaMix has been assessed on clinical datasets from sterile tissue, its performance
compared to that of other methods addressing the community profiling task. For the
clinical cases the ground truth is naturally not known. However, the presence of the
potential viral pathogens was confirmed with further experiments. Additionally, the
parsimonious profile produced by metaMix fits logically with our current knowledge
on communities in sterile tissues. These datasets proved to be challenging for the other
state-of-the-art methods. All exhibited lower specificity than metaMix presenting a
larger number of taxa in their profiles which, given the nature of these samples, are
most likely false positives. Some of the methods struggled particularly with viruses,
introducing a plethora of viral species in their results. Others failed to cope with reads
originating from species not in the database, which resulted in misassignments.
On the other hand, a first limitation of metaMix is the Poisson probability ap-
proach for the estimation of the generative pi j probabilities using the number of mis-
matches. Consideration of the differences between mismatches and the fact that some
substitutions are more likely than others, especially on the amino-acid level, can lead
to more accurate estimation of the pi j probabilities. Such information is captured by
the BLASTx similarity score, whose informational wealth is not used to its full ex-
tent by metaMix. A modification in the probability estimation that uses this metric has
other added benefits, such as automatically incorporating information on the length of
the read sequence and the target sequence. This will also be useful for contexts where
nucleotide, rather than protein search is the optimal strategy. Human clinical samples
where the infectious agents of interest are most likely bacteria benefit more from nu-
cleotide comparisons and target sequence length has to be taken into account.
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Relevant to this point, even though metaMix has been used extensively with the
type of samples described above (30 nPOD samples and several brain biopsies since the
end of the PhD), it has not been applied nor tested on different types of data. This in-
cludes datasets originating from metagenomics samples open to the environment (skin,
throat swabs, stool) where a plethora of bacterial species are expected or where the
infecting pathogen is a bacterial species. The only exception is the FAMeS benchmark
datasets which consist of real Sanger senquencing reads which are combined to sim-
ulate different mock communities (bacteria, plethora of organisms and some related
strains, different combinations of dominant populations) to the ones we typically ana-
lyze. Albeit different, the FAMeS datasets were selected during the metaMix bench-
marking stage as there were very few datasets for which the exact ground truth was
known in terms of both composition and abundance that we could use for method as-
sessment and comparison, and are widely known and used for testing. This proved that
the same ideas can work for different datasets to the ones metaMix was designed and
optimised for. metaMix outperformed the other methods in terms of better balance of
sensitivity and specificity. Still, additional work will be required for optimisation of
metaMix for different settings to the ones it was created for. For example, the fixed
generative probability for the “unknown” category will need to be estimated again for
such datasets, in order to account for the significant differences between the genome
lengths of human, bacteria and viruses. Ultimately, the metaMix extension will benefit
mostly from the more accurate pi j estimation that will utilise the BLAST score. Other
modifications will be required in the bioinformatics preprocessing pipeline, such as re-
taining ribosomal RNA which would now provide useuful information or as mentioned
usage of BLASTn instead of BLASTx.
I have strived to make this method as sensitive and specific as possible while main-
taining the efficiency that would allow its use on larger scale data sets. Again, this refers
to datasets where the majority of the read sequences is removed as human and thus
leaves a manageable amount (up to one million reads) for community profiling. The
high sensitivity and specificity of metaMix comes at an increased computational cost,
requiring access to a multi-core computer to run efficiently. For the datasets presented
here, the computation time remained manageable and did not exceed a few hours, using
twelve cores to run twelve parallel chains. Nevertheless, the second obvious limitation
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of metaMix is the increased processing time for very large datasets. Speed related
improvements can be implemented in scenarios where the species ambiguity concerns
only a small proportion of the read set. Reads with certain assignments can be flagged
prior to the MCMC exploration of the state-space. Their assignment information can
then be carried forward, thereby reducing the size of the similarity matrix used as input
by the mixture model. Another area of possible improvement is MCMC convergence
determination. The current version of metaMix produces log-likelihood traceplots al-
lowing the user to visually inspect the MCMC convergence, however additional diag-
nostic criteria can be implemented in future versions.
A final limitation of metaMix which is universal for similarity based methods, is
its reliance on the content and completeness of public reference databases. As men-
tioned previously, public databases hardly represent the real biological diversity, espe-
cially pertinent for the viruses that are mostly undiscovered. Additionally their content
is biased towards cultivable organisms and human pathogens. Therefore reads from
novel microorganisms that are sufficiently divergent from known species will remain
unclassified. The users of metaMix can easily obtain the unclassified reads for follow
up investigations regarding their nature. The classifications and resulting profile may
differ depending on the choice of the database. Informed database selection will im-
prove results, however users should always bear in mind the inherent limitations, biases
and potential errors in order to avoid misinterpretations of unlikely findings.
7.2 Deep sequencing for medical diagnostics
Deep sequencing has been a tranformative technology, affecting the whole breadth of
the biomedical sciences. The potential for massive parallelisation and automation has
made large scale sequencing projects possible. It has reshaped the field of metage-
nomics as it provides the opportunity to sequence uncultured microorganisms sampled
directly from their natural habitats.
Metagenomics can detect bacteria, viruses, fungi and parasites simultaneously.
RNA viruses are detected with the use of metatranscriptomics, however for the remain-
ing of the discussion we will not make this distinction and use the term metagenomics
for both approaches. A promising application of metagenomics can be found in medi-
cal diagnostics, where high throughput sequencing is starting to revolutionise pathogen
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detection and to inform treatment strategies. Widely used traditional techniques for
pathogen detection can be time consuming - viruses in particular are difficult and often
impossible to culture - and require prior information on the potential infectious agents.
This hampers the detection of unsuspected or undiscovered pathogens. Metagenomics
offers a target-independent approach for pathogen detection and no prior knowledge on
the cause of the infection or outbreak is required. Additionally it offers the possibil-
ity to characterise both individual organisms as well as the community in the sample.
Other properties of a pathogen such as virulence and drug resistance may be uncovered.
Diagnostic virology has already benefitted by the successful use of metage-
nomics.1 Quick and target independent viral identification and discovery was pre-
viously hindered by the difficulty associated with culturing viruses and their lack of
a universally conserved genetic element shared between viral genomes. Challenges
such as the emergence of novel strains have been resolved with the use of metage-
nomics. Accurate identification is crucial for avoiding misdiagnoses that may lead
to improper clinical treatment and which negatively affects survival or transmission
rates. The detection and response to viral pathogen outbreaks is another application
of metagenomics, successfully used for example in influenza outbreaks to determine
viral subtype. Another attractive feature of deep sequencing is the ability to detect
variants at low frequencies. This is useful for identifying drug resistant mutations or
transmission patterns of the viruses and for evaluating the impact of minority variants
on treatment efficacy. Finally, a number of viruses that have not been associated with
human diseases have been detected in healthy human hosts, establishing the existence
of a normal human virome.
There are various challenges and bottlenecks that need to be addressed before
routine application in diagnostic capacity is feasible. These include computational lim-
itations that are not only related to data processing but also to data storage. Addition-
ally, access to state-of-the-art computer equipment is not necessarily straightforward
for hospitals that do not collaborate with academic institutions. Sequencing and library
preparation costs need to be further reduced, while automation to a greater extent and
standardization of sample preparation and bioinformatic analysis will further facilitate
1Similarly, advances in diagnostic bacteriology are now obvious due to the metagenomics approach.
A number of studies where bacterial pathogens have been successfully detected and identified by metage-
nomic sequencing are discussed in (Pallen, 2014).
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its wider use. Both of these have the potential to offer more coherent results and limited
contamination. Microbial contamination - either bacteria or viruses - can take place
throughout the process of sample handling, nucleid acids isolation and sequencing.
Sources include sample handling in the laboratory or contaminated laboratory reagents
and/or nucleic acid extraction kits. There are a number of publications reporting com-
mon contaminants and researchers need to keep up to date with this information. It
is advised that the same extraction and deep sequencing methods that are used on the
clinical samples are also used on negative controls.
The relevance and plausibility of metagenomics findings should always be crit-
ically examined, even more so in cases of unlikely findings. The biases of public
databases towards cultivable organisms and human pathogens as well as their incom-
pleteness with regards to real biological diversity must be always taken into account.
The resulting classification will differ depending on the choice of the database as well
as the chosen community profiling method; it has been observed that each method intro-
duces distinct false positives. False positives can be reduced with careful database and
method choices, in the end though critical assessment and further validation remains
invaluable.
Proving disease causation for metagenomics findings is challenging. The Koch
postulates of causation may be modified and adapted in different times, given changes
in technology and disease knowledge. Despite the relevance of the newer adapted ver-
sions to the molecular era, these cannot be satisfied for viruses in all instances. Viral
infection patterns vary along with factors such as genetic susceptibility, age or previous
exposure to other agents. Things are easier with acute infectious diseases where the
responsible microorganism replicates in the tissue of interest and can be readily iden-
tified with traditional methods, there is evidence of an adaptive immune response as
well as evident morphological changes consistent with infection. However when clas-
sical hallmarks of infection are not present, the pathogenesis mechanism is not direct,
the microorganism has latent effects or requires cofactors such as coinfection, confirm-
ing causation is more challenging. In such cases, the strength of the epidemiological
association in the patients needs to be statistically assessed.
The technology developed by Oxford Nanopore Technologies (ONT) is partic-
ularly exciting for medical applications. Their mobile USB-powered single molecule
7.3. Final thoughts 134
sequencer (MinION) offers the opportunity for patient samples to be directly sequenced
in hospitals, reducing the time from sample isolation to diagnosis and subsequent treat-
ment. Furthermore this protability offers new opportunities for developing countries.
Using the MinION samples can be sequenced on-site, avoiding long transportation and
shipping times. Short response times are often critical in the case of serious outbreaks.
This was recently demonstrated with the Ebola virus outbreak in Guinea (Quick et al.,
2015) with data released almost instantly, permitting the tracking of the transmission
routes in real time. The commercial launch of MinION has not been announced yet and
error rates for the nanopore reads are currently higher compared to other sequencing
technologies. Still, the promise of low-cost portable sequencer producing very long se-
quences with low error rates at the point-of-care seem less distant as time goes by. This
development has the potential to completely transform infectious disease diagnosis.
Finally, ethical issues arising from metagenomics applications in the clinical set-
ting have not been widely discussed yet. An example of such an issue would be how
to proceed with incidental detection of pathogens. Established guidelines for consent
and reporting of incidental findings are necessary when handling and analyzing human
metagenomic data.
7.3 Final thoughts
This thesis has provided an initial insight in what metagenomic sequencing and
methodological work can deliver in a diagnostic capacity. The potential of deep se-
quencing and bioinformatics solutions have contributed to a sense of great expecta-
tions. However in order to reach meaningful conclusions based on the generated data,
the choice and suitability of analytic method is essential. It is also of paramount impor-
tance that the biases and errors inherent in the sequencing process, the bioinformatics
algorithms, the community profiling methods and the public databases are carefully
considered.
For this thesis I have contributed novel methodological ideas in the field of method
development for community profiling. The main objective was to develop an open-
source, sensitive and specific similarity based community profiling method at a high
taxonomic resolution, employing the two ideas of parallel MCMC and mixture mod-
els. The methodological work has been published in Bioinformatics (Morfopoulou
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and Plagnol, 2015). metaMix is implemented as an R package, freely available from
CRAN, thereby allowing its wider use.
The method owes its conception and development to the nPOD project. Chapter 6
described our involvement in this colloborative effort with the goal to give a definitive
answer to whether enteroviruses are implicated in the onset of T1D. The work has
not resulted in a positive result, with the caveats mentioned in the previous chapter
complicating the interpretation of the negative result. This work has been written as a
negative results paper (Morfopoulou et al., Transcriptome sequencing of nPOD type 1
diabetes pancreatic samples for viral sequence identification: insights from the nPOD-
V group), pending the results from the few remaining experiments.
Finally, metaMix has been used as the first step for diagnosing clinical cases of
patients with undiagnosed viral encephalitis. Two of these results are included in the
thesis and are either published (Brown et al., 2015) or are currently under review (Mor-
fopoulou et al., Novel human coronavirus OC43 in an infant with severe combined
immunodeficiency and fatal encephalitis, The New England Journal of Medicine).
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Appendix A
Observations on the assembly step
A.1 Abundant organisms overwhelm real but weak sig-
nal during assembly
The primary goal was to assess to what extent the assembled contigs reflect the real
abundance or even presence of a species in a metagenomic sample. Simulations de-
signed to quantify how much of the signal is contained in the assembled contigs were
carried out. Default settings were used for Velvet.
The first dataset was generated using MetaSim (Richter et al., 2008) designed to
simulate a simple scenario. This comprised two viruses arbitrarily chosen, one regarded
to be the “signal” (enterovirus) and one the “noise” (measles virus). The idea was to
keep the “signal” genome at a steady coverage of either 1x or 5x, while increasing the
coverage of the noise. 50 such mixed datasets were simulated. The proportion of the
“signal” contained in the assembled contigs reduces as the coverage depth for the noise
increases, as demonstrated in Figures A.1 and A.2.
However a typical scenario would entail greater complexity such as detecting rare
sequences in an ocean of possibly irrelevant reads. A dataset generated from a real clin-
ical serum sample of high complexity was spiked-in bioinformatically with a low viral
signal. The coverage for the spiked-in signal fluctuated from 1x to 10x (50 simulations).
Different assemblies were generated, using all non host reads or alternatively using all
reads that showed some similarity to viral proteins in RefSeq. In the spiked-in dataset,
as the coverage for the true signal reduces, fewer “signal” reads are incorporated into
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contigs successfully, plotted in Figure A.3.
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Figure A.3: Spiked-in dataset: % of “signal” genome contained in assembly, coverage depth
from 1x to 10x. Results based on 50 simulations.
An alternative approach was borrowed by de novo transcriptome assembly (Schulz
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et al., 2012), (Surget-Groba and Montoya-Burgos, 2010). The main idea is to merge
multiple assemblies resulting from different k-mer values into one. The motivation
behind this approach is to detect differently expressed genes by merging sensitive as-
semblies with specific ones. It has been shown that longer k-values perform best on
high expression genes, but poorly on low expression genes. An obvious disadvantage
of this approach is that short k-mer assemblies may introduce misassemblies.
For metagenomics assembly, one may use an array of k-values to partition the
metagenomic sequence mix into species bins and then merge the assemblies together.
Applying this to the spiked-in dataset with the signal at 1x coverage, 6% of the genome
was recovered. The obvious conclusion is that when the coverage is low, the assembly
step is going to yield unsatisfactory results despite parameter fine-tuning.
A.2 Unassembled reads are necessary for rare signal
detection
An accidental discovery strengthened the argument for using all available reads, in-
cluding the unassembled ones for species identification, especially when the goal is to
detect potential rare pathogens. During the early stages of the project that will be dis-
cussed in chapter 6, RNA-seq data from a human post-mortem pancreatic sample were
analysed using the assembly-based pipeline This analysis resulted in the identification
of two short contigs (200-300bp) originating from a Murine Leukemia virus (MuLV).
Upon annotation of the unassembled reads, 50 additional reads mapped confidently to
the MuLV genome (Figure A.4) providing further support to the presence of the species
in the sample.
It is not difficult to imagine a scenario where due to low coverage it is not possible
to obtain any contigs, even after careful and iterative assembly. Low coverage depth for
pathogens of interest could for example be encountered when dealing with degraded
tissue samples, or when sample collection has happened long after the infection has
taken place. Relying only on assembly results would lead in such an instance to miss
the opportunity to observe the signal in the sample.
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Figure A.4: Alignment view of contigs (red) and reads (blue) against the MuLV genome.
Appendix B
Supplementary Tables
Table B1: simHC FAMeS dataset - predicted species and number of reads assigned to these by
metaMix and Pathoscope.
metaMix Pathoscope
Taxon Scientific True Read Assigned Posterior Final Best Hit
identifier Name Counts Reads Probability Read Numbers
339671 Actinobacillus succinogenes 130Z 483 474 1 135.32
187272 Alkalilimnicola ehrlichei MLHE-1 829 798 1 278.52
293826 Alkaliphillus metalliredigenes UNDEF 1091 982 1 590.12
240292 Anabaena variabilis ATCC 29413 1703 1686 1 507.02
290397 Anaeromyxobacter dehalogenans 2CP-C 1273 1263 1 368.52
290399 Arthrobacter sp. FB24 1211 1181 1 358.10
322710 Azotobacter vinelandii AvOP 1311 1257 1 1 420.53 1
315749 Bacillus cereus NVH391-98 1000 844 1 242.15
205913 Bifidobacterium longum DJO10A 610 557 1 156.58
288000 Bradyrhizobium sp. BTAi1 2127 2060 1 731.57
321955 Brevibacterium linens BL2 1088 1185 1 565.65
339670 Burkholderia ambifaria AMMD 1937 1877 1 706.35
331271 Burkholderia cenocepacia AU 1054 1791 2174 1 1256.00
331272 Burkholderia cenocepacia HI2424 2045 1656 1 1206.98
269483 Burkholderia sp. sp.strain 383 2191 2215 2 1 1009.3 2
269482 Burkholderia vietnamiensis G4 2083 1989 1 747.98
266265 Burkholderia xenovorans LB400 2384 2335 1 799.70
351627 Caldicellulosiruptor accharolyticus UNDEF 658 640 1 196.20
290315 Chlorobium limicola DSMZ 245(T) 671 638 1 594.15
290317 Chlorobium phaeobacteroides DSM 266 719 705 1 631.02
The organisms in bold font are the ones for which metaMix or Pathoscope (or both) identified as present a different strain of the
same species or a different species of the same genus.
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Table B1 continued: simHC FAMeS dataset - predicted species and number of reads assigned
to these by metaMix and Pathoscope
.
metaMix Pathoscope
Taxon Scientific True Read Assigned Posterior Final Best Hit
identifier Name Counts Reads Probability Read Numbers
290318 Chlorobium vvibrioforme f. thiosulfatophilum DSMZ 265(T) 534 543 1 450.97
324602 Chloroflexus aurantiacus J-10-fl 1277 1210 3 1 NA
290398 Chromohalobacter salexigens DSM3043 888 859 1 284.42
290402 Clostridium beijerincki NCIMB 8052 1411 1317 1 453.28
203119 Clostridium thermocellum ATCC 27405 932 875 1 338.98
165597 Crocosphaera watsonii WH 8501 1593 2897 1 1146.68
269798 Cytophaga hutchinsonii ATCC 33406 1161 1102 1 755.40
159087 Dechloromonas aromatica RCB 1132 1104 1 421.18
319795 Deinococcus geothermalis DSM11300 809 833 1 225.65
272564 Desulfitobacterium hafniense DCB-2 1486 1333 1 518.28
207559 Desulfovibrio desulfuricans G20 919 858 1 410.38
269484 Ehrlichia canis Jake 283 206 1 142.05
332415 Ehrlichia chaffeensis sapulpa 255 296 1 201.12
333849 Enterococcus faecium DO 676 358 1 124.05
262543 Exiguobacterium UNDEF 255-15 788 733 1 275.80
333146 Ferroplasma acidarmanus fer1 471 414 1 270.32
106370 Frankia sp. CcI3 1334 1278 1 601.87
298653 Frankia sp. EAN1pec 2248 2176 1 932.93
269799 Geobacter metallireducens GS-15 1025 1035 1 476.35
205914 Haemophilus somnus 129PT 513 497 1 148.72
290400 Jannaschia sp. CCS1 1148 1037 1 448.28
266940 Kineococcus radiotolerans SRS30216 1187 1190 1 440.92
387344 Lactobacillus brevis ATCC 367 445 395 1 172.60
321967 Lactobacillus casei ATCC 334 648 606 1 235.95
321956 Lactobacillus delbrueckii bulgaricus ATCC BAA-365 391 322 1 84.4 4
324831 Lactobacillus gasseri ATCC 33323 551 555 1 182.17
272622 Lactococcus lactis cremoris SK11 584 524 1 155.73
203120 Leuconostoc mesenteroides mesenteroides ATCC 8293 473 471 1 155.12
156889 Magnetococcus sp. MC-1 1153 999 1 761.50
351348 Marinobacter aquaeolei VT8 1164 1127 1 449.60
266779 Mesorhizobium sp. BNC1 1289 1244 1 478.72
259564 Methanococcoides burtonii DSM6242 663 614 1 329.70
The organisms in bold font are the ones for which metaMix or Pathoscope (or both) identified as present a different strain of the
same species or a different species of the same genus.
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Table B1 continued: simHC FAMeS dataset - predicted species and number of reads assigned
to these by metaMix and Pathoscope
.
metaMix Pathoscope
Taxon Scientific True Read Assigned Posterior Final Best Hit
identifier Name Counts Reads Probability Read Numbers
269797 Methanosarcina barkeri Fusaro 1213 1192 1 509.47
323259 Methanospirillum hungatei JF-1 919 817 1 589.37
265072 Methylobacillus flagellatus strain KT 687 606 1 252.75
264732 Moorella thermoacetica ATCC 39073 1426 696 1 352.22
323097 Nitrobacter hamburgensis UNDEF 1272 1308 1 672.03
323098 Nitrobacter winogradskyi Nb-255 857 727 1 446.38
323261 Nitrosococcus oceani UNDEF 868 809 1 304.95
335283 Nitrosomonas eutropha C71 649 596 1 245.85
323848 Nitrosospira multiformis ATCC 25196 814 757 1 375.75
196162 Nocardioides sp. JS614 1337 1333 1 449.52
279238 Novosphingobium aromaticivorans DSM 12444 (F199) 1093 1054 1 440.17
203123 Oenococcus oeni PSU-1 422 406 1 216.73
318586 Paracoccus denitrificans PD1222 1362 1497 1 498.58
278197 Pediococcus pentosaceus ATCC 25745 456 451 1 157.27
338963 Pelobacter carbinolicus DSM 2380 896 783 1 480.70
338966 Pelobacter propionicus DSM 2379 1145 1093 1 531.03
319225 Pelodictyon luteolum UNDEF 581 550 1 493.32
324925 Pelodictyon phaeoclathratiforme BU-1 (DSMZ 5477(T)) 703 676 1 573.25
296591 Polaromonas sp. JS666 1489 1468 1 561.72
74546 Prochlorococcus marinus str. MIT 9312 404 392 1 124.35
59920 Prochlorococcus sp. NATL2A 480 398 1 146.95
290512 Prosthecochloris aestuarii SK413/DSMZ 271(t) 692 633 1 481.98
331678 Prosthecochloris sp. BS1 1082 769 1 488.95
342610 Pseudoalteromonas atlantica T6c 1301 1233 1 474.07
205922 Pseudomonas fluorescens PfO-1 1587 1544 1 502.55
351746 Pseudomonas putida F1 1528 1542 1 416.47
205918 Pseudomonas syringae B728a 1545 1455 1 462.07
259536 Psychrobacter arcticum 273-4 623 555 1 259.20
335284 Psychrobacter cryopegella UNDEF 793 785 1 393.28
272943 Rhodobacter sphaeroides 2.4.1 1119 1130 1 408.28
338969 Rhodoferax ferrireducens UNDEF 1276 1258 1 485.52
316055 Rhodopseudomonas palustris BisA53 1392 1333 1 760.55
The organisms in bold font are the ones for which metaMix or Pathoscope (or both) identified as present a different strain of the
same species or a different species of the same genus.
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Table B1 continued: simHC FAMeS dataset - predicted species and number of reads assigned
to these by metaMix and Pathoscope
.
metaMix Pathoscope
Taxon Scientific True Read Assigned Posterior Final Best Hit
identifier Name Counts Reads Probability Read Numbers
316056 Rhodopseudomonas palustris BisB18 1348 1344 1 760.72
316057 Rhodopseudomonas palustris BisB5 1200 1200 1 805.37
316058 Rhodopseudomonas palustris HaA2 1339 1586 1 940.77
269796 Rhodospirillum rubrum ATCC 11170 1062 983 1 320.37
266117 Rubrobacter xylanophilus DSM 9941 799 758 1 307.28
203122 Saccharophagus degradans 2-40 1324 1174 1 796.72
326297 Shewanella amazonensis SB2B 1055 953 1 433.48
325240 Shewanella baltica OS155 1313 1384 1 678.57
318167 Shewanella frigidimarina NCMB400 1257 1133 1 429.40
319224 Shewanella putefaciens UNDEF 1153 1438 1 750.38
94122 Shewanella sp. ANA-3 1279 1298 1 688.37
60481 Shewanella sp. MR-7 1177 1225 1 645.57
323850 Shewanella sp. PV-4 1165 1106 1 487.83
351745 Shewanella sp. W3-18-1 1214 1015 1 670.82
292414 Silicibacter sp. TM1040 1065 1030 1 373.45
317655 Sphingopyxis alaskensis RB2256 846 807 1 275.92
286604 Streptococcus suis 89/1591 490 1017 1 253.07
322159 Streptococcus thermophilus LMD-9 501 290 1 78.97
1140 Synechococcus sp. PCC 7942 (elongatus) 646 634 1 200.42
335543 Syntrophobacter fumaroxidans MPOB 1181 1067 1 642.47
335541 Syntrophomonas wolfei Goettingen 708 649 1 385.48
340099 Thermoanaerobacter ethanolicus 39E 570 588 5 1 13.05 6
269800 Thermobifida fusca YX 930 915 1 343.93
292415 Thiobacillus denitrificans ATCC 25259 741 742 1 242.93
317025 Thiomicrospira crunogena XCL-2 603 563 1 302.28
326298 Thiomicrospira denitrificans ATCC 33889 490 503 1 198.52
203124 Trichodesmium erythraeum IMS101 2051 1904 1 1156.00
155920 Xylella fastidiosa Ann-1 627 NA 7 NA NA 7
155919 Xylella fastidiosa Dixon 1303 1343 1 598.32
The organisms in bold font are the ones for which metaMix or Pathoscope (or both) identified as present a different strain of the
same species or a different species of the same genus.
1 Identified Azotobacter vinelandii CA instead (taxon id:1283330).
2 Burkholderia lata (taxon id: 482957, which includes Burkholderia sp. 383).
3 Chloroflexus sp. Y-400-fl 1 (taxon id: 480224).
4 Lactobacillus delbrueckii subsp. Bulgaricus 2038 (taxon id: 353496).
5 Thermoanaerobacter brockii subsp. finnii Ako-1 (taxon id: 509193).
6 Thermoanaerobacterium thermosaccharolyticum DSM 571 (taxon id: 580327).
7 For 155920, the fasta file supposed to contain the reads from it, contained reads from the closely related strain 155919. Therefore
even though the community theoretically consists of 113 species, the dataset has reads from 112 organisms.
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Table B2: simHC FAMeS dataset - False Positives for metaMix and Pathoscope.
metaMix
Taxon identifier Scientific Name Assigned Reads Posterior Probability
NA unknown 2284 1
395019 Burkholderia multivorans ATCC 17616 131 1
395960 Rhodopseudomonas palustris TIE-1 102 1
742013 Delftia sp. Cs1-4 98 0.9658119658
866768 Escherichia coli ’BL21-Gold(DE3)pLysS AG’ 60 0.9252136752
Pathoscope
Taxon identifier Scientific Name Final Best Hit Read Numbers
395019 Burkholderia multivorans ATCC 17616 687.33
416344 Burkholderia sp. KJ006 501.90
407976 Shewanella baltica OS223 458.13
335659 Bradyrhizobium sp. S23321 295.43
1196325 Pseudomonas putida DOT-T1E 289.97
349102 Rhodobacter sphaeroides ATCC 17025 242.95
1345695 Clostridium saccharobutylicum DSM 13864 164.12
1155766 Enterococcus faecium Aus0004 160.72
999541 Burkholderia gladioli BSR3 153.08
720554 Clostridium clariflavum DSM 19732 105.78
690566 Sphingobium chlorophenolicum L-1 100.63
396588 Thioalkalivibrio sulfidophilus HL-EbGr7 92.38
65393 Cyanothece sp. PCC 7424 89.22
349124 Halorhodospira halophila SL1 86.17
526225 Geodermatophilus obscurus DSM 43160 83.98
404589 Anaeromyxobacter sp. Fw109-5 79.00
497965 Cyanothece sp. PCC 7822 78.63
867904 Methanomethylovorans hollandica DSM 15978 73.87
483219 Myxococcus fulvus HW-1 55.53
266264 Cupriavidus metallidurans CH34 53.73
272568 Gluconacetobacter diazotrophicus PAl 5 52.30
868597 Stenotrophomonas maltophilia JV3 27.77
572480 Arcobacter nitrofigilis DSM 7299 26.52
517418 Chloroherpeton thalassium ATCC 35110 26.00
1128398 Clostridium acidurici 9a 25.37
146
Table B2 continued: simHC FAMeS dataset - False Positives for metaMix and Pathoscope.
Pathoscope
Taxon identifier Scientific Name Final Best Hit Read Numbers
436717 Acinetobacter oleivorans DR1 25.18
929556 Solitalea canadensis DSM 3403 24.92
583345 Methylotenera mobilis JLW8 23.65
176299 Agrobacterium fabrum str. C58 23.27
222523 Bacillus cereus ATCC 10987 21.35
1036172 Arcobacter butzleri 7h1h 20.40
880070 Cyclobacterium marinum DSM 745 19.37
880071 Flexibacter litoralis DSM 6794 19.08
762903 Pedobacter saltans DSM 12145 16.93
288681 Bacillus cereus E33L 16.02
651182 Desulfobacula toluolica Tol2 15.83
557599 Mycobacterium kansasii ATCC 12478 15.17
866536 Belliella baltica DSM 15883 14.88
760192 Haliscomenobacter hydrossis DSM 1100 12.38
755732 Fluviicola taffensis DSM 16823 11.58
926556 Echinicola vietnamensis DSM 17526 10.87
748449 Halobacteroides halobius DSM 5150 10.48
1096996 Acinetobacter baumannii BJAB0715 10.23
1094466 Flavobacterium indicum GPTSA100-9 10.03
110662 Synechococcus sp. CC9605 9.88
1041826 Flavobacterium columnare ATCC 49512 9.58
411154 Gramella forsetii KT0803 8.33
694427 Paludibacter propionicigenes WB4 7.68
746697 Aequorivita sublithincola DSM 14238 7.53
458233 Macrococcus caseolyticus JCSC5402 3.55
867902 Ornithobacterium rhinotracheale DSM 15997 2.95
347256 Mycoplasma hominis ATCC 23114 2.80
943945 Mycoplasma fermentans M64 2.70
515635 Dictyoglomus turgidum DSM 6724 2.45
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Table B3: Clinical Case 1 - Pathoscope summary.
Taxon identifier Scientific Name Final Best Hit Read Numbers
374840 Enterobacteria phage phiX174 sensu lato 65327
9606 Homo sapiens 554
133448 Citrobacter youngae 169
13690 Sphingobium yanoikuyae 135
28090 Acinetobacter lwoffii 126
469 Acinetobacter 123
56946 Afipia broomeae 77
409438 Escherichia coli SE11 49
645687 Astrovirus VA1 46
199310 Escherichia coli CFT073 35
1747 Propionibacterium acnes 35
1282 Staphylococcus epidermidis 10
28211 Alphaproteobacteria 10
28037 Streptococcus mitis 8
562 Escherichia coli 8
509173 Acinetobacter baumannii AYE 7
41297 Sphingomonadaceae 6
40214 Acinetobacter johnsonii 6
29391 Gemella morbillorum 5
76122 Alloprevotella tannerae 4
652103 Rhodopseudomonas palustris DX-1 2
268747 Prochlorococcus phage P-SSM4 2
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Table B4: Clinical Case 2 - Pathoscope summary (thetaPrior ∈ (10,100).
Taxon identifier Scientific Name Final Best Hit Read Numbers
31631 Human coronavirus OC43 996661
9606 Homo sapiens 25036
627439 Human enteric coronavirus strain 4408 12498
47229 Massilia timonae 538
10090 Mus musculus 477
85698 Achromobacter xylosoxidans 282
56946 Afipia broomeae 119
11128 Bovine coronavirus 113
47671 Lautropia mirabilis 89
133448 Citrobacter youngae 65
509173 Acinetobacter baumannii AYE 62
258 Sphingobacterium spiritivorum 58
13690 Sphingobium yanoikuyae 46
72556 Achromobacter piechaudii 43
488 Neisseria mucosa 38
158836 Enterobacter hormaechei 37
1747 Propionibacterium acnes 32
816 Bacteroides 29
29430 Acinetobacter haemolyticus 22
43767 Rhodococcus equi 19
847 Oxalobacter formigenes 18
194702 Cardiobacterium valvarum 15
250 Chryseobacterium gleum 13
469 Acinetobacter 12
471 Acinetobacter calcoaceticus 12
618 Serratia odorifera 12
1034 Afipia clevelandensis 10
486 Neisseria lactamica 9
502105 Bovine respiratory coronavirus 9
729 Haemophilus parainfluenzae 8
28037 Streptococcus mitis 8
38284 Corynebacterium accolens 8
502 Kingella denitrificans 7
2718 Cardiobacterium hominis 7
40214 Acinetobacter johnsonii 7
199310 Escherichia coli CFT073 7
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Table B4 continued: Clinical Case 2 - Pathoscope summary (thetaPrior ∈ (10,100).
Taxon identifier Scientific Name Final Best Hit Read Numbers
489 Neisseria polysaccharea 6
1282 Staphylococcus epidermidis 6
1827 Rhodococcus 6
29466 Veillonella parvula 5
511145 Escherichia coli str. K-12 substr. MG1655 5
1743 Propionibacterium 3
648 Aeromonas caviae 2
1270 Micrococcus luteus 2
331111 Escherichia coli E24377A 2
409438 Escherichia coli SE11 2
557600 Acinetobacter baumannii AB307-0294 2
1292 Staphylococcus warneri 1
502108 Bovine respiratory coronavirus AH187 1
696748 Actinobacillus suis H91-0380 1
698737 Staphylococcus lugdunensis HKU09-01 1
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Table B5: Mutations in the coronavirus sequence in the brain compared to the GenBank
KP198610 genotype E sequence.
POS REF ALT DEPTH EFFECT Nucleotide Amino Acid Gene
471 C T DP=5927 missense Cat/Tat p.His88Tyr/c.262C>T AJC98124.1
2462 C A DP=2672 missense ttC/ttA p.Phe751Leu/c.2253C>A AJC98124.1
3202 C T DP=2087 missense gCt/gTt p.Ala998Val/c.2993C>T AJC98124.1
3684 A G DP=1064 missense Aag/Gag p.Lys1159Glu/c.3475A>G AJC98124.1
4129 G A DP=945 missense gGt/gAt p.Gly1307Asp/c.3920G>A AJC98124.1
5753 G T DP=474 missense aaG/aaT p.Lys1848Asn/c.5544G>T AJC98124.1
6589 T C DP=273 missense gTt/gCt p.Val2127Ala/c.6380T>C AJC98124.1
8089 T G DP=104 missense tTt/tGt p.Phe2627Cys/c.7880T>G AJC98124.1
8463 G A DP=157 missense Gtt/Att p.Val2752Ile/c.8254G>A AJC98124.1
10864 A G DP=191 missense cAc/cGc p.His3552Arg/c.10655A>G AJC98124.1
11287 G A DP=90 missense cGt/cAt p.Arg3693His/c.11078G>A AJC98124.1
11919 A G DP=108 missense Agc/Ggc p.Ser3904Gly/c.11710A>G AJC98124.1
12547 A G DP=126 missense tAt/tGt p.Tyr4113Cys/c.12338A>G AJC98124.1
12738 C T DP=141 missense Ctt/Ttt p.Leu4177Phe/c.12529C>T AJC98124.1
13757 G A DP=142 missense Gta/Ata p.Val4517Ile/c.13549G>A AJC98124.1
20009 C G DP=143 missense Cag/Gag p.Gln6601Glu/c.19801C>G AJC98124.1
20207 G T DP=213 missense Gat/Tat p.Asp6667Tyr/c.19999G>T AJC98124.1
22037 A G DP=331 missense Aaa/Gaa p.Lys178Glu/c.532A>G ns2a
22537 T C DP=262 missense Tcc/Ccc p.Ser62Pro/c.184T>C HE
22577 G A DP=249 missense gGc/gAc p.Gly75Asp/c.224G>A HE
22829 T C DP=316 missense aTa/aCa p.Ile159Thr/c.476T>C HE
22850 A G DP=337 missense aAt/aGt p.Asn166Ser/c.497A>G HE
22871 C T DP=340 missense gCt/gTt p.Ala173Val/c.518C>T HE
22886 G A DP=342 missense cGa/cAa p.Arg178Gln/c.533G>A HE
23580 G T DP=329 missense ttG/ttT p.Leu409Phe/c.1227G>T HE
23736 A G DP=375 missense Ata/Gta p.Ile33Val/c.97A>G S
23996 T A DP=342 missense gaT/gaA p.Asp119Glu/c.357T>A S
24170 T A DP=481 missense caT/caA p.His177Gln/c.531T>A S
24432 G A DP=404 missense Gat/Aat p.Asp265Asn/c.793G>A S
24781 C T DP=581 missense gCa/gTa p.Ala381Val/c.1142C>T S
25077 C T DP=822 missense Ctt/Ttt p.Leu480Phe/c.1438C>T S
25608 A T DP=637 missense Aac/Tac p.Asn657Tyr/c.1969A>T S
25699 A G DP=450 missense cAt/cGt p.His687Arg/c.2060A>G S
25714 A T DP=514 missense tAt/tTt p.Tyr692Phe/c.2075A>T S
25789 C T DP=639 missense aCa/aTa p.Thr717Ile/c.2150C>T S
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Table B5: Mutations in the coronavirus sequence in the brain compared to the GenBank
KP198610 genotype E sequence.
POS REF ALT DEPTH EFFECT Nucleotide Amino Acid Gene
25924 A C DP=796 missense aAc/aCc p.Asn762Thr/c.2285A>C S
26152 T C DP=1030 missense tTa/tCa p.Leu838Ser/c.2513T>C S
26328 C T DP=645 missense Cct/Tct p.Pro897Ser/c.2689C>T S
26434 A C DP=887 missense gAg/gCg p.Glu932Ala/c.2795A>C S
27153 C A DP=1402 missense Cct/Act p.Pro1172Thr/c.3514C>A S
27348 C T DP=1338 missense Ccc/Tcc p.Pro1237Ser/c.3709C>T S
27444 T C DP=1647 missense Ttc/Ctc p.Phe1269Leu/c.3805T>C S
28225 G T DP=4918 missense Gta/Tta p.Val32Leu/c.94G>T E
28664 C T DP=7144 missense Ctc/Ttc p.Leu89Phe/c.265C>T M
29265 C T DP=7455 missense tCa/tTa p.Ser55Leu/c.164C>T N
29727 C T DP=7585 missense tCt/tTt p.Ser209Phe/c.626C>T N
29787 C T DP=7445 missense aCa/aTa p.Thr229Ile/c.686C>T N
287 A G DP=7745 silent gaA/gaG p.Glu26Glu/c.78A>G AJC98124.1
1334 A C DP=5910 silent ggA/ggC p.Gly375Gly/c.1125A>C AJC98124.1
2813 C T DP=2659 silent agC/agT p.Ser868Ser/c.2604C>T AJC98124.1
4574 C T DP=576 silent taC/taT p.Tyr1455Tyr/c.4365C>T AJC98124.1
5528 A G DP=358 silent gaA/gaG p.Glu1773Glu/c.5319A>G AJC98124.1
6704 C T DP=345 silent atC/atT p.Ile2165Ile/c.6495C>T AJC98124.1
7664 T C DP=215 silent gtT/gtC p.Val2485Val/c.7455T>C AJC98124.1
7823 C T DP=178 silent gcC/gcT p.Ala2538Ala/c.7614C>T AJC98124.1
9410 C T DP=127 silent aaC/aaT p.Asn3067Asn/c.9201C>T AJC98124.1
9668 C T DP=82 silent gtC/gtT p.Val3153Val/c.9459C>T AJC98124.1
9914 G T DP=82 silent ccG/ccT p.Pro3235Pro/c.9705G>T AJC98124.1
11927 C T DP=118 silent tgC/tgT p.Cys3906Cys/c.11718C>T AJC98124.1
13768 T C DP=108 silent ggT/ggC p.Gly4520Gly/c.13560T>C AJC98124.1
13783 T C DP=100 silent taT/taC p.Tyr4525Tyr/c.13575T>C AJC98124.1
13924 T C DP=76 silent ggT/ggC p.Gly4572Gly/c.13716T>C AJC98124.1
14197 G T DP=72 silent acG/acT p.Thr4663Thr/c.13989G>T AJC98124.1
14689 C T DP=92 silent acC/acT p.Thr4827Thr/c.14481C>T AJC98124.1
14812 C T DP=70 silent ggC/ggT p.Gly4868Gly/c.14604C>T AJC98124.1
15733 C T DP=143 silent caC/caT p.His5175His/c.15525C>T AJC98124.1
16651 T C DP=128 silent ggT/ggC p.Gly5481Gly/c.16443T>C AJC98124.1
17029 C T DP=132 silent caC/caT p.His5607His/c.16821C>T AJC98124.1
17107 G A DP=103 silent aaG/aaA p.Lys5633Lys/c.16899G>A AJC98124.1
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Table B5: Mutations in the coronavirus sequence in the brain compared to the GenBank
KP198610 genotype E sequence.
POS REF ALT DEPTH EFFECT Nucleotide Amino Acid Gene
21991 C T DP=247 silent ccC/ccT p.Pro162Pro/c.486C>T ns2a
23046 C T DP=227 silent atC/atT p.Ile231Ile/c.693C>T HE
23061 A T DP=267 silent tcA/tcT p.Ser236Ser/c.708A>T HE
23518 C T DP=413 silent Cta/Tta p.Leu389Leu/c.1165C>T HE
23544 C T DP=403 silent ctC/ctT p.Leu397Leu/c.1191C>T HE
24317 C T DP=453 silent acC/acT p.Thr226Thr/c.678C>T S
24698 G T DP=666 silent tcG/tcT p.Ser353Ser/c.1059G>T S
25199 C T DP=835 silent ggC/ggT p.Gly520Gly/c.1560C>T S
25718 T C DP=504 silent caT/caC p.His693His/c.2079T>C S
25721 C T DP=534 silent gcC/gcT p.Ala694Ala/c.2082C>T S
25769 C T DP=535 silent taC/taT p.Tyr710Tyr/c.2130C>T S
25946 C T DP=663 silent atC/atT p.Ile769Ile/c.2307C>T S
26009 G A DP=677 silent ttG/ttA p.Leu790Leu/c.2370G>A S
26030 T C DP=665 silent taT/taC p.Tyr797Tyr/c.2391T>C S
26096 C T DP=948 silent ccC/ccT p.Pro819Pro/c.2457C>T S
26216 A G DP=1096 silent gaA/gaG p.Glu859Glu/c.2577A>G S
26225 T C DP=1162 silent gaT/gaC p.Asp862Asp/c.2586T>C S
26267 T C DP=1123 silent gtT/gtC p.Val876Val/c.2628T>C S
26294 T C DP=951 silent ggT/ggC p.Gly885Gly/c.2655T>C S
26453 A T DP=728 silent acA/acT p.Thr938Thr/c.2814A>T S
26501 C T DP=694 silent ggC/ggT p.Gly954Gly/c.2862C>T S
26549 T C DP=875 silent taT/taC p.Tyr970Tyr/c.2910T>C S
26564 C T DP=922 silent acC/acT p.Thr975Thr/c.2925C>T S
26573 T C DP=930 silent agT/agC p.Ser978Ser/c.2934T>C S
26576 A G DP=931 silent ctA/ctG p.Leu979Leu/c.2937A>G S
27107 C T DP=1560 silent atC/atT p.Ile1156Ile/c.3468C>T S
28651 T C DP=6766 silent ggT/ggC p.Gly84Gly/c.252T>C M
28825 T C DP=7006 silent taT/taC p.Tyr142Tyr/c.426T>C M
29887 T C DP=7411 silent gtT/gtC p.Val262Val/c.786T>C N
30175 G A DP=7086 silent agG/agA p.Arg358Arg/c.1074G>A N
26 T A DP=1158
30454 C T DP=7269
30455 G T DP=7269
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Table B6: Stage II nPOD-V: metaMix summary profile for sample 6141. The RIN score was
6.7 and the duration of the disease for this case was 28 years.
taxonID scientName finalAssignments poster.prob
374840 Enterobacteria phage phiX174 sensu lato 192806 1
unknown unknown 47606 1
133448 Citrobacter youngae 11800 1
409438 Escherichia coli SE11 8180 1
199310 Escherichia coli CFT073 7711 1
2 Bacteria 4503 1
158877 Yokenella regensburgei 3070 1
13690 Sphingobium yanoikuyae 2060 1
69218 Enterobacter cancerogenus 1933 1
1747 Propionibacterium acnes 1545 1
155864 Escherichia coli O157:H7 str. EDL933 1383 1
47229 Massilia timonae 1375 1
511145 Escherichia coli str. K-12 substr. MG1655 1036 1
56946 Afipia broomeae 806 1
331111 Escherichia coli E24377A 769 1
618 Serratia odorifera 678 1
72556 Achromobacter piechaudii 662 1
85698 Achromobacter xylosoxidans 659 1
76832 Myroides odoratimimus 524 1
655817 Escherichia coli ABU 83972 412 1
158836 Enterobacter hormaechei 398 0.99
562 Escherichia coli 381 1
258 Sphingobacterium spiritivorum 361 1
1282 Staphylococcus epidermidis 341 1
1035 Afipia felis 320 1
847 Oxalobacter formigenes 296 1
76831 Myroides 279 1
9606 Homo sapiens 266 1
204525 Roseomonas cervicalis 245 0.99
1034 Afipia clevelandensis 223 1
469 Acinetobacter 218 1
28211 Alphaproteobacteria 198 1
1270 Micrococcus luteus 194 1
47671 Lautropia mirabilis 191 0.99
250 Chryseobacterium gleum 187 1
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Table B6 continued: Stage II nPOD-V: metaMix summary profile for sample 6141. The RIN
score was 6.7 and the duration of the disease for this case was 28 years.
taxonID scientName finalAssignments poster.prob
1833 Rhodococcus erythropolis 184 1
40215 Acinetobacter junii 177 1
488 Neisseria mucosa 172 1
43767 Rhodococcus hoagii 149 0.99
225324 Enhydrobacter aerosaccus 147 1
40214 Acinetobacter johnsonii 145 1
219314 Aeromicrobium marinum 144 1
1019 Capnocytophaga sputigena 140 1
816 Bacteroides 126 1
471 Acinetobacter calcoaceticus 115 1
546271 Selenomonas sputigena ATCC 35185 114 1
587 Providencia rettgeri 113 1
39488 [Eubacterium] hallii 96 1
300269 Shigella sonnei Ss046 95 1
29388 Staphylococcus capitis 90 1
386585 Escherichia coli O157:H7 str. Sakai 89 1
636 Edwardsiella tarda 89 1
28090 Acinetobacter lwoffii 86 1
548476 Corynebacterium aurimucosum ATCC 700975 86 0.96
607712 Neisseria shayeganii 81 0.98
1303 Streptococcus oralis 71 0.92
102862 Proteus penneri 70 0.94
103621 Actinomyces urogenitalis 69 0.99
126385 Providencia alcalifaciens 69 0.97
1351 Enterococcus faecalis 69 1
46503 Parabacteroides merdae 68 1
163665 Dysgonomonas mossii 63 0.96
569 Hafnia alvei 62 1
246787 Bacteroides cellulosilyticus 61 0.99
55884 Enterobacteria phage SfV 54 0.99
1292 Staphylococcus warneri 53 1
43675 Rothia mucilaginosa 51 0.99
29430 Acinetobacter haemolyticus 49 0.92
43768 Corynebacterium matruchotii 49 1
1290 Staphylococcus hominis 48 0.99
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Table B6 continued: Stage II nPOD-V: metaMix summary profile for sample 6141. The RIN
score was 6.7 and the duration of the disease for this case was 28 years.
taxonID scientName finalAssignments poster.prob
1343 Streptococcus vestibularis 47 0.98
158 Treponema denticola 43 0.97
362663 Escherichia coli 536 41 1
331112 Escherichia coli HS 39 1
100886 Catenibacterium mitsuokai 37 1
28037 Streptococcus mitis 37 0.99
364106 Escherichia coli UTI89 36 1
1305 Streptococcus sanguinis 35 0.99
1827 Rhodococcus 35 0.92
1743 Propionibacterium 34 0.99
194699 Bordetella phage BPP-1 29 0.98
90370 Salmonella enterica subsp. enterica serovar Typhi 27 1
198214 Shigella flexneri 2a str. 301 24 0.98
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Table B7: Stage III nPOD-V: metaMix summary profile for sample 6198. The RIN score was
3.1.
taxonID scientName finalAssignments poster.prob
unknown unknown 438481 1
374840 Enterobacteria phage phiX174 sensu lato 37139 1
2 Bacteria 3087 1
562 Escherichia coli 1583 1
47229 Massilia timonae 1272 1
1343 Streptococcus vestibularis 1222 1
1747 Propionibacterium acnes 1152 1
1034 Afipia clevelandensis 1093 1
56946 Afipia broomeae 1093 1
1035 Afipia felis 919 1
13690 Sphingobium yanoikuyae 552 1
69218 Enterobacter cancerogenus 495 1
199310 Escherichia coli CFT073 491 1
72556 Achromobacter piechaudii 439 1
409438 Escherichia coli SE11 421 1
85698 Achromobacter xylosoxidans 407 1
10090 Mus musculus 310 1
158877 Yokenella regensburgei 280 1
133448 Citrobacter youngae 261 1
9606 Homo sapiens 249 1
1304 Streptococcus salivarius 246 1
469 Acinetobacter 227 1
1033 Afipia 224 0.99
40214 Acinetobacter johnsonii 196 1
618 Serratia odorifera 183 0.97
471 Acinetobacter calcoaceticus 144 1
1305 Streptococcus sanguinis 105 1
488 Neisseria mucosa 95 1
41294 Bradyrhizobiaceae 89 1
511145 Escherichia coli str. K-12 substr. MG1655 87 1
204525 Roseomonas cervicalis 81 0.97
1303 Streptococcus oralis 80 0.98
28037 Streptococcus mitis 79 1
1301 Streptococcus 76 1
1282 Staphylococcus epidermidis 70 1
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Table B7 continued: Stage III nPOD-V: metaMix summary profile for sample 6198. The RIN
score was 3.1.
taxonID scientName finalAssignments poster.prob
40215 Acinetobacter junii 69 0.97
28090 Acinetobacter lwoffii 68 1
250 Chryseobacterium gleum 67 1
47671 Lautropia mirabilis 67 1
225324 Enhydrobacter aerosaccus 66 1
155864 Escherichia coli O157:H7 str. EDL933 65 0.99
267747 Propionibacterium acnes KPA171202 64 1
28211 Alphaproteobacteria 60 1
762948 Rothia dentocariosa ATCC 17931 56 0.98
1270 Micrococcus luteus 51 1
553199 Propionibacterium acnes SK137 49 0.98
43768 Corynebacterium matruchotii 47 1
331111 Escherichia coli E24377A 45 1
587 Providencia rettgeri 45 0.92
1833 Rhodococcus erythropolis 43 0.93
38304 Corynebacterium tuberculostearicum 39 0.97
39778 Veillonella dispar 29 0.95
470 Acinetobacter baumannii 21 0.91
Appendix C
Supplementary Text
Parameter setting for Phylogenetic Tree estimation
The following options were used for the construction of the phylogram: General Time Reversible model,
Bootstrap branch support of 100 replicates, optimized invariable sites and across site rate variation. The
tree searching operation used was the best of NNI snd SPR, with starting tree BioNJ and optimizing the
tree topology.
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